
<SEC-DOCUMENT>0001445866-16-002507.txt : 20160815
<SEC-HEADER>0001445866-16-002507.hdr.sgml : 20160815
<ACCEPTANCE-DATETIME>20160815160016
ACCESSION NUMBER:
CONFORMED SUBMISSION TYPE:
PUBLIC DOCUMENT COUNT:
CONFORMED PERIOD OF REPORT:
FILED AS OF DATE:
DATE AS OF CHANGE:
10-Q
42
20160630
0001445866-16-002507
20160815
20160815
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME:
CENTRAL INDEX KEY:
STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS
Growblox Sciences, Inc.
0001165320
[1311]
IRS NUMBER:
STATE OF INCORPORATION:
FISCAL YEAR END:
593733133
DE
0831
FILING VALUES:
FORM TYPE:
SEC ACT:
SEC FILE NUMBER: 000-55462
FILM NUMBER:
10-Q
1934 Act
161832445
BUSINESS ADDRESS:
STREET 1:
CITY:
STATE:
ZIP:
BUSINESS PHONE:
6450 CAMERON STREET #110A
LAS VEGAS
NV
89118
(844) 843-2569
MAIL ADDRESS:
STREET 1:
CITY:
STATE:
ZIP:
6450 CAMERON STREET #110A
LAS VEGAS
NV
89118
FORMER COMPANY:
FORMER CONFORMED NAME: Signature Exploration & Production Corp.
DATE OF NAME CHANGE:
20080602
FORMER COMPANY:
FORMER CONFORMED NAME: Diabetic Treatment Centers of America, Inc.
DATE OF NAME CHANGE:
20040812
FORMER COMPANY:
FORMER CONFORMED NAME: FLAGSTICK VENTURES INC
DATE OF NAME CHANGE:
20020117
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>growblox10q06302016.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: colonialfilings.com
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights
reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" 
text="#000000" bgcolor="#ffffff">
<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-BOTTOM: black 1px 
solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BACKGROUND-COLOR: 
#ffffff; MARGIN-RIGHT: auto" align="center">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">UNITED STATES</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECURITIES AND EXCHANGE 
COMMISSION</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Washington, 
D.C.&#160;&#160;20549</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">________________________</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FORM 10-Q</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">__________________________</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">(Mark One)</div>
<div>
<table id="zec9fca6417594bdfaa0f39fedbb9b857" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 6.66%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Wingdings; TEXT-ALIGN: left; LINE-
HEIGHT: 1.25">&#253;</div>
</td>
<td style="WIDTH: 93.34%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF 
THE SECURITIES EXCHANGE ACT OF 1934</div>
</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div>
<table id="z5a9b9cbc4cb54c62a9149b2fe428b29a" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">For the quarterly period ended June 30, 
2016</div>
</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div>
<table id="zeaae7550400a4f54993584e821e6a6d3" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 6.66%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="WIDTH: 93.34%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF 
THE SECURITIES EXCHANGE ACT OF 1934</div>
</td>
</tr>
</table>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">For the transition period from __________ to 
___________</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div>
<table id="z3ff0ee4abd4f41a7bb1dd963340b0ffc" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 100%; VERTICAL-ALIGN: top; BORDER-LEFT-
COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">Commission file number:&#160;&#160;<font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"><u><u>000-
55462</u></u></font></div>
</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, 
INC.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">(Exact name of registrant as specified in its 
charter)</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div>
<table id="z163914d929f84985b6471f59bd3a2c05" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 33.33%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Delaware</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">(State or other Jurisdiction of Incorporation 
or organization)</div>
</td>
<td style="WIDTH: 33.33%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 33.33%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">59-3733133</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">(IRS Employer I.D. No.)</div>
</td>
</tr>
</table>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3550 W. Teco Avenue</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Las Vegas, Nevada 
89118</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Phone: (866) 721-0297</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">(Address and telephone number of</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">principal executive offices)</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">N/A</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">(Former name, former address and former fiscal
year, if changed since last report<font style="FONT-SIZE: 10pt; FONT-FAMILY:
'Times New Roman', Times, serif; FONT-WEIGHT: bold">)</font></div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Indicate by check mark 
whether registrant (1) has filed all reports required to be filed by Section 13 
or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to file such 
reports), and (2) has been subject to such filing requirements for the past 90 
days.&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 
Wingdings">&#253;</font>&#160;&#160;Yes&#160;&#160;&#160;&#160;&#160;<font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">&#9744;</font>&#160;&#160;No</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Indicate by check mark 
whether the registrant has submitted electronically and posted on its corporate 
Web site, if any, every Interactive Data File required to be submitted and 
posted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) 
during the preceding 12 months (or for such shorter period that the registrant 
was required to submit and post such files). &#160;&#160;<font style="FONT-SIZE:
10pt; FONT-FAMILY: 
Wingdings">&#253;</font>&#160;&#160;Yes&#160;&#160;&#160;&#160;&#160;<font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">&#9744;</font>&#160;&#160;No</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Indicate by check mark 
whether the registrant is a large accelerated filer, an accelerated filer, a 
non-accelerated filer or a smaller reporting company. See the definitions of 
"large accelerated filer," "accelerated filer," and "smaller reporting company" 
in Rule 12b-2 of the Exchange Act.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div>
<table id="z5e7546dbee604a659b7d25072739b88c" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 25%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Large accelerated filer <font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">&#9744;</font>&#160;&#160;&#160;</div>
</td>
<td style="WIDTH: 16.6%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Accelerated filer <font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, 
serif">&#9744;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="WIDTH: 31.93%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Non-accelerated filer <font style="FONT-SIZE:
10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">(Do not check if a smaller Reporting 
Company)</div>
</td>
<td style="WIDTH: 26.14%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Smaller reporting company&#160;&#160;<font 
style="FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</font></div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
</table>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is
a shell company (as defined by Rule 12b-2 of the Act).&#160;&#160;<font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">&#9744;</font>&#160;&#160;Yes&#160;&#160;&#160;&#160;&#160;<font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 
Wingdings">&#253;</font>&#160;&#160;No&#160;&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">There were <font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif">64,495,701</font> shares of common 
stock, par value $0.0001 per share, outstanding as of August 9, 2016.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><img style="HEIGHT: 2px; 
WIDTH: 2px" src="image2.jpg"></div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: right; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, 
INC.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FORM 10-Q</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FOR THE QUARTERLY PERIOD 
ENDED JUNE 30, 2016</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="INDEX"><!--
Anchor--></a>INDEX</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div>
<table id="z2f2a2df330fc455a8b988eb167c6b4c4" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" 
cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 91.52%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PART I &#8211; FINANCIAL 
INFORMATION</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Page</div>
</td>
</tr>
<tr>
<td style="WIDTH: 91.52%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM1.FinancialStatements">Item 
1.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM1.FinancialStatements">Financial 
Statements</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM1.FinancialStatements">3</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#CONSOLIDATEDCONDENSEDBALA">Condensed 
Consolidated Balance Sheets at June 30, 2016 (unaudited) and March 31, 
2016</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#CONSOLIDATEDCONDENSEDBALA">3</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#STATEMENTSOFOPERATIONS">Condensed 
Consolidated Statements of Operations (unaudited) for the&#160;Three Months 
Ended June 30, 2016 and 2015</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a href="#STATEMENTSOFOPERATIONS">4</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#CONDENSEDCONSOLIDATEDSTAT">Condensed 
Consolidated Statements of Cash Flows (unaudited) for the Three Months Ended 
June 30, 2016 and 2015</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#CONDENSEDCONSOLIDATEDSTAT">5</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#NOTESTOCONDENSEDCONSOLIDA">Notes to 
Condensed Consolidated Financial Statements (unaudited)</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#NOTESTOCONDENSEDCONSOLIDA">6</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM2.UnregisteredSalesof">Item 
2.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a 
href="#ITEM2.UnregisteredSalesof">Management's Discussion and Analysis of 
Financial Condition and Results of Operations</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM2.UnregisteredSalesof">11</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM3.DefaultsUponSeniorS">Item 
3.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a 
href="#ITEM3.DefaultsUponSeniorS">Quantitative and Qualitative Disclosures About
Market Risk</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM3.DefaultsUponSeniorS">14</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM4.MineSafetyDisclosur">Item 
4.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM4.MineSafetyDisclosur">Controls 
and Procedures</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM4.MineSafetyDisclosur">14</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 91.52%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PART II &#8211; OTHER 
INFORMATION</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 91.52%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM1.LegalProceedings">Item 
1.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM1.LegalProceedings">Legal 
Proceedings</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a href="#ITEM1.LegalProceedings">16</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM1A.RiskFactors">Item 
1A&#160;</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM1A.RiskFactors">Risk 
Factors</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a href="#ITEM1A.RiskFactors">17</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM2.UnregisteredSalesof">Item 
2.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a 
href="#ITEM2.UnregisteredSalesof">Unregistered Sales of Equity Securities and 
Use of Proceeds</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM2.UnregisteredSalesof">17</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM3.DefaultsUponSeniorS">Item 
3.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM3.DefaultsUponSeniorS">Defaults 
Upon Senior Securities</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM3.DefaultsUponSeniorS">18</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM4.MineSafetyDisclosur">Item 
4.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM4.MineSafetyDisclosur">Mine Safety
Disclosures</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a 
href="#ITEM4.MineSafetyDisclosur">18</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM5.OtherInformation">Item 
5.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM5.OtherInformation">Other 
Information</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a href="#ITEM5.OtherInformation">18</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM6.Exhibits">Item 6.</a></div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><a href="#ITEM6.Exhibits">Exhibits</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a href="#ITEM6.Exhibits">19</a></div>
</td>
</tr>
<tr>
<td style="WIDTH: 9.4%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 82.53%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 91.52%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a 
href="#SIGNATURES">SIGNATURES</a></div>
</td>
<td style="WIDTH: 8.48%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25"><a href="#SIGNATURES">21</a></div>
</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
<!--Anchor--></div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times,
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>PART&#160;I. FINANCIAL 
INFORMATION</u></div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a 
name="ITEM1.FinancialStatements"><!--Anchor--></a>ITEM 1. Financial 
Statements</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div>
<table id="z4ff24faafe034189b713ca15ae7dd957" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" 
cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, INC. AND
SUBSIDIARIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a 
name="CONSOLIDATEDCONDENSEDBALA"><!--Anchor--></a>CONSOLIDATED CONDENSED BALANCE
SHEETS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">30-Jun-16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">31-Mar-16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">CURRENT ASSETS:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;Cash and 
cash equivalents</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">178,325</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">34,824</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;Accounts 
receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">67,862</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">67,862</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid 
expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">89,849</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">104,851</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">TOTAL CURRENT ASSETS</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">336,036</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">207,537</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Property and Equipment, Net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,935,172</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,953,048</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Deposits and Prepayments</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">269,560</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">271,455</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Other Assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">19,134</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">3,555</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">TOTAL ASSETS</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">3,559,902</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,435,595</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">CURRENT LIABILITIES:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Accounts Payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">762,577</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">902,123</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Accrued Interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">95,145</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">61,786</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Accrued Liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">844,815</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">834,348</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Notes Payable, net of 
unamortized discount of $0.3 million and $0.4 million at June 30, 2016 and March
31, 2016, respectively</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">499,847</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">463,532</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">&#160;&#160;&#160;&#160;TOTAL
CURRENT LIABILITIES</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,202,384</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,261,789</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr style="HEIGHT: 19px">
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Note Payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,020,195</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,148,556</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">TOTAL LIABILITIES</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">4,222,579</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">4,410,345</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Commitments and Contingencies (Note 7)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">STOCKHOLDERS' (DEFICIT)/ EQUITY:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Common Stock Common Stock, 
$0.0001 par value, 250,000,000 shares authorized, 57,973,614 and 47,335,147 
shares issued and outstanding at June 30, 2016 and March 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">5,797</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">4,733</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Deferred Stock 
Compensation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,318,827</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,240,662</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Additional Paid In 
Capital</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">19,180,234</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">16,638,318</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Accumulated Deficit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(22,120,731</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(20,779,860</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">TOTAL GROWBLOX SCIENCES, INC.
STOCKHOLDERS' (DEFICIT)/EQUITY</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(615,873</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,896,147</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Non-controlling 
interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(46,804</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(78,603</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">TOTAL (DEFICIT)/EQUITY</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(662,677</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,974,750</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">TOTAL LIABILITIES AND 
STOCKHOLDERS' (DEFICIT)/EQUITY</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">3,559,902</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">2,435,595</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" 
valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom"
nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" 
valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" 
colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of
these condensed consolidated financial statements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>
<div>&#160;</div>
<div>&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div>&#160;</div>
<div>&#160;</div>
<div>
<table id="z6baf4e155d914ad0871e451091ae2d68" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" 
cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, INC. AND
SUBSIDIARIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a 
name="STATEMENTSOFOPERATIONS"><!--Anchor--></a>STATEMENTS OF OPERATIONS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom" 
colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom" 
colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom" 
colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom" 
colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom" 
colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom" 
colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">For the Three Months Ended 
June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN:
center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN:
center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">NET REVENUE</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">GENERAL AND ADMINISTRATIVE EXPENSES</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,207,781</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,522,765</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">LOSS FROM OPERATIONS</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,207,781</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,522,765</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">OTHER INCOME (EXPENSE)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;Interest Expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(158,713</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(658</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Other Income/(Expense)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(12,416</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,219</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Total other expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(171,129</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">561</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">NET LOSS</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,378,910</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,522,204</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Net loss attributable to non-
controlling interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(38,201</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(180,456</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">NET LOSS ATTRIBUTABLE TO GROWBLOX SCIENCES, 
INC.</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,340,709</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,341,748</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Net loss per share - basic and 
diluted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(0.03</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(0.03</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Weighted average common shares 
outstanding - basic and diluted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">50,068,724</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">41,026,532</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" 
valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" 
valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" 
colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of
these consolidated condensed financial statements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>
<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>
<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div>&#160;</div>
<div>
<table id="z82dc70c8218040b0b126e793da268411" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" 
cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, INC. AND
SUBSIDIARIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a 
name="CONDENSEDCONSOLIDATEDSTAT"><!--Anchor--></a>CONDENSED CONSOLIDATED 
STATEMENTS OF CASH FLOWS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three Months Ended June 
30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">OPERATING ACTIVITIES:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Net income (loss)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,378,910</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,522,204</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;Adjustments to reconcile
net loss to net cash used in operating activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Depreciation and 
amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">46,761</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">43,519</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Stock-based 
compensation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">452,497</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">398,411</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Amortization of debt discount
and discount for beneficial conversion feature</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">125,174</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Loss on disposal</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">5,572</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Changes in operating assets 
and liabilities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Prepaid expenses and other 
assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">15,002</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(21,747</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(206,339</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(12,960</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(17,675</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">28,117</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 40pt">Net cash used in operating 
activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(957,918</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(1,086,864</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">INVESTING ACTIVITIES:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Purchase of property and 
equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(877,697</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(197,797</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Change in deposits</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(14,764</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(4,717</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 40pt">Net cash used in investing 
activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(892,461</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(202,514</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">FINANCING ACTIVITIES:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from issuance of 
common stock and warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,293,804</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,308,165</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from non-controlling
interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">70,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">300,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from notes 
payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">100,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Cash used to purchase 
warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">(56,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Other financing 
activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">630,076</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">&#160;&#160;&#160;Net cash 
provided by financing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,993,880</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">1,652,165</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Net change in cash and cash equivalent</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">143,501</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">362,787</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CASH AND CASH EQUIVALENT AT 
BEGINNING OF PERIOD</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">34,824</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CASH AND CASH EQUIVALENT AT 
END OF PERIOD</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">178,325</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; LINE-HEIGHT: 1.25">332,787</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Non-cash transactions:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Stock issued to settle 
payables</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">255,232</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Stock issued to upon partial 
conversion of long-term note payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">500,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Stock issued to settle 
advance</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-
HEIGHT: 1.25">150,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of
these consolidated condensed financial statements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>
<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a 
name="NOTESTOCONDENSEDCONSOLIDA"><!--Anchor--></a>NOTES TO CONDENSED 
CONSOLIDATED FINANCIAL STATEMENTS</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(UNAUDITED)</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 1 &#8211; <font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">Basis of Presentation and Significant Accounting Policies</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Basis of Presentation</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The accompanying unaudited interim condensed 
consolidated financial statements of Growblox Sciences, Inc. (the "Company," 
"We" or "Us") have been prepared in accordance with U.S. generally accepted 
accounting principles ("U.S. GAAP") for interim financial information and with 
the instructions to Form 10-Q and Article 8 of Regulations S-X.&#160; 
Accordingly, they do not include all of the information and footnotes required 
by U.S. GAAP for complete financial statements.&#160; In the opinion of 
management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included.&#160; Operating results 
for the periods presented are not necessarily indicative of the results that may
be expected for the year ending March 31, 2017. The balance sheet at March 31, 
2016 has been derived from the audited financial statements at that date but 
does not include all of the information and footnotes required by U.S. GAAP for 
complete financial statements. For further information, refer to the 
consolidated financial statements and footnotes thereto included in the 
Company's annual report on Form 10-K for the year ended March 31, 2016.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Principles of 
Consolidation</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The consolidated financial statements include 
all operating divisions and majority owned subsidiaries, reported as a single 
operating segment, for which we maintain controlling interests. Intercompany 
accounts and transactions have been eliminated in consolidation.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Use of Estimates</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The preparation of financial statements in 
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.&#160; Actual results could
differ from those estimates.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Reclassifications</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Certain reclassifications have been made to the 
comparative period amounts in order to conform to the current period 
presentation.&#160; These reclassifications had no effect on the reported 
financial position, results of operations or cash flows of the entity.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Significant Accounting 
Policies</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">A description of the Company's significant 
accounting policies is included in Note 3 of its Annual Report on Form 
10&#8211;K for the fiscal year ended March 31, 2016.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Recent 
Accounting Pronouncements</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In February 2016, the 
Financial Accounting Standards Board ("FASB") issued amended accounting guidance
that changes the accounting for leases and requires expanded disclosures about 
leasing activities. Under the new guidance, lessees will be required to 
recognize a right-of-use asset and a lease liability, measured on a discounted 
basis, at the commencement date for all leases with terms greater than twelve 
months. Lessor accounting will remain largely unchanged, other than certain 
targeted improvements intended to align lessor accounting with the lessee 
accounting model and with the updated revenue recognition guidance issued in 
2014. Lessees and lessors must apply a modified retrospective transition 
approach for leases existing at, or entered into after, the beginning of the 
earliest comparative period presented in the financial statements. The amended 
guidance is effective for annual reporting periods (including interim periods 
within those periods) beginning after December 15, 2018, and early application 
is permitted. The Company is currently evaluating the impact this guidance will 
have on its financial position and results of operations.</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Management does not believe
that any other recently issued but not yet effective accounting pronouncements, 
if adopted, would have a material effect on the accompanying consolidated 
financial statements.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 2 &#8211; Going 
Concern</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company's financial statements have been 
prepared assuming the Company will continue as a going concern. The Company has 
sustained net losses since inception, which have caused an accumulated deficit 
of approximately $22.1 million at June 30, 2016. In addition, the Company has 
consumed cash in its operating activities of approximately $1 million for the 
three months ended June 30, 2016 compared to $1.1 million for the same period 
last year. These factors, among others, raise substantial doubt about the 
Company's ability to continue as a going concern.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Management has been able, thus far, to finance 
the losses through a public offering, private placements and obtaining operating
funds from stockholders. The Company is continuing to seek sources of 
financing.&#160; There are no assurances that the Company will be successful in 
achieving its goals.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In view of these conditions, the Company's 
ability to continue as a going concern is dependent upon its ability to obtain 
additional financing or capital sources, to meet its financing requirements, and
ultimately to achieve profitable operations. Management believes that its 
current and future plans provide an opportunity to continue as a going concern. 
The accompanying financial statements do not include any adjustments relating to
the recoverability and classification of recorded assets, or the amounts and 
classification of liabilities that may be necessary in the event the Company is 
unable to continue as a going concern.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 3 &#8211; Convertible 
Notes</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In February 2016, the Company issued a short-
term Promissory Note ("Note") with a face value of $192,500 resulting in 
aggregate proceeds of $175,000 reflecting a 9.1% original discount and a nominal
rate of 10%. The Note is payable within one year of issuance and is convertible 
into 962,500 shares of the Company's common stock and 962,500 common stock 
purchase warrants at any time and from time to time before maturity at the 
option of the holder. Each warrant gives the Noteholder the right to purchase 
one share of common stock of the Company at an exercise price of $0.50 per share
for a period of three years.&#160; The beneficial conversion feature resulting 
from the discounted conversion price compared to the market price was calculated
based on the date of issuance to be $94,037 after adjusting the effective 
conversion price for the relative fair value of the note proceeds compared to 
the fair value of the attached warrants and note. In addition to this discount 
related to the beneficial conversion feature, an additional discount of $66,912 
was recorded based on the fair value of the 962,500 warrants attached to the 
note. This value was derived using the Black-Scholes valuation model. At June 
30, 2016, the Note had a balance of $0.09 million net of $0.1 million 
unamortized discount and beneficial conversion feature.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In March 2016, the Company issued a short-term 
Promissory Note ("Note") with a face value of $300,000 resulting in aggregate 
proceeds of $250,000 reflecting a 16.67% original discount and a nominal rate of
20%. The Note is payable within one year of issuance and is convertible into 
1,500,000 shares of the Company's common stock and 1,500,000 common stock to 
purchase warrants at any time and from time to time before maturity at the 
option of the holder. Each warrant gives the Noteholder the right to purchase 
one share of common stock of the Company at an exercise price of $0.50 per share
for a period of three years. The beneficial conversion feature resulting from 
the discounted conversion price compared to the market price was calculated 
based on the date of issuance to be $143,750 after adjusting the effective 
conversion price for the relative fair value of the note proceeds compared to 
the fair value of the attached warrants and note. In addition to this discount 
related to the beneficial conversion feature, an additional discount of $93,750 
was recorded based on the fair value of the 1,500,000 warrants attached to the 
note. At June 30, 2016, the Note had a balance of $0.1 million net of $0.2 
million unamortized discount and beneficial conversion feature.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Notes and Warrants were issued in reliance 
on the exemption from registration provided by Section&#160;4(2)&#160;of the 
Securities Act of 1933 (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times 
New Roman', Times, serif"><u>Securities Act</u></font>") and/or Rule 506 of 
Regulation D under the Securities Act, as amended.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 4&#8211; Note 
Payable</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company entered into a Note Purchase 
Agreement, dated May 12, 2015 and effective as of June 8, 2015, with Pacific 
Leaf Ventures, LP ("Pacific Leaf"), pursuant to which Pacific Leaf has made 
installment loans (the "Loans") to us in the aggregate amount of $1.75 million. 
The purpose of the financing is to provide for the acquisition and installation 
of an operating facility, equipment and other tangible assets by GBSN. Such 
facility and equipment will be dedicated to the cultivation of cannabis and the 
extraction of oils and other constituents present in cannabis, subject at all 
times to Nevada legal requirements. The note is convertible at the option of the
holder into common shares at a conversion price of $0.50, subject to anti-
dilution adjustments.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">To evidence the Loans, the Company issued to 
Pacific Leaf a 6% senior secured convertible promissory note (the "Note"), 
bearing interest at the rate of 6% per annum, payable quarterly. All outstanding
principal and interest due under the Note were due and payable on May 12, 2020. 
We were required to prepay the outstanding principal amount of the Note on a 
quarterly basis in an amount equal to 50% of the cash flow (accrued EBITDA) of 
GB Sciences Nevada, LLC ("GBSN") attributable to our percentage interest in GBSN
no later than the earlier to occur of (a) the fifth (5th) business day following
receipt of a distribution of the Company's Share of GBSN's EBITDA for the 
calendar quarter in question, or (b) thirty (30) days following the end of the 
calendar quarter in question, with the first such prepayment to be made not 
later than July 31, 2015 with respect to the quarter ending June 30, 2015. In 
order to induce the Pacific Leaf to extend the loan to the Company and to secure
the payment and performance of all of the Secured Obligations, the Company 
agreed to grant Secured Party a security interest in certain of its assets and 
enter into the lending agreement.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On February 8, 2016, the Company entered into 
the Amended and Restated 6% Senior Convertible Promissory Note ("Amended Note") 
with Pacific Leaf Ventures, LP ("Pacific Leaf").&#160; The amended agreement 
modifies the 6% Senior Secure Convertible Promissory Note dated May 12, 2015 and
effective as of June 8, 2015, in the principal amount of $1.75 million.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Per the terms of the amended agreement, Pacific 
Leaf may make up to $1.0 million in additional advances to the Company under the
Amended Note bringing the total in the aggregate to $2.75 million. The note is 
convertible at the option of the holder into common shares at a conversion price
of $0.25, subject to anti-dilution adjustments. The Company has an option to 
prepay the Amended Note, without premium or penalty, in whole or in part, with 
accrued interest to the date of such prepayment.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Until the payment in full of the Amended Note, 
the Investor or its designee shall have the option (the "Option") to purchase up
to a 20% membership interest in GBSN for a purchase price equal to $100,000 for 
each 2% of membership interest purchased (i.e., $1,000,000 if the Option is 
exercised in full), provided that the Option may not be exercised for less than 
a 1% membership interest in GBSN.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Amended Note, the Company
also entered into the Amended and Restated Royalty Agreement with Pacific Leaf 
dated and effective as of February 8, 2016.&#160; Per the terms of the Amended 
Royalty Agreement, the royalty rate at any time shall equal to the sum of (i) 
9.1%, and (ii) the percentage calculated by dividing the amount advanced in 
excess of $1.75 million by $1.0 million, multiplied by the gross revenues of 
GBSN.&#160; On the earlier of (i) the seventh anniversary of the royalty payment
date, or (ii) the date that all amounts outstanding under the Amended Note have 
been paid in full, the royalty rate shall be reduced by 50%.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 13, 2016 the Company received notice 
from Pacific Leaf Ventures, LP ("Pacific Leaf") that it had elected to convert 
$500,000 of the Company's indebtedness to Pacific Leaf Note into common stock of
the Company pursuant to the Amended and Restated 6% Senior Secured Convertible 
Promissory.&#160; Accordingly, the Company has issued 2,000,000 shares of its 
common stock ($500,000 converted at a price of $0.25 per share) to Pacific Leaf 
and the Company's indebtedness to Pacific Leaf pursuant to the Note has been 
reduced by $500,000. As of June 30, 2016, the total amount of installments 
received, net of conversion, is $2.02 million.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 5 &#8211; Property and 
Equipment</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment balances as of June 30, 
2016 and March 31, 2016:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div>
<table id="z8468d76eb71546239a2b27bcca6ba396" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" 
cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">As of June 
30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">As of March
31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Computer and software</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">151,748</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">151,748</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Machinery and 
equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">643,394</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">641,898</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Leaseholds</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">357,418</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">363,317</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Construction in 
progress</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">2,075,086</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">1,043,042</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">3,227,646</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">2,200,005</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Less accumulated 
depreciation and amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(292,474</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; 
TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid;
TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(246,957</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, 
net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">2,935,172</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double;
TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px 
double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">1,953,048</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: 
left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>
<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 6 &#8211; Capital 
Transactions</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">During the three months ended June 30, 2016, the
Company issued an aggregate of 835,967 shares of common stock in settlement and 
release of certain obligations owed by the Company to various persons and 
recorded related expenses of $0.3 million, as follows:</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z574b23bdc50b4c2caad76aab4f1afe26" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; WIDTH: 18pt; VERTICAL-
ALIGN: top; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">The Company issued 512,275 shares 
of its common stock in connection with the conversion of $0.2 million in 
indebtedness owed by us to various persons at a conversion price of 
approximately $0.38 per share.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc8db566e6f1c4495bdd1accd7ad0d4e3" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; WIDTH: 18pt; VERTICAL-
ALIGN: top; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">The Company issued 323,692 shares 
of common stock in connection with settlement of payroll liabilities owed by us 
to our executives at a conversion price of $0.19 per share. The Company recorded
approximately $0.1 million of compensation expense.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company issued 100,000 shares of common 
stock to employees and recorded an expense of $0.03 million.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On April 8, 2016, the Company issued 200,000 of 
its common shares to its former Chief Financial Officer, in exchange for a full 
dismissal with prejudice of all causes of action pending in the complaint filed 
against the Company on August 19, 2015.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company issued 50,000 shares in exchange for
consulting services and recorded a related expense of $0.02 million.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 13, 2016 the Company received notice 
from Pacific Leaf Ventures, LP ("Pacific Leaf") that it had elected to convert 
$500,000 of the Company's indebtedness to Pacific Leaf Note into common stock of
the Company pursuant to the Amended and Restated 6% Senior Secured Convertible 
Promissory.&#160; Accordingly, the Company has issued 2,000,000 shares of its 
common stock ($500,000 converted at a price of $0.25 per share) to Pacific 
Leaf.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">During three months ended June 30, 2016, the 
Company sold 7,425,500 units through a private placement at a price of $0.20 per
unit resulting in net proceeds of $1.3 million. &#160;Each unit consisted of one
share of common stock and one common stock purchase warrant, expiring in three 
years, with an exercise price of $0.50.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Options</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 1, 2016, we issued 900,000 stock options
under our 2014 Equity Incentive Plan to the independent members of the Company's
Board of Directors. The options are exercisable upon vesting for a period of 7 
years from issuance at an exercise price of $0.16 per share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 1, 2016, we issued 1,400,000 stock 
options under our 2014 Equity Incentive plan to our Chief Executive Officer. The
options are exercisable upon vesting for a period of 7 years from issuance at an
exercise price of $0.30 per share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 1, 2016, we issued 1,200,000 stock 
options under our 2014 Equity Incentive plan to our Chief Sciences Officer. The 
options are exercisable upon vesting for a period of 10 years from issuance at 
an exercise price of $0.30 per share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 30, 2016, we issued 200,000 stock 
options under our 2014 Equity Incentive Plan to various employees. The options 
are exercisable upon vesting for a period of 10 years from issuance at an 
exercise price of $0.30 per share.&#160; All of the foregoing securities were 
issued in reliance on the exemption from registration provided by 
Section&#160;4(a)(2)&#160;of the Securities Act of 1933 (the "<font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Securities 
Act</u></font>") and/or Rule 506 of Regulation D under the Securities Act, as 
amended.<br style="LINE-HEIGHT: 1.25">
</div>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 7 &#8211; Commitments 
and Contingencies</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #231f20; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-
HEIGHT: 1.25">Growblox Sciences, Inc.&#160; v. GCM Administrative Services, 
LLC</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On April 2, 2014, we commenced an action in the 
United States District Court for the Southern District of New York captioned 
Signature Exploration and Production Corporation v. GCM Administrative Services,
LLC, Strategic Turnaround Equity Partners, L.P. (Cayman), Seth M. Lukash, and 
Gary Herman, 14 Civ. 02280 (ER) (the "Action"). After the change of name of 
Signature Exploration and Production Corporation, the caption was amended to 
substitute GrowBlox Sciences, Inc. as the plaintiff. The complaint in the Action
sought a declaratory judgment that neither Lukash nor Herman was entitled to 
receive any interest in, including any shares of stock of, Growblox pursuant to 
certain share conversion rights held under promissory notes in the aggregate 
amount of $75,000, given by a related party of ours to the entity defendants GCM
and Strategic.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On May 9, 2014, defendants filed an answer 
denying the complaint's material allegations, and asserted a counterclaim 
against us, against persons identified as certain of our officers or directors, 
and against GrowOpp, LLC and Tumbleweed Holdings, Inc. On November 19, 2014, 
defendants filed an amended counterclaim, including a prayer for monetary relief
or damages in the sum of $9 million. We moved to dismiss the counterclaim and by
opinion dated June 2, 2015, the Court granted the motion in part and dismissed 
counts one and two (for declaratory judgment as to an alleged partnership or 
joint venture, and for breach of fiduciary duty predicated upon those 
allegations), and denied the motion in part, leaving counts three and four of 
the counterclaim standing. The Court viewed the third and fourth claims as a 
single claim for unjust enrichment, in which recovery would be based on quantum 
meruit, that is, upon the alleged value of any benefit conferred by defendants 
to us through alleged work and services rendered. In view of the fact that the 
pleading did not assign a particular value to that claim we are unable at 
present to advise what specific sum of money damages is sought. We did not 
challenge the fifth count of the counterclaim at this stage that seeks damages 
of $75,000 for alleged non-payment of the above-referenced promissory 
notes.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company and its adversaries entered an 
agreement in principle, subject to the execution of formal documents and dated 
as of June 20, 3016, to settle and dismiss the action. The Company's board 
approved the settlement on July 6, 2016. The parties are in the process of 
executing a formal, written settlement agreement. Under the settlement, the 
Company will deliver 1,400,000 shares of its common stock to its adversaries. 
Craig Ellins, formerly CEO of the Company and now its chief scientific officer, 
will deliver 3,000,000 shares that he owns personally. Based on our estimate of 
potential outcomes, we have accrued $0.5 million with respect to this matter as 
of June 30, 2016.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cathryn 
Kennedy Complaint Settlement</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On August 19, 2015, Cathryn Kennedy, our former 
Chief Financial Officer, filed a Complaint against us in the District Court in 
Clark County, Nevada alleging that she was assigned new duties by us which 
constituted a termination without cause effective July 24, 2015, and that as a 
consequence thereof she is entitled to severance, vacation pay and stock 
compensation from us pursuant to her Employment Agreement dated November 18, 
2014.&#160; On April 8, 2016, the Company entered into a mutual agreement with 
Cathryn Kennedy per terms of which the Company issued 200,000 of its 
unrestricted common shares in exchange for a full dismissal with prejudice of 
all causes of action pending in the above-referenced Complaint.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">From time to time, the Company also becomes 
involved in certain legal proceedings and claims which arise in the ordinary
course of business. In our opinion, based on consultations with outside counsel,
the results of any of these ordinary course matters, individually and in the 
aggregate, are not expected to have a material effect on our results of 
operations, financial condition, or cash flows. As more information becomes 
available, if management should determine that an unfavorable outcome is 
probable on such a claim and that the amount of such probable loss that it will 
incur on that claim is reasonably estimable, we will record a reserve for the 
claim in question. If and when we record such a reserve is recorded, it could be
material and could adversely impact our results of operations, financial 
condition, and cash flows.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Note 8 &#8211; Loss per 
Share</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25">The Company's basic loss per share has been 
calculated using the weighted average number of common shares outstanding during
the period. The Company had 31,359,167 and 27,558,334 of potentially dilutive 
common shares at June 30, 2016 and March 31, 2016, respectively.&#160; However, 
such common stock equivalents were not included in the computation of diluted 
net loss per share as their inclusion would have been anti-dilutive.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Note 9 &#8211; Subsequent 
Events</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #222222; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT:
1.25">GB Sciences Nevada LLC</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #333333; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: 
#ffffff">On July 21, 2016, an entity associated with Pacific Leaf Partners, LLC 
completed the purchase of the building housing the Company's cultivation 
facility at 3550 W. Teco Ave., Las Vegas, NV. In connection with the purchase, 
the Company entered into an amended lease agreement per the terms of which the 
initial term of the lease covering the facility was extended to ten years, with 
an optional five-year extension.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #333333; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: 
#ffffff">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #333333; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">On August 4, 2016, the </font><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#333333">Company </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; COLOR: #333333">entered into </font><font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the Second Omnibus 
Amendment ("Amendment") </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times
New Roman', Times, serif; COLOR: #333333">of its existing agreements with 
Pacific Leaf </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif">Ventures, LP ("Pacific Leaf").&#160; Principally, the 
Amendment</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; COLOR: #333333"> eliminates Pacific Leaf's option to </font><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">purchase 
up to a 20% membership interest in GB Sciences Nevada LLC ("GBSN")</font><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#222222"> and </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif">reduces</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif; COLOR: #222222">&#160;</font><font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#333333">Pacific Leaf's existing royalty</font><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif"> rate</font><font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #333333"> to 
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">16.4%. It also caps maximum aggregate </font><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #333333">royalty 
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">payments to be made </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif; COLOR: #333333">to Pacific Leaf </font><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">at 
$2,420,000 with respect to any calendar year. In consideration of the 
amended</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; COLOR: #000000"> terms</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif">, Pacific Leaf will receive 1,000,000 
shares of the Company's common stock and a five-year warrant to purchase 
1,500,000 shares of the Company's common stock at $0.36 per share.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #231f20; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-
HEIGHT: 1.25">Growblox Sciences, Inc.&#160; v. GCM Administrative Services, LLC 
Settlement</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">On August 9, 2016, the Company finalized a 
settlement agreement in final disposition of the lawsuit filed by the Company on
April 2, 2014, in the United States District Court for the Southern District of 
New York.&#160; The Company's obligation under the agreement is to issue 
1,400,000 shares</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; COLOR: #000000"> of </font><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">restricted common stock to certain
non-affiliates of the Company.</font></div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 
1.25">Executive Appointments</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">On August 5, 2016, the Company's Board of 
Directors accepted the resignation of John Poss as Chief Financial Officer of
the Company and appointed Ksenia Griswold as the Company's Vice President and 
Chief Financial Officer. Mr. Poss</font> will <font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">continue to serve as the 
President, Chief Executive Officer, and Chief Operating Officer of the Company. 
Ms. Griswold has been serving as the controller of the Company since November, 
2015.&#160; For the five years prior to that time beginning in October, 2010, 
she worked in the Las Vegas, Nevada office of Ernst &amp; Young, LLP.&#160; At 
the time of her departure from Ernst &amp; Young, she was audit manager.&#160; 
It is expected that an amendment to Ms. Griswold's employment agreement and 
compensation will be negotiated during the upcoming fiscal quarter.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left"><a name="ITEM2.ManagementsDiscussi"><!--Anchor--
></a>ITEM 2.<font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; 
DISPLAY: inline-block">&#160;</font><font id="TRGRRTFtoHTMLTab" style="FONT-
SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
9pt; DISPLAY: inline-block">&#160;</font>Management's Discussion and Analysis of
Financial Condition and Results of Operations</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The following discussion and
analysis contains "forward-looking statements," as defined in the United States 
Private Securities Litigation Reform Act of 1995. In some cases, you can 
identify forward-looking statements by terminology such as "may", "will", 
"should", "could", "expects", "plans", "intends", "anticipates", "believes", 
"estimates", "predicts" or "continue" , which list is not meant to be all-
inclusive and other such negative terms and comparable 
technology.&#160;&#160;These forward-looking statements, include, without 
limitation, statements about our market opportunity, our strategies, 
competition, expected activities and expenditures as we pursue our business 
plan, and the adequacy of our available cash resources. Although we believe the 
expectations reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance or 
achievements. Actual results may differ materially from the predictions 
discussed in these forward-looking statements.&#160;&#160;The economic 
environment within which we operate could materially affect our actual results. 
Additional factors that could materially affect these forward-looking statements
and/or predictions include among other things: (1)product demand, market and 
customer acceptance of Growblox Sciences products, equipment and other goods, 
(ii) ability to obtain financing to expand its operations, (iii) ability to 
attract qualified personnel, (iv)competition pricing and development 
difficulties, (v) general industry and market conditions and growth rates, 
unexpected natural disasters, and other factors, which we have little or no 
control: and other factors discussed in the Company's filings with the 
Securities and Exchange Commission ("SEC").&#160;The Company does not undertake 
any obligation to update forward-looking statements to reflect events or 
circumstances occurring after the date of this report.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The following discussion highlights the 
Company's results of operations and the principal factors that have affected our
financial condition, as well as our liquidity and capital resources for the 
periods described, and provides information that management believes is relevant
for an assessment and understanding of the statements of financial condition and
results of operations presented herein. The following discussion and analysis is
based on the Company's unaudited financial statements contained in this 
Quarterly Report, which we have prepared in accordance with United States 
generally accepted accounting principles. You should read this discussion and 
analysis together with such financial statements and the related notes 
thereto.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Overview</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company seeks to be an innovative technology
and solution company that converts the cannabis plant into medicines, therapies 
and treatments for a variety of ailments. The Company is developing and 
utilizing state of the art technologies in plant biology, cultivation and 
extraction techniques, combined with biotechnology, and plans to produce 
consistent and measurable medical-grade cannabis, cannabis concentrates and 
cannabinoid therapies.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Although we believe that maximum shareholder 
value will ultimately be achieved through the development, production and 
marketing of certified cannabinoid medicines, therapies and treatments, in order
to generate cash flow and near term profitability, we intend to cultivate and 
dispense cannabis for medical purposes in both Nevada and other states which 
permit such sales and in which we and our operating partners are able to obtain 
cultivation and dispensing licenses.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">We seek to become a trusted producer of 
consistent and efficacious medicinal strains and products, combining both 
cannabinoids and terpenes, which we intend to market in those states within the
United States and in other countries where the sale of medical cannabis products
are permitted. In addition, subject to obtaining Food and Drug Administrative 
(FDA) certification, we intend to market our cannabinoid based drug discoveries 
on a world-wide basis.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">We were incorporated in the State of Delaware on
April 4, 2001, under the name "Flagstick Venture, Inc." On March 28, 2008, 
stockholders owning a majority of our outstanding common stock approved changing
our then name "Signature Exploration and Production Corp." as our business model
had changed.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On March 13, 2014, we entered into a definitive 
assets purchase agreement for the acquisition of assets, including the 
Growblox(TM) cultivation technology which resulted in a change in our corporate 
name on April 4, 2014, from Signature Exploration and Production Corporation to 
Growblox Sciences, Inc.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Plan of Operation</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company will cultivate cannabis using 
innovative, but conventional methods in its wholly owned subsidiary, GB Sciences
Nevada, LLC ("GBSN").&#160; GBSN is in the final states of opening Phase 1 of an
approximately 28,000 sq. ft. facility in Las Vegas, Nevada.&#160; When all 
phases of construction are completed, the facility is expected to produce 6,800 
pounds of marijuana per year and generate revenues of $16.9 million, based on a 
projected wholesale price of $2,500 per pound.&#160; Completion of all Phases of
this facility is dependent upon the availability of capital to complete
construction. The Company has made completion of all Phases of this facility its
number one priority. In that connection, we have received every approval from 
licensing and occupancy permit that we have sought to date, and we expect to 
have our first crop growing in our state-of-the-art pharmaceutical grade 
cultivation rooms by October 1, 2016. Our first harvest will be approximately 10
weeks later.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">We expect our products to compete well in the 
marketplace because of the considerable efforts we have made in the plant 
genetics and tissue culturing of our proprietary strains of cannabis.&#160; And,
we are the exclusive Nevada grower of Kyle Kushman's proprietary marijuana 
strains which have been highly rated top sellers in California. Furthermore our 
ownership interest in the Showgrow dispensary on Fort Apache Boulevard in Las 
Vegas guarantees retail distribution of our products from that facility.&#160; 
Our products will have enough exposure to ensure that consumers can appreciate 
its quality and superiority compared to other brands.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The current emphasis on near-term cash flow 
allows us to plan for exploiting the potential of our science assets.&#160; We 
recently formed Growblox Life Sciences, LLC and have retained Fenwick &amp; 
West, a Silicon Valley based law firm focusing on life sciences and high 
technology companies with a nationally top-ranked intellectual property 
practice, to development strategies for the protection of the Company's 
intellectual property.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Our proprietary Growblox chambers, anticipated 
to be commercially ready during the second quarter of fiscal 2017 will enable us
to grow a 100% consistent and cost-effective pharmaceutical grade cannabis which
is important irrespective of its ultimate consumers; a consistent recreational 
brand will be as important to consumers as a consistent medicine will be to its 
patients. Ultimately, our science will enable us to identify and develop 
proprietary strains, which will provide us with raw materials for our soon to be
patented medical compounds.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">RESULTS OF OPERATIONS</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The following table sets forth certain of our 
Statements of Operations data:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div>
<table id="z50b5f911645946bc85fda535973e356f" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" 
cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three 
months ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" 
valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" 
valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN: middle" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenue</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">General and administrative 
expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">1,207,781</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">1,522,765</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other income/
(expense)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(171,129</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">561</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Loss attributable to non-
controlling interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(38,201</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(180,456</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 70%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff" 
valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif;
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net income/(loss)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(1,340,709</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" 
valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-
COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">(1,341,748</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-
COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>
</div>
<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Comparison of the Three 
Months Ended June 30, 2016 and 2015</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenues</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company has not achieved any operating 
revenues to date.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">General and administrative 
expenses</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">General and administrative expenses decreased 
$0.3 million to $1.2 million for the three months ended June 30, 2016 compared 
to $1.5 million for the three months ended June 30, 2015. The decrease in 
primarily attributable to $0.2 million decrease in consulting and advisory 
services related to development of our proprietary GrowBLOX Suites combined with
a $0.1 million decrease in legal expenses.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other expense</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Total other expense increased by $0.2 million 
compared to the same period in prior year. The increase in primarily due to the 
recognition of $0.03 million in accrued interest related to the Pacific Leaf 
Loan and $0.13 million amortization of the debt discount related to the 
beneficial conversion features discount recorded on the convertible debt.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">LIQUIDITY AND CAPITAL 
RESOURCES</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current Liquidity</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company will need additional capital to 
implement our strategies. There is no assurance that it will be able to raise 
the amount of capital needed for future growth plans. Even if financing is 
available, it may not be on terms that are acceptable. If unable to raise the 
necessary capital at the times required, the Company may have to materially 
change the business plan, including delaying implementation of aspects of the 
business plan or curtailing or abandoning the business plan. The Company 
represents a speculative investment and investors may lose all of their 
investment. In order to be able to achieve the strategic goals, the Company 
needs to further expand its business and financing activities. Based upon the
cash position, it is necessary to raise additional capital by the end of the 
next quarter in order to continue to fund current operations. These factors 
raise substantial doubt about the ability to continue as a going concern.&#160; 
The Company is pursuing several alternatives to address this situation, 
including the raising of additional funding through equity or debt financings. 
In order to finance existing operations and pay current liabilities over the 
next twelve months, the Company will need to raise approximately $4-5 million of
capital depending upon license status. No assurance can be given that the 
Company will be able to operate profitably on a consistent basis, or at all, in 
the future.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The principal sources of liquidity to date have 
been cash generated from sales of debt and equity securities and loans.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25">At June 30, 2016, cash was $0.18 million, 
other current assets excluding cash were $0.16 million and our working capital 
deficit was $1.9 million. At the same time, current liabilities were 
approximately $2.2 million, which consisted principally of $0.8 million in 
accrued liabilities, $0.8 million in accounts payable, and $0.5 million in notes
payable. At March 31, 2016, the Company had cash balance $0.03 million, other 
current assets excluding cash were $0.2 million and our working capital deficit 
was $2.1 million. Current liabilities were approximately $2.3 million, which 
consisted principally of $0.9 million in accounts payable, $0.8 million in 
accrued liabilities, and $0.5 million in notes payable. An improvement in our 
liquidity position at June 30, 2016 compared to March 31, 2016 is primarily 
attributable to the capital raised through private offerings.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Sources and Uses of 
Cash</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Operating 
Activities</u></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Net cash used in operating activities was $1 
million for the three months ended June 30, 2016, as compared to net cash used 
of $1.1 million for the three months ended June 30, 2015. We anticipate that 
cash flows from operations may be insufficient to fund business operations for 
the next twelve-month period. Accordingly, we will have to generate additional 
liquidity or cash flow to fund our current and anticipated operations. This will
likely require the sale of additional common stock or other securities. There is
no assurance that we will be able to realize any significant proceeds from such 
sales, if at all.</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman',
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Investing 
Activities</u></div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">During the three months ended June 30, 2016 and 
2015, the Company used $0.9 million and $0.2 million, respectively, of cash in 
investing activities. The cash used in investing activities during the three 
months ended June 30, 2016 and 2015 was primarily for the purchase of property 
and equipment.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Financing 
Activities</u></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">During the three months ended June 30, 2016 and 
2015, cash flows from financing activities totaled $2 million and $1.7 million, 
respectively. Cash flows from financing activities for the three months ended 
June 30, 2016 related primarily to $1.3 million in proceeds from the issuance of
common stock and warrants, $0.6 million in other financing activities consisting
primarily of deferred stock compensation, and $0.07 million in proceeds from 
non-controlling interests. Cash flows from financing activities for the three 
months ended June 30, 2015 related primarily to $1.3 million in proceeds from 
the issuance of common stock and warrants, $0.3 million in proceeds from non-
controlling interests, and $0.1 million in proceeds from notes payable.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">GOING CONCERN</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The unaudited interim financial statements have 
been prepared on a going concern basis which assumes that the Company will be 
able to realize assets and discharge liabilities in the normal course of 
business for the foreseeable future. The Company has incurred losses since 
inception resulting in an accumulated deficit of approximately $22.1 million as
of June 30, 2016, and further losses are anticipated in the development of the 
business raising substantial doubt about the ability to continue as a going 
concern. The ability to continue as a going concern is dependent upon generating
profitable operations in the future and/or obtaining the necessary financing to 
meet obligations and repay liabilities arising from normal business operations 
when they come due. Management intends to finance operating costs over the next 
twelve months with existing cash on hand and/or private placements of debt and 
equity securities. The financials do not include any adjustments relating to the
recoverability and reclassification of recorded asset amounts, or amounts and 
classifications of liabilities that might result from this uncertainty.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">VARIABLES AND TRENDS</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In the event the Company is able to obtain the 
necessary financing to progress with its business plan, the Company expects 
expenses to increase significantly to grow the business. Accordingly, the 
comparison of the financial data for the periods presented may not be a 
meaningful indicator of future performance and must be considered in light of 
these circumstances.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CRITICAL ACCOUNTING 
POLICIES</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">A description of the Company's significant 
accounting policies is included in Note 3 of its Annual Report on Form 
10&#8211;K for the fiscal year ended March 31, 2016.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM3.QuantitativeandQual"><!--Anchor--></a>ITEM 3.</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; FONT-WEIGHT: bold">Quantitative and Qualitative 
Disclosures About Market Risk</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">As a "smaller reporting company" as defined by 
Item 10 of Regulation S-K, the Company is not required to provide information 
required by this Item.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM4.ControlsandProcedur"><!--Anchor--></a>ITEM 4.</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; FONT-WEIGHT: bold">Controls and Procedures</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Evaluation of Disclosure 
Controls and Procedures</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company&#160;&#160;maintains disclosure 
controls and procedures that are designed to ensure that material information 
required to be disclosed in the periodic reports filed under the Securities 
Exchange Act of 1934, as amended, or 1934 Act, is recorded, processed, 
summarized, and reported within the time periods specified in the SEC's rules 
and forms and to ensure that such information is accumulated and communicated to
management, including the chief executive officer and chief financial officer as
appropriate, to allow timely decisions regarding required disclosure. At the end
of the quarter ended June 30, 2016, the Company carried out an evaluation, under
the supervision and with the participation of management, including the 
principal executive officer and the principal financial officer, of the 
effectiveness of the design and operation of disclosure controls and procedures,
as defined in Rule 13(a)-15(e) and Rule 15d-15(e) under the 1934 Act. Based on 
this evaluation, management concluded that as of June 30, 2016 the disclosure 
controls and procedures were not effective due to material weaknesses as no 
member of our board of directors qualifies as an "audit committee financial 
expert" as defined in Item 407(d)(5) of Regulation S-K promulgated under the 
Securities Act.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Limitations on Effectiveness 
of Controls and Procedures</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Management, including the Chief Executive
Officer (Principal Executive Officer) and Chief Financial Officer (Principal 
Financial Officer), does not expect that disclosure controls and procedures will
prevent all errors and all fraud. A control system, no matter how well conceived
and operated, can provide only reasonable, not absolute, assurance that the 
objectives of the control system are met. Further, the design of a control 
system must reflect the fact that there are resource constraints and the 
benefits of controls must be considered relative to their costs. Because of the 
inherent limitations in all control systems, no evaluation of controls can 
provide absolute assurance that all control issues and instances of fraud, if 
any, within the Company have been detected. These inherent limitations include, 
but are not limited to, the realities that judgments in decision-making can be 
faulty and that breakdowns can occur because of simple error or mistake. 
Additionally, controls can be circumvented by the individual acts of some 
persons, by collusion of two or more people, or by management override of the 
control. The design of any system of controls also is based in part upon certain
assumptions about the likelihood of future events and there can be no assurance 
that any design will succeed in achieving its stated goals under all potential 
future conditions. Over time, controls may become inadequate because of changes 
in conditions, or the degree of compliance with the policies or procedures may 
deteriorate. Because of the inherent limitations in a cost-effective control 
system, misstatements due to error or fraud may occur and not be detected.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Changes in Internal 
Controls</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">During the fiscal quarter ended June 30, 2016, 
there have been no changes in the internal controls over financial reporting 
that have materially affected or are reasonably likely to materially affect the 
internal controls over financial reporting.&#160;</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a 
name="PARTIIOTHERINFORMATION"><!--Anchor--></a>PART II &#8211; OTHER
INFORMATION</div>
<div style="LINE-HEIGHT: 1.25"><a name="ITEM1.LegalProceedings"><!--Anchor--
></a></div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">ITEM 
1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif; FONT-WEIGHT: bold">Legal 
Proceedings</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #231f20; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-
HEIGHT: 1.25">Growblox Sciences, Inc.&#160; v. GCM Administrative Services, 
LLC</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On April 2, 2014, we commenced an action in the 
United States District Court for the Southern District of New York captioned 
Signature Exploration and Production Corporation v. GCM Administrative Services,
LLC, Strategic Turnaround Equity Partners, L.P. (Cayman), Seth M. Lukash, and 
Gary Herman, 14 Civ. 02280 (ER) (the "Action"). After the change of name of 
Signature Exploration and Production Corporation, the caption was amended to 
substitute GrowBlox Sciences, Inc. as the plaintiff. The complaint in the Action
sought a declaratory judgment that neither Lukash nor Herman was entitled to 
receive any interest in, including any shares of stock of, Growblox pursuant to 
certain share conversion rights held under promissory notes in the aggregate 
amount of $75,000, given by a related party of ours to the entity defendants GCM
and Strategic.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On May 9, 2014, defendants filed an answer 
denying the complaint's material allegations, and asserted a counterclaim 
against us, against persons identified as certain of our officers or directors, 
and against GrowOpp, LLC and Tumbleweed Holdings, Inc. On November 19, 2014, 
defendants filed an amended counterclaim, including a prayer for monetary relief
or damages in the sum of $9 million. We moved to dismiss the counterclaim and by
opinion dated June 2, 2015, the Court granted the motion in part and dismissed 
counts one and two (for declaratory judgment as to an alleged partnership or 
joint venture, and for breach of fiduciary duty predicated upon those 
allegations), and denied the motion in part, leaving counts three and four of 
the counterclaim standing. The Court viewed the third and fourth claims as a 
single claim for unjust enrichment, in which recovery would be based on quantum 
meruit, that is, upon the alleged value of any benefit conferred by defendants 
to us through alleged work and services rendered. In view of the fact that the 
pleading did not assign a particular value to that claim we are unable at 
present to advise what specific sum of money damages is sought. We did not 
challenge the fifth count of the counterclaim at this stage that seeks damages 
of $75,000 for alleged non-payment of the above-referenced promissory 
notes.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Company and its adversaries entered an 
agreement in principle, subject to the execution of formal documents and dated 
as of June 20, 3016, to settle and dismiss the action. The Company's board 
approved the settlement on July 6, 2016. The parties are in the process of 
executing a formal, written settlement agreement. Under the settlement, the 
Company will deliver 1,400,000 shares of its common stock to its adversaries. 
Craig Ellins, formerly CEO of the Company and now its chief scientific officer, 
will deliver 3,000,000 shares that he owns personally. Based on our estimate of 
potential outcomes, we have accrued $0.5 million with respect to this matter as 
of June 30, 2016.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cathryn 
Kennedy Complaint Settlement</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On August 19, 2015, Cathryn Kennedy, our former 
Chief Financial Officer, filed a Complaint against us in the District Court in 
Clark County, Nevada alleging that she was assigned new duties by us which 
constituted a termination without cause effective July 24, 2015, and that as a 
consequence thereof she is entitled to severance, vacation pay and stock 
compensation from us pursuant to her Employment Agreement dated November 18, 
2014.&#160; On April 8, 2016, the Company entered into a mutual agreement with 
Cathryn Kennedy per terms of which the Company issued 200,000 of its 
unrestricted common shares in exchange for a full dismissal with prejudice of 
all causes of action pending in the above-referenced Complaint.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM1A.RiskFactors"><!--Anchor--></a>ITEM 1A.&#160; <font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New
Roman', Times, serif; FONT-WEIGHT: bold"><font id="TRGRRTFtoHTMLTab" 
style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font>Risk Factors</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">There are no material changes from the risk 
factors previously disclosed in the Company's Annual Report on Form 10-K for the
fiscal year ended March 31, 2016, as filed with the SEC.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM2.UnregisteredSalesof"><!--Anchor--></a>ITEM 2.&#160; <font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
9pt; DISPLAY: inline-block">&#160;</font><font id="TRGRRTFtoHTMLTab" 
style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New
Roman', Times, serif; FONT-WEIGHT: bold">Unregistered Sales of Equity Securities
and Use of Proceeds</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common Stock</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 13, 2016 the Company received notice 
from Pacific Leaf Ventures, LP ("Pacific Leaf") that it had elected to convert 
$500,000 of the Company's indebtedness to Pacific Leaf Note into common stock of
the Company pursuant to the Amended and Restated 6% Senior Secured Convertible 
Promissory.&#160; Accordingly, the Company has issued 2,000,000 shares of its 
common stock ($500,000 converted at a price of $0.25 per share) to Pacific 
Leaf.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25">During three months ended June 30, 2016, the 
Company sold 7,425,500 units through a private placement at a price of $0.20 per
unit resulting in net proceeds of $1.3 million. &#160;Each unit consisted of one
share of common stock and one common stock purchase warrant, expiring in three 
years, with an exercise price of $0.50.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Options</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 1, 2016, we issued 900,000 stock options
under our 2014 Equity Incentive Plan to the independent members of the Company's
Board of Directors. The options are exercisable upon vesting for a period of 7 
years from issuance at an exercise price of $0.16 per share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 1, 2016, we issued 1,400,000 stock 
options under our 2014 Equity Incentive plan to our Chief Executive Officer. The
options are exercisable upon vesting for a period of 7 years from issuance at an
exercise price of $0.30 per share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 1, 2016, we issued 1,200,000 stock 
options under our 2014 Equity Incentive plan to our Chief Sciences Officer. The 
options are exercisable upon vesting for a period of 10 years from issuance at 
an exercise price of $0.30 per share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">On June 30, 2016, we issued 200,000 stock 
options under our 2014 Equity Incentive Plan to various employees. The options 
are exercisable upon vesting for a period of 10 years from issuance at an 
exercise price of $0.30 per share.&#160; All of the foregoing securities were 
issued in reliance on the exemption from registration provided by 
Section&#160;4(a)(2)&#160;of the Securities Act of 1933 (the "<font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Securities 
Act</u></font>") and/or Rule 506 of Regulation D under the Securities Act, as 
amended.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">17</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM3.DefaultsUponSeniorS"><!--Anchor--></a>ITEM 3.</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; FONT-WEIGHT: bold">Defaults Upon Senior 
Securities</font></div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">None.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM4.MineSafetyDisclosur"><!--Anchor--></a>ITEM 4.</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; FONT-WEIGHT: bold">Mine Safety Disclosures</font></div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Not Applicable.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a 
name="ITEM5.OtherInformation"><!--Anchor--></a>ITEM 5.</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; FONT-WEIGHT: bold">Other Information</font></div>
<div style="LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT:
1.25">Board of Directors Expansion and Management Changes</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Effective April 29, 2016 
the Company's Board of Directors was expanded to five members. As a result of 
the expansion, the Board of Directors elected Leslie Bocskor, Shane Terry and 
John Poss to serve as Members of the Board of Directors for a term of three 
years to fill the three existing vacancies.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif; COLOR: #000000">The </font>Board of Directors 
also accepted the resignation of Craig Ellins as Chief Executive Officer of the 
Company and immediately appointed Craig Ellins to serve as Chief Innovation 
Officer of the Company.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The Board of Directors elected John Poss to 
serve as Chief Executive Officer until such time as the Board of Directors can 
identify and hire a suitable replacement. <font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Mr. Poss has been 
serving as the CFO of the Company since August, 2015 and its COO since December 
31, 2015.&#160;&#160;He will continue serving as CFO and COO until suitable 
replacements can be recruited.</font></div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: 
#ffffff">On June 1, 2016, the Board of Directors established compensation for 
outside directors to be $25,000 annually with an additional $1,000 for each 
meeting attended.&#160; The compensation is payable in cash or stock at the 
election of the Company.&#160; The outside directors also each received options 
to purchase 450,000 shares of stock which vest over 24 months.&#160; The strike 
price of the options is $0.16 per share, the market value of the Company's 
common stock on the date the outside directors were elected to the Board.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT:
1.25; BACKGROUND-COLOR: #ffffff">Amendments to the Executive Employment 
Agreements</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Pursuant to the appointment of Mr. Poss <font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000; BACKGROUND-COLOR: #ffffff">as the Company's President, Chief Executive 
Officer and Board Member, the Company entered into an Amended and Restated 
Employment Agreement, effective June 1, 2016.&#160; The agreement will end on 
May 1, 2017, which end date can be extended upon the mutual agreement of the 
parties.&#160; Under the agreement Mr. Poss will receive an annual salary of not
less than $120,000 and quarterly bonuses equal to the value of 125,000 shares of
Growblox common stock.&#160; Bonuses are payable in S-8 stock or cash in the 
discretion of the Company.&#160; Under the agreement, Mr. Poss will also receive
options to acquire 1,400,000 shares of the Company's common stock subject to 
certain vesting requirements.&#160; The option strike price is the market value 
of the stock on the date the options were granted.</font></div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Effective on June 1, 2016, 
the Company amended its employment agreement with its Chief Science Officer, 
Andrea Small-Howard.&#160; Pursuant to the amendment, Ms. Small-Howard 
surrendered a stock award for 450,000 shares of common stock in exchange for 
warrants to purchase 1.2 million common shares at the strike price of $0.30 per 
share.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Also on June 1, 2016, the 
Board amended compensation arrangements with Mr. Craig Ellins, the Chairman and 
Chief Innovation Officer of the Company.&#160; Pursuant to the amendment, 
warrants issued on June 22, 2015, for the purchase of 5,000,000 shares of common
stock of the Company at the exercise price of $0.45 per share were cancelled and
warrants for the purchase of 5,000,000 shares of common stock of the Company at 
the exercise price of $0.30 were issued to Mr. Ellins.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">18</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><br style="LINE-
HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 
1.25">Establishment of Audit and Compensation Committees</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Audit 
Committee</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On July 6, 2016, the 
Board established the Audit Committee and approved and adopted a charter (the 
"Audit Committee Charter") to govern the Audit Committee. The audit committee is
comprised of Leslie Bocskor and Shane Terry, each of whom is independent under 
the rules of the Securities and Exchange Commission and the Nasdaq Stock Market 
listing standards. Leslie Bocskor is designated the chairperson of the 
committee. In addition to the enumerated responsibilities of the Audit Committee
in the Audit Committee Charter, the primary function of the Audit Committee is 
to assist the Board in its general oversight of our accounting and financial 
reporting processes, audits of our financial statements, and internal control 
and audit functions.</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 
1.25">Compensation Committee</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On July 6, 2016, the 
Board established the Compensation Committee and approved and adopted a charter 
(the "Compensation Committee Charter"). The compensation committee is comprised 
of Leslie Bocskor and Shane Terry, each of whom is independent under the rules 
of the Securities and Exchange Commission and the Nasdaq Stock Market listing 
standards. Leslie Bocskor is designated the chairperson of the committee. In 
addition to the enumerated responsibilities of the Compensation Committee in the
Compensation Committee Charter, the primary function of the Compensation 
Committee is to oversee the compensation of our executives, produce an annual 
report on executive compensation for inclusion in our proxy statement, if and 
when required by applicable laws or regulations, and advise the Board on the 
adoption of policies that govern our compensation programs.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">ITEM 
6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif; FONT-WEIGHT: bold">Exhibits</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In reviewing the agreements included as exhibits
to this Form 10-Q, please remember that they are included to provide you with 
information regarding their terms and are not intended to provide any other 
factual or disclosure information about the Company or the other parties to the 
agreements. The agreements may contain representations and warranties by each of
the parties to the applicable agreement. These representations and warranties 
have been made solely for the benefit of the parties to the applicable agreement
and:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf3f43c5f439a4538985a4a3e9bcddbdc" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; WIDTH: 18pt; VERTICAL-
ALIGN: top; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">should not in all instances be 
treated as categorical statements of fact, but rather as a way of allocating the
risk to one of the parties if those statements prove to be inaccurate;</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3abd8827e95144f58db9e9bede5dfe89" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; WIDTH: 18pt; VERTICAL-
ALIGN: top; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">have been qualified by disclosures 
that were made to the other party in connection with the negotiation of the 
applicable agreement, which disclosures are not necessarily reflected in the 
agreement;</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1d52a4f0e77248c6995ecb7729875943" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; WIDTH: 18pt; VERTICAL-
ALIGN: top; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">may apply standards of materiality 
in a way that is different from what may be viewed as material to you or other 
investors; and</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zbfe14916e5d94da1bbb8be1c9ed0fd5d" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; WIDTH: 18pt; VERTICAL-
ALIGN: top; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">were made only as of the date of 
the applicable agreement or such other date or dates as may be specified in the 
agreement and are subject to more recent developments.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25">Accordingly, these representations and warranties
may not describe the actual state of affairs as of the date they were made or at
any other time. Additional information about the Company may be found elsewhere 
in this Form 10-Q and the Company's other public filings, which are available 
without charge through the SEC's website at http://www.sec.gov.</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">19</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">The following exhibits are included as part of 
this report:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div>
<table id="zbcebafb1621c48639e223bbfc8de77b7" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px 
solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Exhibit Number</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px 
solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Description of Exhibit</div>
</td>
</tr>
<tr style="HEIGHT: 5px">
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">3.1</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Articles of Incorporation (</font><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">Incorporated by reference to an exhibit to Form SB-2 No. 333-82580 filed 
with the Commission on February 12, 2002)</font></div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">3.2</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Amendment to Articles of Incorporation 
(</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">Incorporated by reference to Exhibit 3.2 to Form S-1/A No. 333-82580 
filed with the Commission on October 6, 2014 and Exhibit 3.2 to Form 10-K No. 
333-82580 filed with the Commission on June 27, 2014</font><font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">)</font></div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">3.3</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Bylaws (</font><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">Incorporated by reference to an 
exhibit to Form SB-2 No. 333-82580 filed with the Commission on February 12, 
2002</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">)</font></div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">10.1</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Pacific Leaf Ventures LP Second Omnibus 
Amendment and Waiver</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">31.1</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Certification of Principal Executive Officer and
Pursuant to Rule 13a-14</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">31.2</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Certification of Principal Financial Officer 
Pursuant to Rule 13a-14</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">32.1*</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">CEO Certification Pursuant to Section 906 of the
Sarbanes-Oxley Act</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">32.2*</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">CFO Certification Pursuant to Section 906 of the
Sarbanes-Oxley Act</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">101.INS</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">XBRL Instance Document</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">101.SCH</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Schema Document</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">101.CAL</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Calculation Linkbase 
Document</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">101.LAB</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Labels Linkbase 
Document</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">101.PRE</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Presentation Linkbase 
Document</div>
</td>
</tr>
<tr>
<td style="WIDTH: 11.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">101.DEF</div>
</td>
<td style="WIDTH: 1.28%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 87.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Definition Linkbase 
Document</div>
</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">* This certification is being furnished and 
shall not be deemed "filed" with the SEC for purposes of Section 18 of the 
Exchange Act, or otherwise subject to the liability of that section, and shall 
not be deemed to be incorporated by reference into any filing under the 
Securities Act or the Exchange Act, except to the extent that the registrant 
specifically incorporates it by reference</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">20</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
<div id="DSPFPageHeader" style="WIDTH: 100%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, 
serif"><a href="#INDEX">INDEX</a></div>
</div>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="SIGNATURES"><!--
Anchor--></a>SIGNATURES</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In accordance with the requirements of the 
Securities Exchange Act of 1934, the Registrant has caused this report to be 
signed on its behalf by the undersigned, thereunto duly authorized.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25">
<table id="z556974a7acf1497f996f280bd7a8d62a" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, INC.</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">August 15, 2016</div>
</td>
<td style="WIDTH: 3.84%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">By:</div>
</td>
<td style="WIDTH: 46.16%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px 
solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">/s/ John Poss</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">John Poss, Chief Executive Officer (Principal 
Executive Officer)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">GROWBLOX SCIENCES, INC.</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">August 15, 2016</div>
</td>
<td style="WIDTH: 3.84%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">By:</div>
</td>
<td style="WIDTH: 46.16%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px 
solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">/s/ Ksenia Griswold</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Ksenia Griswold, Chief Financial Officer 
(Principal Financial Officer)</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
</table>
</div>
<div></div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageFooter"></div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman',
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">21</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal"></font>
<div id="DSPFPageFooter"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: 
normal">&#160; </font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: colonialfilings.com
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights 
reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" 
text="#000000" bgcolor="#ffffff">
<div>
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, 
serif">Exhibit 10.1</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>SECOND OMNIBUS 
AMENDMENT</u></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">THIS SECOND OMNIBUS 
AMENDMENT (this "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Amendment</font>") is 
entered into as of August 4, 2016 (the "<font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: 
italic">Amendment Date</font>"), between Growblox Sciences, Inc., a Delaware 
corporation (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Company</font>"), <font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000; BACKGROUND-COLOR: #ffffff">GB Sciences Nevada LLC, a Nevada limited 
liability company ("</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New
Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; FONT-STYLE: italic;
BACKGROUND-COLOR: #ffffff">GBS Nevada</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; BACKGROUND-COLOR: 
#ffffff">") </font>and Pacific Leaf Ventures, LP (the "<font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-
STYLE: italic">Investor</font>").</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>R E C I T A L 
S</u></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">A.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The Company and the Investor are parties to 
that certain Note Purchase Agreement dated as of May 12, 2015 and made effective
June 8, 2015 (as amended from time to time, the "<font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: 
italic">Purchase Agreement</font>"), and a related Amended and Restated 6% 
Senior Secured Convertible Promissory Note in the nominal principal amount of 
$2,750,000 (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Note</font>").</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">B.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">GBS Nevada and the Investor are parties to that
certain Amended and Restated Royalty Agreement dated as of February 8, 2016 (the
"<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-WEIGHT: bold; FONT-STYLE: italic">Royalty Agreement</font>").&#160; Unless 
otherwise indicated herein, all capitalized terms used herein have the 
respective meanings set forth in the Purchase Agreement.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">C.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The Company, GBS Nevada and the Investor 
previously entered into an Omnibus Amendment and Waiver, dated as of February 8,
2016 (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif; FONT-WEIGHT: bold; FONT-STYLE: italic">First 
Amendment</font>").</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">D.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The Company, GBS Nevada and the Investor desire
to further amend the Royalty Agreement, the Note, and the First Amendment, and 
to enter into certain related agreements in connection therewith, as set forth 
in this Amendment.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">NOW, THEREFORE, in 
consideration of these premises and other valuable consideration, the receipt 
and adequacy of which are hereby acknowledged, the parties hereto agree, as 
follows:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Funding of the 
Note</u></font>.&#160; The Investor and the Company acknowledge and agree that 
the principal amount of loans advanced by the Investor to the Company under the 
Note as of the date hereof is $2,595,195, which amount includes (i) $75,000 of 
expenses incurred by the Investor at the Company's request in connection with 
the sale of the Teco F<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; COLOR: #000000; BACKGROUND-COLOR: #ffffff">acility, which 
expenses are hereby deemed to constitute advances to the Company under the Note,
and (ii) $500,000 of advances that have been converted to common stock of the 
Company.&#160; The Investor hereby commits to make additional advances to the 
Company under the Note in the aggregate amount of $154,805 no later than 
December 31, 2016 so that Investor shall have made aggregate advances to the 
Company under the Note in the amount of $2,750,000.</font></font></div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">2.<font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
9pt; DISPLAY: inline-block">&#160;</font><font id="TRGRRTFtoHTMLTab" 
style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><u>Amendment to Royalty Agreement</u></font>. <font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic">Section 1.2</font><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: 
italic">&#160;</font>of the Royalty Agreement is hereby amended and restated in 
its entirety to read as follows:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">"1.2&#160; <font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold"><u>Royalty Payments</u></font>.&#160; In consideration of the 
transfer by PACIFIC LEAF of the Intellectual Property pursuant to the Section 
1.1, and the Support provided by PACIFIC LEAF to GBS Nevada and GBS Delaware, 
during the period (the "Royalty Period") commencing on the Effective Date and 
ending ten (10) years after the date the first complete royalty payment in 
excess of twenty-five thousand dollars ($25,000) is actually made to PACIFIC 
LEAF with respect to any fiscal quarter under this Agreement (the "First Royalty
Payment Date"), GBS Nevada shall pay to PACIFIC LEAF within forty-five (45) days
after the end of each calendar quarter an amount equal to the Royalty Rate 
(defined below) multiplied by the gross sales revenues of GBS Nevada and its 
subsidiaries from all sources during the preceding fiscal quarter, including, 
without limitation (i) from the sale of cannabis produced at the Teco Facility, 
(ii) from the sale of</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">its cannabis at 
dispensaries operated by GBS Partners, and (iii) received by it in respect of 
the Profits Interest issued to under the GBS Partners Agreements.&#160; The 
Royalty Rate at any time shall be equal to 16.4%; <font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">provided, 
however</font>, that following the later of (i) the seventh anniversary of the 
First Royalty Payment Date, and (ii) the date that all amounts outstanding under
the Note have been repaid in full, the Royalty Rate shall be reduced to 
8.2%.&#160; Notwithstanding the foregoing, (i) the maximum aggregate royalty 
payments to be made to PACIFIC LEAF under this Agreement shall not exceed 
$2,420,000 with respect to any calendar year, and (ii) in the event the royalty 
payment required to be paid to PACIFIC LEAF with respect to any fiscal quarter 
exceeds GBS Nevada's Adjusted EBITDA (as defined below) for such quarter, GBS 
Delaware shall be entitled to defer the payment of such excess until the next 
royalty payment is to be made to PACIFIC LEAF hereunder for the succeeding 
calendar quarter.&#160; For the purposes hereof, "<font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: 
italic">Adjusted EBITDA</font>" means, with respect to any calendar quarter, 
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
COLOR: #000000">the sum of GBS Nevada's (i) net income, (ii) interest expense, 
(iii) income taxes, (iv) depreciation, and (v) amortization, minus the royalty 
payment to be made hereunder to </font>PACIFIC LEAF with respect to such 
calendar quarter.&#160; Adjusted EBITDA shall be <font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">calculated in 
accordance with U.S. generally accepted accounting principles and consistent 
with the Company's financial statements it files with the Securities and 
Exchange Commission.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Amendment to Note</u></font>. 
Section 3A(viii) of the Note (Management of GBS Nevada) Amendment is hereby 
deleted in its entirety.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Amendment to First Amendment 
Agreement</u></font>. Section 7 of the First Amendment (GBS Nevada Purchase 
Option) is hereby de</font></div>
<div style="text-align: justify; line-height: 1.25; font-size: 10pt; font-
family: 'Times New Roman', Times, serif;">leted in its entirety.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Disclosure of Non-public 
Information</u></font>.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif; COLOR: #000000">&#160; Each of the Company and GBS Nevada 
covenant and agree that until the Note has been repaid in full, unless the 
provisions of this paragraph are expressly waived in writing by the Investor (i)
neither the Company nor GBS Nevada shall disclose to the Investor any non-public
information with respect to the Company or any of its subsidiaries (including 
GBS Nevada) that could be deemed to be material to an investor in the common 
stock of the Company, and (ii) in the event the Company or GBS Nevada discloses 
such information to the Investor in violation of clause (i) above, the Company 
shall immediately disclose such information in a Current Report on Form 8-K 
filed with the Securities and Exchange Commission.</font></font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Issuance of Common Stock and 
Warrant</u></font>.&#160; In consideration of the agreements of the Investor 
under this Amendment, the Company shall issue to the Investor immediately 
following the execution of this Amendment (i) 1,000,000 shares of the Company's 
common stock, and (ii) a five-year warrant to purchase 1,500,000 shares of the 
Company's common stock at a price equal to the closing price of the common stock
on the date hereof, substantially in the form of Exhibit A hereto (which 
includes provisions for cashless exercise).</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Reaffirmation of Loan 
Documents</u></font>. Except as amended and modified hereby, all of the terms 
and provisions of the Purchase Agreement and the other Transaction Documents 
shall remain in full force and effect and are hereby in all respects ratified 
and confirmed by the Company.&#160; The Company hereby agrees that except as 
expressly provided in this Amendment, the amendments and modifications herein 
contained shall in no manner affect or impair the liabilities, duties and 
obligations of the Company under the Transaction Documents.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><u>Representations and 
Warranties</u></font>.&#160; As a material inducement for the Investor to enter
into this Amendment, the Company hereby represents and warrants to the Investor 
that after giving effect to this Amendment: (a) all representations and 
warranties in the Purchase Agreement and the other Transaction Documents are 
true and correct in all material respects, as though made on the date hereof, 
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-STYLE: italic">except</font> to the</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25">extent that (i)&#160;any of them speak to a 
different specific date or may have otherwise been made inaccurate by the mere 
passage of time; or (ii)&#160;the facts or circumstances on which any of them 
were based have been changed by transactions or events not prohibited by the 
Transaction Documents; (b)&#160;no Event of Default under the Note will exist 
after giving effect to this Amendment; and (c)&#160;this Amendment has been duly
authorized and approved by all necessary organizational action and requires the 
consent of no other person, and is binding and enforceable against the Company 
in accordance with its terms.&#160; The Company further represents and warrants 
to the Investor as of the date of this Amendment that (i) GBS Nevada holds a 
duly issued provisional certificate (the "<font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: 
italic">Certificate</font>") from the Division of Public &amp; Behavioral Health
of the Nevada Department of Health and Human Services to operate an 
establishment to cultivate medical cannabis at <font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; BACKGROUND-COLOR: 
#ffffff">3550 W. Teco Avenue, Las Vegas, Nevada, (ii) such Certificate is in 
good standing, (iii) GBS Nevada is in compliance with all applicable legal 
requirements for the issuance and maintenance of the Certificate, and (iv) 
neither the Company nor GBS Nevada has received any notice that such Certificate
may be revoked nor is any of them aware of any grounds for such 
revocation.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: 
#000000">9.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 
36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, 
serif"><u>Miscellaneous</u></font>.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z05dab0add46d47a18ae355329b8ce1f6" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">(a)</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">All of the terms and provisions 
of this Amendment shall bind and inure to the benefit of the parties hereto and 
their respective successors and assigns.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z98fa2b3d9c04416a8faa71320ffa3cc0" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">(b)</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">This Amendment may be executed 
in counterparts and by different parties hereto in separate counterparts each of
which when so executed and delivered shall be deemed an original, but all such 
counterparts together shall constitute but one and the same instrument; 
signature pages may be detached from multiple separate counterparts and attached
to a single counterpart so that all signature pages are physically attached to 
the same document.&#160; Delivery of photocopies of the signature pages to this 
Amendment by facsimile or electronic mail shall be effective as delivery of 
manually executed counterparts of this Amendment.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z55ec716a7dc54053bf59ad388d8326e6" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">(c)</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">The headings, captions and 
arrangements used in this Amendment are, unless specified otherwise, for 
convenience only and shall not be deemed to limit, amplify or modify the terms 
of this Amendment, nor affect the meaning thereof.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z0fd717ba40364af7a95c2540734fa5cb" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">(d)</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">Any provision of this Amendment 
held to be invalid, illegal or unenforceable in any jurisdiction shall, as to 
such jurisdiction, be ineffective to the extent of such invalidity, illegality 
or unenforceability without affecting the validity, legality and enforceability 
of the remaining provisions hereof; and the invalidity of a particular provision
in a particular jurisdiction shall not invalidate such provision in any other 
jurisdiction.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zf8d495d5c664429692fe8a40fd3f743d" class="DSPFListTable" style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" 
cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">(e)</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH:
auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">This Amendment shall be 
construed in accordance with and governed by the laws of the State of 
Delaware.</td>
</tr>
</table>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: center; LINE-HEIGHT: 1.25">[Signature Page Follows]</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">IN WITNESS WHEREOF, the 
parties hereto have executed this Amendment as of the date first set forth 
above.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; MARGIN-LEFT: 216pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">GROWBLOX 
SCIENCES, INC.</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><br>
</font><br style="LINE-HEIGHT: 1.25">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">By: </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-STYLE: italic"><u>/s/ John 
Poss&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;</u></font><font
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Name: John Poss<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><br>
</font>Title: President<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><br>
</font></div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; MARGIN-LEFT: 216pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif; FONT-WEIGHT: bold">GB SCIENCES NEVADA LLC</font><font style="FONT-SIZE: 
10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><br style="LINE-HEIGHT: 1.25">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">By: </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-STYLE: italic"><u>/s/ John 
Poss&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16
0;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 
&#160;&#160;&#160;</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times 
New Roman', Times, serif"><br>
</font>Name: John Poss<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><br>
</font>Title: President<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><br>
</font><br style="LINE-HEIGHT: 1.25">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif; FONT-WEIGHT: bold">PACIFIC LEAF VENTURES, LP</font><font style="FONT-
SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><br style="LINE-HEIGHT: 1.25">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">By: </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', 
Times, serif"><u>/</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times 
New Roman', Times, serif; FONT-STYLE: italic"><u>s/ Sean 
Harris&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#
160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 
</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif"><br>
</font>Name: Sean Harris<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif"><br>
</font> Title: Manager of General Partner</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: center; LINE-HEIGHT:
1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: center; LINE-HEIGHT: 
1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: center; LINE-HEIGHT: 
1.25">Signature Page to Second Omnibus Amendment</div>
</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font 
id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', 
Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: colonialfilings.com
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights 
reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" 
text="#000000" bgcolor="#ffffff">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Exhibit 31.1</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION OF PRINCIPAL 
EXECUTIVE AND FINANCIAL OFFICER&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO SECTION 302 OF 
THE SARBANES-OXLEY ACT OF 2002</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">I, John Poss, certify 
that:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">I have reviewed this quarterly report on Form 
10-Q of Growblox Sciences, Inc.;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Based on my knowledge, the quarterly report 
does not contain any untrue statement of material fact or omit to state a 
material fact necessary to make the statements made, in light of the 
circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Based on my knowledge, the financial 
statements, and other financial information included in this quarterly report, 
fairly present in all material respects the financial condition, results of 
operations and cash flows of the registrant as of and for the periods presented 
in this report;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The registrant's other certifying officer and I
are responsible for establishing and maintaining disclosure controls and 
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 
internal control over financial reporting (as defined in Exchange Act Rules 13a-
15(f) and 15d-15(f)) for the registrant and have:</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Designed such disclosure controls and 
procedures, or caused such disclosure controls and procedures to be designed 
under our supervision, to ensure that material information relating to the 
registrant, including its consolidated subsidiaries, is made known to us by 
others within those entities, particularly during the period in which this 
report is being prepared;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Designed such internal control over financial 
reporting, or caused such internal control over financial reporting to be 
designed under our supervision, to provide reasonable assurance regarding the 
reliability of financial reporting and the preparation of financial statements 
for external purposes in accordance with generally accepted accounting 
principles;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Evaluated the effectiveness of the registrant's
disclosure controls and procedures; and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Disclosed in this report any change in the 
registrant's internal control over financial reporting that occurred during the 
registrant's most recent fiscal quarter that has materially affected, or is 
reasonably likely to materially affect, the registrant's internal control over 
financial reporting; and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The registrant's other certifying officer and I
have disclosed, based on our most recent evaluation of internal control over 
financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent 
function):</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">All significant deficiencies and material 
weaknesses in the design or operation of internal control over financial 
reporting which are reasonably likely to adversely affect the registrant's 
ability to record, process, summarize and report financial information; 
and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">any fraud, whether or not material, that
involves management or other employees who have a significant role in the 
registrant's internal controls.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<table id="zb1f52150cd024ad3b63ddcc4697594a9" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Date:&#160;&#160;August 15, 2016</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">/s/ John Poss</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">John Poss, Chief Executive Officer (Principal 
Executive Officer)</div>
</td>
</tr>
</table>
</div>
<div>&#160;</div>
<div>&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: colonialfilings.com
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights 
reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" 
text="#000000" bgcolor="#ffffff">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Exhibit 31.2</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION OF PRINCIPAL 
EXECUTIVE AND FINANCIAL OFFICER</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO SECTION 302 OF 
THE SARBANES-OXLEY ACT OF 2002</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">I, Ksenia Griswold, certify 
that:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">I have reviewed this quarterly report on Form 
10-Q of Growblox Sciences, Inc.;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Based on my knowledge, the quarterly report 
does not contain any untrue statement of material fact or omit to state a 
material fact necessary to make the statements made, in light of the 
circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Based on my knowledge, the financial 
statements, and other financial information included in this quarterly report, 
fairly present in all material respects the financial condition, results of 
operations and cash flows of the registrant as of and for the periods presented 
in this report;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The registrant's other certifying officer and I
are responsible for establishing and maintaining disclosure controls and 
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules 13a-
15(f) and 15d-15(f)) for the registrant and have:</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Designed such disclosure controls and 
procedures, or caused such disclosure controls and procedures to be designed 
under our supervision, to ensure that material information relating to the 
registrant, including its consolidated subsidiaries, is made known to us by 
others within those entities, particularly during the period in which this 
report is being prepared;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Designed such internal control over financial 
reporting, or caused such internal control over financial reporting to be 
designed under our supervision, to provide reasonable assurance regarding the 
reliability of financial reporting and the preparation of financial statements 
for external purposes in accordance with generally accepted accounting 
principles;</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Evaluated the effectiveness of the registrant's
disclosure controls and procedures; and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">Disclosed in this report any change in the 
registrant's internal control over financial reporting that occurred during the 
registrant's most recent fiscal quarter that has materially affected, or is 
reasonably likely to materially affect, the registrant's internal control over 
financial reporting; and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; 
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">The registrant's other certifying officer and I
have disclosed, based on our most recent evaluation of internal control over 
financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent 
function):</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">All significant deficiencies and material 
weaknesses in the design or operation of internal control over financial 
reporting which are reasonably likely to adversely affect the registrant's 
ability to record, process, summarize and report financial information; 
and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 63pt"><font 
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, 
serif">(b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 45pt;
DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 
'Times New Roman', Times, serif">any fraud, whether or not material, that 
involves management or other employees who have a significant role in the 
registrant's internal controls.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<table id="z207c5441b9754b59aff952f5acd73e19" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr style="HEIGHT: 19px">
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Date:&#160;&#160;August 15, 2016</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">/s/&#160;Ksenia 
Griswold</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Ksenia Griswold, Chief Financial Officer 
(Principal Financial Officer)</div>
</td>
</tr>
</table>
</div>
<div>&#160;</div>
<div>&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: colonialfilings.com
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights 
reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" 
text="#000000" bgcolor="#ffffff">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Exhibit 32.1</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350,</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT 
TO</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 906 OF THE 
SARBANES-OXLEY ACT OF 2002</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Quarterly Report of 
Growblox Sciences, Inc. (the "Company") on Form 10-Q for the quarter ended June 
30, 2016 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, John Poss, Chief Executive Officer of the Company, certify, 
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the 
Sarbanes-Oxley Act of 2002, that:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">(1)</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif">The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">(2)</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif">The information contained in the Report fairly presents, 
in all material respects, the financial condition and results of operations of 
the Company.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">A signed original of this written statement 
required by Section 906 has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange Commission or its staff
upon request.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<table id="z5b8d5f60b4474f35b26cad832958f837" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Date:&#160;&#160;August 15, 2016</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">/s/ John Poss</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">John Poss, Chief Executive Officer (Principal 
Executive&#160;&#160;Officer)</div>
</td>
</tr>
</table>
</div>
<div>&#160;</div>
<div>&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex322.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: colonialfilings.com
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights 
reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" 
text="#000000" bgcolor="#ffffff">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Exhibit 32.2</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350,</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT 
TO</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 906 OF THE 
SARBANES-OXLEY ACT OF 2002</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-
align: left; line-height: 1.25;">In connection with the Quarterly Report of 
Growblox Sciences, Inc. (the "Company") on Form 10-Q for the quarter ended June 
30, 2016 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman',
Times, serif">Ksenia Griswold</font>, Chief Financial Officer of the Company, 
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 
of the Sarbanes-Oxley Act of 2002, that:</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">(1)</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New 
Roman', Times, serif">The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; 
FONT-FAMILY: 'Times New Roman', Times, serif">(2)</font><font 
id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-
block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New
Roman', Times, serif">The information contained in the Report fairly presents, 
in all material respects, the financial condition and results of operations of 
the Company.</font></div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">A signed original of this written statement 
required by Section 906 has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange Commission or its staff
upon request.</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>
<table id="zd030342cab9c4e2fa5e12e7c194a9bfa" style="FONT-SIZE: 10pt; FONT-
FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 50.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">Date:&#160;&#160;August 15, 2016</div>
</td>
<td style="WIDTH: 49.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">/s/ Ksenia Griswold</div>
</td>
</tr>
<tr>
<td style="WIDTH: 50.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-
ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 49.8%; VERTICAL-ALIGN: top; FONT-STYLE: normal">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-
align: left; line-height: 1.25;">Ksenia Griswold, Chief Financial Officer 
(Principal Financial Officer)</div>
</td>
</tr>
</table>
</div>
<div>&#160;</div>
<div>&#160;</div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR:
both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 
100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; 
BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>gblx-20160630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., 
Copyright (C) 2008-2016 [PPXCRNPC214XVNLVLZZU]. www.edgarsuite.com -->
<xbrl xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' 
xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-
gaap/2015-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' 
xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' 
xmlns:fil='http://www.growbloxsciences.com/20160630' 
xmlns:xlink='http://www.w3.org/1999/xlink' 
xmlns:utr='http://www.xbrl.org/2009/utr' 
xmlns:num='http://www.xbrl.org/dtr/type/numeric' 
xmlns:link='http://www.xbrl.org/2003/linkbase' 
xmlns:iso4217='http://www.xbrl.org/2003/iso4217' 
xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' 
xmlns:xbrli='http://www.xbrl.org/2003/instance'>
<link:schemaRef xlink:type='simple' xlink:href='gblx-20160630.xsd' />
<us-gaap:Revenues xsi:nil='true' contextRef='Y16Q2' unitRef='USD' />
<us-gaap:Revenues xsi:nil='true' contextRef='Y15Q2' unitRef='USD' />
<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y16Q2'
unitRef='USD'>1207781</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y15Q2'
unitRef='USD'>1522765</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='Y16Q2'
unitRef='USD'>-1207781</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='Y15Q2'
unitRef='USD'>-1522765</us-gaap:OperatingIncomeLoss>
<us-gaap:InterestExpense decimals='INF' contextRef='Y16Q2'
unitRef='USD'>158713</us-gaap:InterestExpense>
<us-gaap:InterestExpense decimals='INF' contextRef='Y15Q2'
unitRef='USD'>658</us-gaap:InterestExpense>
<us-gaap:OtherNonoperatingIncomeExpense decimals='INF' contextRef='Y16Q2'
unitRef='USD'>-12416</us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense decimals='INF' contextRef='Y15Q2'
unitRef='USD'>1219</us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='Y16Q2'
unitRef='USD'>-171129</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='Y15Q2'
unitRef='USD'>561</us-gaap:NonoperatingIncomeExpense>
<us-gaap:IncomeLossAttributableToNoncontrollingInterest decimals='INF'
contextRef='Y16Q2' unitRef='USD'>-38201</us-
gaap:IncomeLossAttributableToNoncontrollingInterest>
<us-gaap:IncomeLossAttributableToNoncontrollingInterest decimals='INF'
contextRef='Y15Q2' unitRef='USD'>-180456</us-
gaap:IncomeLossAttributableToNoncontrollingInterest>
<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y16Q2' unitRef='USD'>-
1340709</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y15Q2' unitRef='USD'>-
1341748</us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y16Q2'
unitRef='UsdPerShare'>-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y15Q2'
unitRef='UsdPerShare'>-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
decimals='INF' contextRef='Y16Q2' unitRef='Shares'>50068724</us-
gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
decimals='INF' contextRef='Y15Q2' unitRef='Shares'>41026532</us-
gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF'
contextRef='E16Q2' unitRef='UsdPerShare'>0.0001</us-
gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF'
contextRef='E16Q1' unitRef='UsdPerShare'>0.0001</us-
gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E16Q2'
unitRef='Shares'>250000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E16Q1'
unitRef='Shares'>250000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E16Q2'
unitRef='Shares'>57973614</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E16Q1'
unitRef='Shares'>47335147</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16Q2'
unitRef='Shares'>57973614</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16Q1'
unitRef='Shares'>47335147</us-gaap:CommonStockSharesOutstanding>
<us-gaap:DebtInstrumentUnamortizedDiscount decimals='INF'
contextRef='E16Q2' unitRef='USD'>300000</us-
gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentUnamortizedDiscount decimals='INF'
contextRef='E16Q1' unitRef='USD'>400000</us-
gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:ProfitLoss decimals='INF' contextRef='Y16Q2' unitRef='USD'>-
1378910</us-gaap:ProfitLoss>
<us-gaap:ProfitLoss decimals='INF' contextRef='Y15Q2' unitRef='USD'>-
1522204</us-gaap:ProfitLoss>
<us-gaap:DepreciationAndAmortization decimals='INF' contextRef='Y16Q2'
unitRef='USD'>46761</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization decimals='INF' contextRef='Y15Q2'
unitRef='USD'>43519</us-gaap:DepreciationAndAmortization>
<us-gaap:ShareBasedCompensation decimals='INF' contextRef='Y16Q2'
unitRef='USD'>452497</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation decimals='INF' contextRef='Y15Q2'
unitRef='USD'>398411</us-gaap:ShareBasedCompensation>
<us-gaap:AmortizationOfDebtDiscountPremium decimals='INF'
contextRef='Y16Q2' unitRef='USD'>125174</us-
gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
decimals='INF' contextRef='Y16Q2' unitRef='USD'>-5572</us-
gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
decimals='INF' contextRef='Y16Q2' unitRef='USD'>-15002</us-
gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
decimals='INF' contextRef='Y15Q2' unitRef='USD'>21747</us-
gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF'
contextRef='Y16Q2' unitRef='USD'>-206339</us-
gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF'
contextRef='Y15Q2' unitRef='USD'>-12960</us-
gaap:IncreaseDecreaseInAccountsPayable>
contextRef='Y16Q2' unitRef='USD'>-17675</us-
gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF'
<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF'
contextRef='Y15Q2' unitRef='USD'>28117</us-
gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals='INF'
contextRef='Y16Q2' unitRef='USD'>877697</us-
gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals='INF'
contextRef='Y15Q2' unitRef='USD'>197797</us-
gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:IncreaseDecreaseInDepositOtherAssets decimals='INF'
contextRef='Y16Q2' unitRef='USD'>14764</us-
gaap:IncreaseDecreaseInDepositOtherAssets>
<us-gaap:IncreaseDecreaseInDepositOtherAssets decimals='INF'
contextRef='Y15Q2' unitRef='USD'>4717</us-
gaap:IncreaseDecreaseInDepositOtherAssets>
<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF'
contextRef='Y16Q2' unitRef='USD'>-892461</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF'
contextRef='Y15Q2' unitRef='USD'>-202514</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF'
contextRef='Y16Q2' unitRef='USD'>1293804</us-
gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF'
contextRef='Y15Q2' unitRef='USD'>1308165</us-
gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromMinorityShareholders decimals='INF'
contextRef='Y16Q2' unitRef='USD'>70000</us-
gaap:ProceedsFromMinorityShareholders>
<us-gaap:ProceedsFromMinorityShareholders decimals='INF'
contextRef='Y15Q2' unitRef='USD'>300000</us-
gaap:ProceedsFromMinorityShareholders>
<us-gaap:StockIssued1 decimals='INF' contextRef='Y16Q2'
unitRef='USD'>255232</us-gaap:StockIssued1>
<us-gaap:ConversionOfStockAmountIssued1 decimals='INF' contextRef='Y16Q2'
unitRef='USD'>500000</us-gaap:ConversionOfStockAmountIssued1>
<fil:StockIssuedToSettleAdvance decimals='INF' contextRef='Y15Q2'
unitRef='USD'>150000</fil:StockIssuedToSettleAdvance>
<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF'
contextRef='E16Q2' unitRef='USD'>178325</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF'
contextRef='E16Q1' unitRef='USD'>34824</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AccountsReceivableNetCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>67862</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent decimals='INF' contextRef='E16Q1'
<us-gaap:ProceedsFromNotesPayable decimals='INF' contextRef='Y15Q2'
unitRef='USD'>100000</us-gaap:ProceedsFromNotesPayable>
<us-gaap:PaymentsForRepurchaseOfWarrants decimals='INF' contextRef='Y15Q2'
unitRef='USD'>56000</us-gaap:PaymentsForRepurchaseOfWarrants>
<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities decimals='INF'
contextRef='Y16Q2' unitRef='USD'>630076</us-
gaap:ProceedsFromPaymentsForOtherFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF'
contextRef='Y16Q2' unitRef='USD'>1993880</us-
gaap:NetCashProvidedByUsedInFinancingActivities>
contextRef='Y15Q2' unitRef='USD'>1652165</us-
gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF'
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF'
contextRef='Y16Q2' unitRef='USD'>143501</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF'
contextRef='Y15Q2' unitRef='USD'>362787</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF'
contextRef='E15Q2' unitRef='USD'>332787</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
unitRef='USD'>67862</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>89849</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>104851</us-gaap:PrepaidExpenseCurrent>
<us-gaap:AssetsCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>336036</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>207537</us-gaap:AssetsCurrent>
<us-gaap:DepositsAssetsNoncurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>269560</us-gaap:DepositsAssetsNoncurrent>
<us-gaap:DepositsAssetsNoncurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>271455</us-gaap:DepositsAssetsNoncurrent>
<us-gaap:OtherAssets decimals='INF' contextRef='E16Q2'
unitRef='USD'>19134</us-gaap:OtherAssets>
<us-gaap:OtherAssets decimals='INF' contextRef='E16Q1'
unitRef='USD'>3555</us-gaap:OtherAssets>
<us-gaap:Assets decimals='INF' contextRef='E16Q2'
unitRef='USD'>3559902</us-gaap:Assets>
<us-gaap:Assets decimals='INF' contextRef='E16Q1'
unitRef='USD'>2435595</us-gaap:Assets>
<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>762577</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>902123</us-gaap:AccountsPayableCurrent>
<us-gaap:InterestPayableCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>95145</us-gaap:InterestPayableCurrent>
<us-gaap:InterestPayableCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>61786</us-gaap:InterestPayableCurrent>
<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>844815</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>834348</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:NotesPayableCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>499847</us-gaap:NotesPayableCurrent>
<us-gaap:NotesPayableCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>463532</us-gaap:NotesPayableCurrent>
<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E16Q2'
unitRef='USD'>2202384</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E16Q1'
unitRef='USD'>2261789</us-gaap:LiabilitiesCurrent>
<us-gaap:LongTermNotesPayable decimals='INF' contextRef='E16Q2'
unitRef='USD'>2020195</us-gaap:LongTermNotesPayable>
<us-gaap:LongTermNotesPayable decimals='INF' contextRef='E16Q1'
unitRef='USD'>2148556</us-gaap:LongTermNotesPayable>
<us-gaap:Liabilities decimals='INF' contextRef='E16Q2'
unitRef='USD'>4222579</us-gaap:Liabilities>
<us-gaap:Liabilities decimals='INF' contextRef='E16Q1'
unitRef='USD'>4410345</us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies xsi:nil='true' contextRef='E16Q2'
unitRef='USD' />
<us-gaap:CommitmentsAndContingencies xsi:nil='true' contextRef='E16Q1'
unitRef='USD' />
<us-gaap:CommonStockValue decimals='INF' contextRef='E16Q2'
unitRef='USD'>5797</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue decimals='INF' contextRef='E16Q1'
unitRef='USD'>4733</us-gaap:CommonStockValue>
<us-gaap:DeferredCompensationEquity decimals='INF' contextRef='E16Q2'
unitRef='USD'>-2318827</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity decimals='INF' contextRef='E16Q1'
unitRef='USD'>-2240662</us-gaap:DeferredCompensationEquity>
<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E16Q2'
unitRef='USD'>19180234</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E16Q1'
unitRef='USD'>16638318</us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF'
contextRef='E16Q1' unitRef='USD'>-20779860</us-
gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity decimals='INF' contextRef='E16Q2'
unitRef='USD'>-615873</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity decimals='INF' contextRef='E16Q1'
unitRef='USD'>-1896147</us-gaap:StockholdersEquity>
<us-gaap:MinorityInterest decimals='INF' contextRef='E16Q2'
unitRef='USD'>-46804</us-gaap:MinorityInterest>
<us-gaap:MinorityInterest decimals='INF' contextRef='E16Q1'
unitRef='USD'>-78603</us-gaap:MinorityInterest>
<us-
gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 
decimals='INF' contextRef='E16Q2' unitRef='USD'>-662677</us-
gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-
gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 
decimals='INF' contextRef='E16Q1' unitRef='USD'>-1974750</us-
gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF'
contextRef='E16Q2' unitRef='USD'>3559902</us-
gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF'
contextRef='E16Q1' unitRef='USD'>2435595</us-
gaap:LiabilitiesAndStockholdersEquity>
<dei:DocumentType contextRef='Y16Q2'>10-Q</dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef='Y16Q2'>2016-06-
30</dei:DocumentPeriodEndDate>
<dei:AmendmentFlag contextRef='Y16Q2'>false</dei:AmendmentFlag>
<dei:EntityRegistrantName contextRef='Y16Q2'>Growblox Sciences,
Inc.</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey
contextRef='Y16Q2'>0001165320</dei:EntityCentralIndexKey>
<dei:TradingSymbol contextRef='Y16Q2'>gblx</dei:TradingSymbol>
<dei:CurrentFiscalYearEndDate contextRef='Y16Q2'>--03-
31</dei:CurrentFiscalYearEndDate>
<dei:EntityCommonStockSharesOutstanding decimals='INF'
contextRef='I160809' 
unitRef='Shares'>64495701</dei:EntityCommonStockSharesOutstanding>
<dei:EntityFilerCategory contextRef='Y16Q2'>Smaller Reporting
Company</dei:EntityFilerCategory>
<dei:EntityCurrentReportingStatus
contextRef='Y16Q2'>Yes</dei:EntityCurrentReportingStatus>
<dei:EntityVoluntaryFilers
contextRef='Y16Q2'>No</dei:EntityVoluntaryFilers>
<dei:EntityWellKnownSeasonedIssuer
contextRef='Y16Q2'>No</dei:EntityWellKnownSeasonedIssuer>
<dei:DocumentFiscalYearFocus
contextRef='Y16Q2'>2017</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus
contextRef='Y16Q2'>Q1</dei:DocumentFiscalPeriodFocus>
<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;b&gt;Note 1 &amp;#150; Basis of Presentation and 
Significant Accounting Policies&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Basis of 
Presentation&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The accompanying unaudited interim 
condensed consolidated financial statements of Growblox Sciences, Inc. (the 
&amp;quot;Company,&amp;quot; &amp;quot;We&amp;quot; or &amp;quot;Us&amp;quot;) 
have been prepared in accordance with U.S. generally accepted accounting 
principles (&amp;quot;U.S. GAAP&amp;quot;) for interim financial information and
with the instructions to Form 10-Q and Article 8 of Regulations S-X.&amp;nbsp; 
Accordingly, they do not include all of the information and footnotes required 
by U.S. GAAP for complete financial statements.&amp;nbsp; In the opinion of 
management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included.&amp;nbsp; Operating 
results for the periods presented are not necessarily indicative of the results 
that may be expected for the year ending March 31, 2017. The balance sheet at 
March 31, 2016 has been derived from the audited financial statements at that 
date but does not include all of the information and footnotes required by U.S. 
GAAP for complete financial statements. For further information, refer to the 
consolidated financial statements and footnotes thereto included in the 
Company&apos;s annual report on Form 10-K for the year ended March 31, 
2016.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Principles of 
Consolidation&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The consolidated financial statements 
include all operating divisions and majority owned subsidiaries, reported as a 
single operating segment, for which we maintain controlling interests. 
Intercompany accounts and transactions have been eliminated in 
consolidation.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Use of 
Estimates&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.&amp;nbsp; Actual results 
could differ from those estimates.&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;Certain reclassifications
have been made to the comparative period amounts in order to conform to the 
current period presentation.&amp;nbsp; These reclassifications had no effect on 
the reported financial position, results of operations or cash flows of the 
entity.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Significant 
Accounting Policies&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;A description of the 
Company&apos;s significant accounting policies is included in Note 3 of its 
Annual Report on Form 10&amp;#150;K for the fiscal year ended March 31, 
2016.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Recent 
Accounting Pronouncements&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;In February 2016, the 
Financial Accounting Standards Board (&amp;quot;FASB&amp;quot;) issued amended 
accounting guidance that changes the accounting for leases and requires expanded
disclosures about leasing activities. Under the new guidance, lessees will be 
required to recognize a right-of-use asset and a lease liability, measured on a 
discounted basis, at the commencement date for all leases with terms greater 
than twelve months. Lessor accounting will remain largely unchanged, other than 
certain targeted improvements intended to align lessor accounting with the 
lessee accounting model and with the updated revenue recognition guidance issued
in 2014. Lessees and lessors must apply a modified retrospective transition 
approach for leases existing at, or entered into after, the beginning of the 
earliest comparative period presented in the financial statements. The amended 
guidance is effective for annual reporting periods (including interim periods 
within those periods) beginning after December 15, 2018, and early application 
is permitted. The Company is currently evaluating the impact this guidance will 
have on its financial position and results of operations.&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;Management does not 
believe that any other recently issued but not yet effective accounting 
pronouncements, if adopted, would have a material effect on the accompanying 
consolidated financial statements.&lt;/p&gt; </us-
gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock
contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;b&gt;Note 2 &amp;#150; Going Concern&lt;/b&gt;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;The Company&apos;s 
financial statements have been prepared assuming the Company will continue as a 
going concern. The Company has sustained net losses since inception, which have 
caused an accumulated deficit of approximately $22.1 million at June 30, 2016. 
In addition, the Company has consumed cash in its operating activities of 
approximately $1 million for the three months ended June 30, 2016 compared to 
$1.1 million for the same period last year. These factors, among others, raise 
substantial doubt about the Company&apos;s ability to continue as a going 
concern.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;Management has been able, thus far, to 
finance the losses through a public offering, private placements and obtaining 
operating funds from stockholders. The Company is continuing to seek sources of 
financing.&amp;nbsp; There are no assurances that the Company will be successful
in achieving its goals.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;In view of these conditions, the
Company&apos;s ability to continue as a going concern is dependent upon its 
ability to obtain additional financing or capital sources, to meet its financing
requirements, and ultimately to achieve profitable operations. Management 
believes that its current and future plans provide an opportunity to continue as
a going concern. The accompanying financial statements do not include any 
adjustments relating to the recoverability and classification of recorded 
assets, or the amounts and classification of liabilities that may be necessary 
in the event the Company is unable to continue as a going 
concern.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<fil:ConvertibleNotes0TextBlock contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;b&gt;Note 3 
&amp;#150; Convertible Notes&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;In February 2016, the 
Company issued a short-term Promissory Note (&amp;quot;Note&amp;quot;) with a 
face value of $192,500 resulting in aggregate proceeds of $175,000 reflecting a 
9.1% original discount and a nominal rate of 10%. The Note is payable within one
year of issuance and is convertible into 962,500 shares of the Company&apos;s 
common stock and 962,500 common stock purchase warrants at any time and from 
time to time before maturity at the option of the holder. Each warrant gives the
Noteholder the right to purchase one share of common stock of the Company at an 
exercise price of $0.50 per share for a period of three years.&amp;nbsp; The 
beneficial conversion feature resulting from the discounted conversion price 
compared to the market price was calculated based on the date of issuance to be 
$94,037 after adjusting the effective conversion price for the relative fair 
value of the note proceeds compared to the fair value of the attached warrants 
and note. In addition to this discount related to the beneficial conversion 
feature, an additional discount of $66,912 was recorded based on the fair value 
of the 962,500 warrants attached to the note. This value was derived using the 
Black-Scholes valuation model. At June 30, 2016, the Note had a balance of $0.09
million net of $0.1 million unamortized discount and beneficial conversion 
feature.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;In March 2016, the Company issued a short-
term Promissory Note (&amp;quot;Note&amp;quot;) with a face value of $300,000 
resulting in aggregate proceeds of $250,000 reflecting a 16.67% original 
discount and a nominal rate of 20%. The Note is payable within one year of 
issuance and is convertible into 1,500,000 shares of the Company&apos;s common 
stock and 1,500,000 common stock to purchase warrants at any time and from time 
to time before maturity at the option of the holder. Each warrant gives the 
Noteholder the right to purchase one share of common stock of the Company at an 
exercise price of $0.50 per share for a period of three years. The beneficial 
conversion feature resulting from the discounted conversion price compared to 
the market price was calculated based on the date of issuance to be $143,750 
after adjusting the effective conversion price for the relative fair value of 
the note proceeds compared to the fair value of the attached warrants and note. 
In addition to this discount related to the beneficial conversion feature, an 
additional discount of $93,750 was recorded based on the fair value of the 
1,500,000 warrants attached to the note. At June 30, 2016, the Note had a 
balance of $0.1 million net of $0.2 million unamortized discount and beneficial 
conversion feature.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The Notes and Warrants were issued in 
reliance on the exemption from registration provided by 
Section&amp;nbsp;4(2)&amp;nbsp;of the Securities Act of 1933 (the 
&amp;quot;&lt;u&gt;Securities Act&lt;/u&gt;&amp;quot;) and/or Rule 506 of 
Regulation D under the Securities Act, as
amended.&lt;/p&gt;</fil:ConvertibleNotes0TextBlock>
<us-gaap:DebtDisclosureTextBlock contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;b&gt;Note 4&amp;#150;
Note Payable&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The Company entered into a Note Purchase 
Agreement, dated May 12, 2015 and effective as of June 8, 2015, with Pacific 
Leaf Ventures, LP (&amp;quot;Pacific Leaf&amp;quot;), pursuant to which Pacific 
Leaf has made installment loans (the &amp;quot;Loans&amp;quot;) to us in the 
aggregate amount of $1.75 million. The purpose of the financing is to provide 
for the acquisition and installation of an operating facility, equipment and 
other tangible assets by GBSN. Such facility and equipment will be dedicated to 
the cultivation of cannabis and the extraction of oils and other constituents 
present in cannabis, subject at all times to Nevada legal requirements. The note
is convertible at the option of the holder into common shares at a conversion 
price of $0.50, subject to anti-dilution adjustments.&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;To evidence the Loans, 
the Company issued to Pacific Leaf a 6% senior secured convertible promissory 
note (the &amp;quot;Note&amp;quot;), bearing interest at the rate of 6% per 
annum, payable quarterly. All outstanding principal and interest due under the 
Note were due and payable on May 12, 2020. We were required to prepay the 
outstanding principal amount of the Note on a quarterly basis in an amount equal
to 50% of the cash flow (accrued EBITDA) of GB Sciences Nevada, LLC 
(&amp;quot;GBSN&amp;quot;) attributable to our percentage interest in GBSN no 
later than the earlier to occur of (a) the fifth (5th) business day following 
receipt of a distribution of the Company&apos;s Share of GBSN&apos;s EBITDA for 
the calendar quarter in question, or (b) thirty (30) days following the end of 
the calendar quarter in question, with the first such prepayment to be made not 
later than July 31, 2015 with respect to the quarter ending June 30, 2015. In 
order to induce the Pacific Leaf to extend the loan to the Company and to secure
the payment and performance of all of the Secured Obligations, the Company 
agreed to grant Secured Party a security interest in certain of its assets and 
enter into the lending agreement.&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;On February 8, 2016, the 
Company entered into the Amended and Restated 6% Senior Convertible Promissory 
Note (&amp;quot;Amended Note&amp;quot;) with Pacific Leaf Ventures, LP 
(&amp;quot;Pacific Leaf&amp;quot;).&amp;nbsp; The amended agreement modifies the
6% Senior Secure Convertible Promissory Note dated May 12, 2015 and effective as
of June 8, 2015, in the principal amount of $1.75 million.&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;Per the terms of the 
amended agreement, Pacific Leaf may make up to $1.0 million in additional 
advances to the Company under the Amended Note bringing the total in the 
aggregate to $2.75 million. The note is convertible at the option of the holder 
into common shares at a conversion price of $0.25, subject to anti-dilution 
adjustments. The Company has an option to prepay the Amended Note, without 
premium or penalty, in whole or in part, with accrued interest to the date of 
such prepayment.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;Until the payment in full of the Amended 
Note, the Investor or its designee shall have the option (the
&amp;quot;Option&amp;quot;) to purchase up to a 20% membership interest in GBSN 
for a purchase price equal to $100,000 for each 2% of membership interest 
purchased (i.e., $1,000,000 if the Option is exercised in full), provided that 
the Option may not be exercised for less than a 1% membership interest in 
GBSN.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt; 
&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;In 
connection with the Amended Note, the Company also entered into the Amended and 
Restated Royalty Agreement with Pacific Leaf dated and effective as of February 
8, 2016.&amp;nbsp; Per the terms of the Amended Royalty Agreement, the royalty 
rate at any time shall equal to the sum of (i) 9.1%, and (ii) the percentage 
calculated by dividing the amount advanced in excess of $1.75 million by $1.0 
million, multiplied by the gross revenues of GBSN.&amp;nbsp; On the earlier of 
(i) the seventh anniversary of the royalty payment date, or (ii) the date that 
all amounts outstanding under the Amended Note have been paid in full, the 
royalty rate shall be reduced by 50%.&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;On June 13, 2016 the 
Company received notice from Pacific Leaf Ventures, LP (&amp;quot;Pacific 
Leaf&amp;quot;) that it had elected to convert $500,000 of the Company&apos;s 
indebtedness to Pacific Leaf Note into common stock of the Company pursuant to 
the Amended and Restated 6% Senior Secured Convertible Promissory.&amp;nbsp; 
Accordingly, the Company has issued 2,000,000 shares of its common stock 
($500,000 converted at a price of $0.25 per share) to Pacific Leaf and the 
Company&apos;s indebtedness to Pacific Leaf pursuant to the Note has been 
reduced by $500,000. As of June 30, 2016, the total amount of installments 
received, net of conversion, is $2.02 million.&lt;/p&gt;</us-
gaap:DebtDisclosureTextBlock>
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;b&gt;Note 5 &amp;#150; Property and 
Equipment&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;Property and equipment balances as of June
30, 2016 and March 31, 2016:&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; 
&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; 
cellpadding=&quot;0&quot; width=&quot;780&quot;&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; style=&apos;width:706.5pt;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:center&apos;&gt;&lt;b&gt;As of June 30, 2016&lt;/b&gt;&lt;/p&gt; 
&lt;/td&gt; &lt;td width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:center&apos;&gt;&lt;b&gt;As of March 31, 2016&lt;/b&gt;&lt;/p&gt; 
&lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td 
width=&quot;1178&quot; valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Computer and software&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;
$151,748&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;219&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;
$151,748&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; 
&lt;td width=&quot;1178&quot; valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Machinery and equipment&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;643,394&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;219&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;641,898&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Leaseholds&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;357,418&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;219&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;363,317&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Construction in progress&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;2,075,086&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;1,043,042&lt;/p&gt; &lt;/td&gt; 
&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;3,227,646&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;2,200,005&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Less accumulated depreciation and amortization&lt;/p&gt;
&lt;/td&gt; &lt;td width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;(292,474)&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;(246,957)&lt;/p&gt; &lt;/td&gt; 
&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;$2,935,172&lt;/p&gt; &lt;/td&gt; &lt;td
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;$1,953,048&lt;/p&gt; &lt;/td&gt; 
&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;/div&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt;</us-
gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock
contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 6 &amp;#150; 
Capital Transactions&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;During the three months 
ended June 30, 2016, the Company issued an aggregate of 835,967 shares of common
stock in settlement and release of certain obligations owed by the Company to 
various persons and recorded related expenses of $0.3 million, as 
follows:&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:47.25pt;text-align:justify;text-indent:-
27.0pt&apos;&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp
;#160;&amp;#160;&amp;#160;&amp;#160; The Company issued 512,275 shares of its 
common stock in connection with the conversion of $0.2 million in indebtedness 
owed by us to various persons at a conversion price of approximately $0.38 per 
share.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:47.25pt;text-align:justify;text-indent:-
27.0pt&apos;&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp
;#160;&amp;#160;&amp;#160;&amp;#160; The Company issued 323,692 shares of common
stock in connection with settlement of payroll liabilities owed by us to our 
executives at a conversion price of $0.19 per share. The Company recorded 
approximately $0.1 million of compensation expense.&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;The Company issued 
100,000 shares of common stock to employees and recorded an expense of $0.03 
million.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;On April 8, 2016, the Company issued 
200,000 of its common shares to its former Chief Financial Officer, in exchange 
for a full dismissal with prejudice of all causes of action pending in the 
complaint filed against the Company on August 19, 2015.&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;The Company issued 50,000
shares in exchange for consulting services and recorded a related expense of 
$0.02 million.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;On June 13, 2016 the Company received 
notice from Pacific Leaf Ventures, LP (&amp;quot;Pacific Leaf&amp;quot;) that it
had elected to convert $500,000 of the Company&apos;s indebtedness to Pacific 
Leaf Note into common stock of the Company pursuant to the Amended and Restated 
6% Senior Secured Convertible Promissory.&amp;nbsp; Accordingly, the Company has
issued 2,000,000 shares of its common stock ($500,000 converted at a price of 
$0.25 per share) to Pacific Leaf.&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;During three months ended
June 30, 2016, the Company sold 7,425,500 units through a private placement at a
price of $0.20 per unit resulting in net proceeds of $1.3 million.&amp;nbsp; 
Each unit consisted of one share of common stock and one common stock purchase 
warrant, expiring in three years, with an exercise price of 
$0.50.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;b&gt;Note 7 &amp;#150; Commitments and 
Contingencies&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in;text-
align:justify&apos;&gt;&lt;b&gt;&lt;i&gt;Growblox Sciences, Inc.&amp;nbsp; v. 
GCM Administrative Services, LLC&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;On April 2, 2014, we 
commenced an action in the United States District Court for the Southern 
District of New York captioned Signature Exploration and Production Corporation 
v. GCM Administrative Services, LLC, Strategic Turnaround Equity Partners, L.P. 
(Cayman), Seth M. Lukash, and Gary Herman, 14 Civ. 02280 (ER) (the 
&amp;quot;Action&amp;quot;). After the change of name of Signature Exploration 
and Production Corporation, the caption was amended to substitute GrowBlox 
Sciences, Inc. as the plaintiff. The complaint in the Action sought a 
declaratory judgment that neither Lukash nor Herman was entitled to receive any 
interest in, including any shares of stock of, Growblox pursuant to certain 
share conversion rights held under promissory notes in the aggregate amount of 
$75,000, given by a related party of ours to the entity defendants GCM and 
Strategic.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;On May 9, 2014, defendants filed an answer
denying the complaint&apos;s material allegations, and asserted a counterclaim 
against us, against persons identified as certain of our officers or directors, 
and against GrowOpp, LLC and Tumbleweed Holdings, Inc. On November 19, 2014, 
defendants filed an amended counterclaim, including a prayer for monetary relief
or damages in the sum of $9 million. We moved to dismiss the counterclaim and by
opinion dated June 2, 2015, the Court granted the motion in part and dismissed 
counts one and two (for declaratory judgment as to an alleged partnership or 
joint venture, and for breach of fiduciary duty predicated upon those 
allegations), and denied the motion in part, leaving counts three and four of 
the counterclaim standing. The Court viewed the third and fourth claims as a 
single claim for unjust enrichment, in which recovery would be based on quantum 
meruit, that is, upon the alleged value of any benefit conferred by defendants 
to us through alleged work and services rendered. In view of the fact that the 
pleading did not assign a particular value to that claim we are unable at 
present to advise what specific sum of money damages is sought. We did not 
challenge the fifth count of the counterclaim at this stage that seeks damages 
of $75,000 for alleged non-payment of the above-referenced promissory 
notes.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The Company and its adversaries entered an
agreement in principle, subject to the execution of formal documents and dated 
as of June 20, 3016, to settle and dismiss the action. The Company&apos;s board 
approved the settlement on July 6, 2016. The parties are in the process of 
executing a formal, written settlement agreement. Under the settlement, the 
Company will deliver 1,400,000 shares of its common stock to its adversaries. 
Craig Ellins, formerly CEO of the Company and now its chief scientific officer, 
will deliver 3,000,000 shares that he owns personally. Based on our estimate of 
potential outcomes, we have accrued $0.5 million with respect to this matter as 
of June 30, 2016.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&lt;b&gt;&lt;i&gt;Cathryn Kennedy 
Complaint Settlement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;On August 19, 2015, 
Cathryn Kennedy, our former Chief Financial Officer, filed a Complaint against 
us in the District Court in Clark County, Nevada alleging that she was assigned
new duties by us which constituted a termination without cause effective July 
24, 2015, and that as a consequence thereof she is entitled to severance, 
vacation pay and stock compensation from us pursuant to her Employment Agreement
dated November 18, 2014.&amp;nbsp; On April 8, 2016, the Company entered into a 
mutual agreement with Cathryn Kennedy per terms of which the Company issued 
200,000 of its unrestricted common shares in exchange for a full dismissal with 
prejudice of all causes of action pending in the above-referenced 
Complaint.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;From time to time, the Company also 
becomes involved in certain legal proceedings and claims which arise in the 
ordinary course of business. In our opinion, based on consultations with outside
counsel, the results of any of these ordinary course matters, individually and 
in the aggregate, are not expected to have a material effect on our results of 
operations, financial condition, or cash flows. As more information becomes 
available, if management should determine that an unfavorable outcome is 
probable on such a claim and that the amount of such probable loss that it will 
incur on that claim is reasonably estimable, we will record a reserve for the 
claim in question. If and when we record such a reserve is recorded, it could be
material and could adversely impact our results of operations, financial 
condition, and cash flows.&lt;/p&gt;</us-
gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:EarningsPerShareTextBlock contextRef='Y16Q2'>&lt;!--egx--
&gt;&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;b&gt;Note 8 
&amp;#150; Loss per Share&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in;text-align:justify&apos;&gt;The 
Company&apos;s basic loss per share has been calculated using the weighted 
average number of common shares outstanding during the period. The Company had 
31,359,167 and 27,558,334 potentially dilutive common shares at June 30, 2016 
and March 31, 2016, respectively.&amp;nbsp; However, such common stock 
equivalents were not included in the computation of diluted net loss per share 
as their inclusion would have been anti-dilutive.&lt;/p&gt;</us-
gaap:EarningsPerShareTextBlock>
<us-gaap:SubsequentEventsTextBlock contextRef='Y16Q2'>&lt;!--egx--
&gt;&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in;text-
align:justify&apos;&gt;&lt;b&gt;Note 9 &amp;#150; Subsequent 
Events&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;&lt;b&gt;&lt;i&gt;GB Sciences Nevada 
LLC&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in;background:white&apos;&gt;On July 21, 2016, an 
entity associated with Pacific Leaf Partners, LLC completed the purchase of the 
building housing the Company&apos;s cultivation facility at 3550 W. Teco Ave., 
Las Vegas, NV. In connection with the purchase, the Company entered into an 
amended lease agreement per the terms of which the initial term of the lease 
covering the facility was extended to ten years, with an optional five-year 
extension.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in;background:white&apos;&gt;On August 4, 2016, the 
&lt;font style=&apos;background:yellow !msorm&apos;&gt;Company
&lt;/font&gt;&lt;font style=&apos;background:yellow !msorm&apos;&gt;entered into
&lt;/font&gt;the Second Omnibus Amendment (&amp;#147;Amendment&amp;#148;) 
&lt;font style=&apos;background:yellow !msorm&apos;&gt;of its existing 
agreements with Pacific Leaf &lt;/font&gt;Ventures, LP (&amp;#147;Pacific 
Leaf&amp;#148;).&amp;nbsp; Principally, the Amendment&lt;font 
style=&apos;background:yellow !msorm&apos;&gt; eliminates Pacific Leaf&apos;s 
option to &lt;/font&gt;purchase up to a 20% membership interest in GB Sciences 
Nevada LLC (&amp;#147;GBSN&amp;#148;)&lt;font style=&apos;background:yellow !
msorm&apos;&gt; and &lt;/font&gt;reduces&lt;font style=&apos;background:yellow !
msorm&apos;&gt; Pacific Leaf&apos;s existing royalty&lt;/font&gt; rate&lt;font 
style=&apos;background:yellow !msorm&apos;&gt; to &lt;/font&gt;16.4%. It also 
caps maximum aggregate &lt;font style=&apos;background:yellow !
msorm&apos;&gt;royalty &lt;/font&gt;payments to be made &lt;font 
style=&apos;background:yellow !msorm&apos;&gt;to Pacific Leaf &lt;/font&gt;at 
$2,420,000 with respect to any calendar year. In consideration of the 
amended&lt;font style=&apos;background:yellow !msorm&apos;&gt; 
terms&lt;/font&gt;, Pacific Leaf will receive 1,000,000 shares of the 
Company&amp;#146;s common stock and a five-year warrant to purchase 1,500,000 
shares of the Company&amp;#146;s common stock at $0.36 per share.&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;text-
align:justify&apos;&gt;&lt;b&gt;Growblox Sciences, Inc. &amp;#160;v. GCM 
Administrative Services, LLC Settlement &lt;/b&gt;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;text-align:justify&apos;&gt;On 
August 9, 2016, the Company finalized a settlement agreement in final 
disposition of the lawsuit filed by the Company on April 2, 2014, in the United 
States District Court for the Southern District of New York.&amp;#160; The 
Company&amp;#146;s obligation under the agreement is to issue 1,400,000 
shares&lt;font style=&apos;background:yellow !msorm&apos;&gt; of 
&lt;/font&gt;restricted common stock to certain non-affiliates of the 
Company.&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-left:0in;text-
align:justify&apos;&gt;&lt;b&gt;Executive Appointments&lt;/b&gt;&lt;/p&gt; &lt;p
style=&apos;margin-right:0in;margin-left:0in;margin:0in !
msorm;background:white !msorm&apos;&gt;On August 5, 2016, the Company&amp;#146;s
Board of Directors accepted the resignation of John Poss as Chief Financial 
Officer of the Company and appointed Ksenia Griswold as the Company&amp;#146;s 
Vice President and Chief Financial Officer. Mr. Poss&lt;font 
style=&apos;background:yellow !msorm&apos;&gt; will &lt;/font&gt;continue to 
serve as the President, Chief Executive Officer, and Chief Operating Officer of 
the Company. Ms. Griswold has been serving as the controller of the Company 
since November, 2015.&amp;#160; For the five years prior to that time beginning 
in October, 2010, she worked in the Las Vegas, Nevada office of Ernst &amp;amp; 
Young, LLP.&amp;#160; At the time of her departure from Ernst &amp;amp; Young, 
she was audit manager.&amp;#160; It is expected that an amendment to Ms. 
Griswold&amp;#146;s employment agreement and compensation will be negotiated 
during the upcoming fiscal quarter.&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in;background:white&apos;&gt;&amp;nbsp;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-
left:0in;background:white&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-
gaap:SubsequentEventsTextBlock>
<us-gaap:BasisOfAccounting contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Basis of 
Presentation&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The accompanying unaudited interim 
condensed consolidated financial statements of Growblox Sciences, Inc. (the 
&amp;quot;Company,&amp;quot; &amp;quot;We&amp;quot; or &amp;quot;Us&amp;quot;) 
have been prepared in accordance with U.S. generally accepted accounting 
principles (&amp;quot;U.S. GAAP&amp;quot;) for interim financial information and
with the instructions to Form 10-Q and Article 8 of Regulations S-X.&amp;nbsp;
Accordingly, they do not include all of the information and footnotes required 
by U.S. GAAP for complete financial statements.&amp;nbsp; In the opinion of 
management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included.&amp;nbsp; Operating 
results for the periods presented are not necessarily indicative of the results 
that may be expected for the year ending March 31, 2017. The balance sheet at 
March 31, 2016 has been derived from the audited financial statements at that 
date but does not include all of the information and footnotes required by U.S. 
GAAP for complete financial statements. For further information, refer to the 
consolidated financial statements and footnotes thereto included in the 
Company&apos;s annual report on Form 10-K for the year ended March 31, 
2016.&lt;/p&gt;</us-gaap:BasisOfAccounting>
<us-gaap:ConsolidationPolicyTextBlock contextRef='Y16Q2'>&lt;!--egx--
&gt;&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Principles of 
Consolidation&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The consolidated financial statements 
include all operating divisions and majority owned subsidiaries, reported as a 
single operating segment, for which we maintain controlling interests. 
Intercompany accounts and transactions have been eliminated in 
consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&lt;i&gt;Use of 
Estimates&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in&apos;&gt;The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.&amp;nbsp; Actual results 
could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
<us-gaap:Reclassifications contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;Certain reclassifications
have been made to the comparative period amounts in order to conform to the 
current period presentation.&amp;nbsp; These reclassifications had no effect on 
the reported financial position, results of operations or cash flows of the 
entity.&lt;/p&gt;</us-gaap:Reclassifications>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef='Y16Q2'>&lt;!--
egx--&gt;&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;i&gt;Significant Accounting Policies&lt;/i&gt;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;#160;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;A description of the 
Company&apos;s significant accounting policies is included in Note 3 of its 
Annual Report on Form 10&amp;#150;K for the fiscal year ended March 31, 
2016.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
contextRef='Y16Q2'>&lt;!--egx--&gt;&lt;p style=&apos;margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in&apos;&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;In February 2016, the 
Financial Accounting Standards Board (&amp;quot;FASB&amp;quot;) issued amended 
accounting guidance that changes the accounting for leases and requires expanded
disclosures about leasing activities. Under the new guidance, lessees will be 
required to recognize a right-of-use asset and a lease liability, measured on a 
discounted basis, at the commencement date for all leases with terms greater 
than twelve months. Lessor accounting will remain largely unchanged, other than 
certain targeted improvements intended to align lessor accounting with the 
lessee accounting model and with the updated revenue recognition guidance issued
in 2014. Lessees and lessors must apply a modified retrospective transition 
approach for leases existing at, or entered into after, the beginning of the 
earliest comparative period presented in the financial statements. The amended 
guidance is effective for annual reporting periods (including interim periods 
within those periods) beginning after December 15, 2018, and early application 
is permitted. The Company is currently evaluating the impact this guidance will 
have on its financial position and results of operations.&lt;/p&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; 
&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;Management does not 
believe that any other recently issued but not yet effective accounting 
pronouncements, if adopted, would have a material effect on the accompanying 
consolidated financial statements.&lt;/p&gt;</us-
gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef='Y16Q2'>&lt;!--
egx--&gt;&lt;p style=&apos;margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in&apos;&gt;Property
and equipment balances as of June 30, 2016 and March 31, 2016:&lt;/p&gt; &lt;div
align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; 
cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;780&quot;&gt; 
&lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; style=&apos;width:706.5pt;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:center&apos;&gt;&lt;b&gt;As of June 30, 2016&lt;/b&gt;&lt;/p&gt; 
&lt;/td&gt; &lt;td width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:center&apos;&gt;&lt;b&gt;As of March 31, 2016&lt;/b&gt;&lt;/p&gt; 
&lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td 
width=&quot;1178&quot; valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Computer and software&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;
$151,748&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;219&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;
$151,748&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; 
&lt;td width=&quot;1178&quot; valign=&quot;bottom&quot;
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Machinery and equipment&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;643,394&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;219&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;641,898&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Leaseholds&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;357,418&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;219&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;363,317&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Construction in progress&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;2,075,086&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;1,043,042&lt;/p&gt; &lt;/td&gt; 
&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;3,227,646&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;2,200,005&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr 
align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Less accumulated depreciation and amortization&lt;/p&gt;
&lt;/td&gt; &lt;td width=&quot;219&quot; valign=&quot;bottom&quot;
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;(292,474)&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;(246,957)&lt;/p&gt; &lt;/td&gt; 
&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;$2,935,172&lt;/p&gt; &lt;/td&gt; &lt;td
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right&apos;&gt;$1,953,048&lt;/p&gt; &lt;/td&gt; 
&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;1178&quot; 
valign=&quot;bottom&quot; 
style=&apos;width:706.5pt;background:white;padding:0&apos;&gt; &lt;p 
style=&apos;margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;td 
width=&quot;219&quot; valign=&quot;bottom&quot; 
style=&apos;width:131.25pt;background:white;padding:0&apos;&gt; &lt;p 
align=&quot;right&quot; style=&apos;margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right&apos;&gt;&amp;#160;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF'
contextRef='E16Q2' unitRef='USD'>-22120731</us-
gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF'
contextRef='Y16Q2' unitRef='USD'>-957918</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF'
contextRef='Y15Q2' unitRef='USD'>-1086864</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:DebtInstrumentFaceAmount decimals='INF'
contextRef='I160229_DebtInstr-ShortTermPromissoryNote1' 
unitRef='USD'>192500</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:ProceedsFromConvertibleDebt decimals='INF'
contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote1' unitRef='USD'>175000</us-
gaap:ProceedsFromConvertibleDebt>
<fil:DebtDiscountRate decimals='INF' contextRef='I160229_DebtInstr-
ShortTermPromissoryNote1' unitRef='Pure'>0.0910</fil:DebtDiscountRate>
<us-gaap:DebtInstrumentInterestRateEffectivePercentage decimals='INF'
contextRef='I160229_DebtInstr-ShortTermPromissoryNote1' 
unitRef='Pure'>0.1000</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments decimals='INF'
contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-CommonStock' 
unitRef='Pure'>962500</us-
gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments decimals='INF'
contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-Warrant' 
unitRef='Pure'>962500</us-
gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
decimals='INF' contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-
Warrant' unitRef='UsdPerShare'>0.50</us-
gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature
decimals='INF' contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-
Warrant' unitRef='USD'>94037</us-
gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentUnamortizedDiscount decimals='INF'
contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-Warrant' 
unitRef='USD'>66912</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:ConvertibleNotesPayableCurrent decimals='-4'
contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote1' unitRef='USD'>90000</us-
gaap:ConvertibleNotesPayableCurrent>
<us-gaap:DebtInstrumentUnamortizedDiscount decimals='-5'
contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote1' unitRef='USD'>100000</us-
gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentFaceAmount decimals='INF'
contextRef='E16Q1_DebtInstr-ShortTermPromissoryNote2' unitRef='USD'>300000</us-
gaap:DebtInstrumentFaceAmount>
<us-gaap:ProceedsFromConvertibleDebt decimals='INF'
contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote2' unitRef='USD'>250000</us-
gaap:ProceedsFromConvertibleDebt>
<fil:DebtDiscountRate decimals='INF' contextRef='E16Q1_DebtInstr-
ShortTermPromissoryNote2' unitRef='Pure'>0.1667</fil:DebtDiscountRate>
<us-gaap:DebtInstrumentInterestRateEffectivePercentage decimals='INF'
contextRef='E16Q1_DebtInstr-ShortTermPromissoryNote2' unitRef='Pure'>0.2000</us-
gaap:DebtInstrumentInterestRateEffectivePercentage>
<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments decimals='INF'
contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-CommonStock' 
unitRef='Pure'>1500000</us-
gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments decimals='INF'
contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-Warrant' 
unitRef='Pure'>1500000</us-
gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
decimals='INF' contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-
Warrant' unitRef='UsdPerShare'>0.50</us-
gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature
decimals='INF' contextRef='Y16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-
Warrant' unitRef='USD'>143750</us-
gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentUnamortizedDiscount decimals='INF'
contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-Warrant' 
unitRef='USD'>93750</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:ConvertibleNotesPayableCurrent decimals='-5'
contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote2' unitRef='USD'>100000</us-
gaap:ConvertibleNotesPayableCurrent>
<us-gaap:DebtInstrumentUnamortizedDiscount decimals='-5'
contextRef='E16Q2_DebtInstr-ShortTermPromissoryNote2' unitRef='USD'>200000</us-
gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentFaceAmount decimals='-4'
contextRef='I150608_LegalEntity-PacificLeafVenturesLp' 
unitRef='USD'>1750000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 decimals='INF'
contextRef='I150608_LegalEntity-PacificLeafVenturesLp' 
unitRef='UsdPerShare'>0.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:DebtInstrumentInterestRateStatedPercentage decimals='INF'
contextRef='I150608_LegalEntity-PacificLeafVenturesLp' 
unitRef='Pure'>0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentMaturityDate contextRef='Y16Q2_LegalEntity-
PacificLeafVenturesLp'>2020-05-12</us-gaap:DebtInstrumentMaturityDate>
<us-gaap:DebtInstrumentCarryingAmount decimals='-4'
contextRef='I160208_LegalEntity-PacificLeafVenturesLp' 
unitRef='USD'>1750000</us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature
contextRef='Y16Q2_LegalEntity-PacificLeafVenturesLp'>Per the terms of the 
amended agreement, Pacific Leaf may make up to $1.0 million in additional 
advances to the Company under the Amended Note bringing the total in the 
aggregate to $2.75 million. The note is convertible at the option of the holder 
into common shares at a conversion price of $0.25, subject to anti-dilution 
adjustments. The Company has an option to prepay the Amended Note, without 
premium or penalty, in whole or in part, with accrued interest to the date of 
such prepayment.</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
<us-gaap:DebtInstrumentPaymentTerms contextRef='Y16Q2_LegalEntity-
PacificLeafVenturesLp'>Until the payment in full of the Amended Note, the 
Investor or its designee shall have the option (the &apos;Option&apos;) to 
purchase up to a 20% membership interest in GBSN for a purchase price equal to 
$100,000 for each 2% of membership interest purchased (i.e., $1,000,000 if the 
Option is exercised in full), provided that the Option may not be exercised for 
less than a 1% membership interest in GBSN.</us-gaap:DebtInstrumentPaymentTerms>
<fil:RoyaltyAgreementAmendedTerms contextRef='Y16Q2_LegalEntity-
PacificLeafVenturesLp'>In connection with the Amended Note, the Company also 
entered into the Amended and Restated Royalty Agreement with Pacific Leaf dated 
and effective as of February 8, 2016. Per the terms of the Amended Royalty 
Agreement, the royalty rate at any time shall equal to the sum of (i) 9.1%, and 
(ii) the percentage calculated by dividing the amount advanced in excess of 
$1.75 million by $1.0 million, multiplied by the gross revenues of GBSN. On the 
earlier of (i) the seventh anniversary of the royalty payment date, or (ii) the 
date that all amounts outstanding under the Amended Note have been paid in full,
the royalty rate shall be reduced by 50%.</fil:RoyaltyAgreementAmendedTerms>
<us-gaap:ProceedsFromConvertibleDebt decimals='-4'
contextRef='D150512_160630_LegalEntity-PacificLeafVenturesLp' 
unitRef='USD'>2020000</us-gaap:ProceedsFromConvertibleDebt>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q2_PpeByType-ComputerEquipment' unitRef='USD'>151748</us-
gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q1_PpeByType-ComputerEquipment' unitRef='USD'>151748</us-
gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q2_PpeByType-MachineryAndEquipment' unitRef='USD'>643394</us-
gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q1_PpeByType-MachineryAndEquipment' unitRef='USD'>641898</us-
gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q2_PpeByType-LeaseholdsAndLeaseholdImprovements' 
unitRef='USD'>357418</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q1_PpeByType-LeaseholdsAndLeaseholdImprovements' 
unitRef='USD'>363317</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q2_PpeByType-CnstrInProgress' unitRef='USD'>2075086</us-
gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF'
contextRef='E16Q1_PpeByType-CnstrInProgress' unitRef='USD'>1043042</us-
gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF' contextRef='E16Q2'
unitRef='USD'>3227646</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross decimals='INF' contextRef='E16Q1'
unitRef='USD'>2200005</us-gaap:PropertyPlantAndEquipmentGross>
<us-
gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment 
decimals='INF' contextRef='E16Q2' unitRef='USD'>292474</us-
gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-
gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment 
decimals='INF' contextRef='E16Q1' unitRef='USD'>246957</us-
gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q2'
unitRef='USD'>2935172</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q1'
unitRef='USD'>1953048</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 decimals='INF'
contextRef='Y16Q2_StEqComps-CommonStock' unitRef='Shares'>835967</us-
gaap:DebtConversionConvertedInstrumentSharesIssued1>
<us-gaap:AllocatedShareBasedCompensationExpense decimals='-5'
contextRef='Y16Q2_StEqComps-CommonStock' unitRef='USD'>300000</us-
gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
decimals='INF' contextRef='Y16Q2_StEqComps-CommonStock' 
unitRef='Shares'>512275</us-
gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:DebtConversionOriginalDebtAmount1 decimals='-5'
contextRef='Y16Q2' unitRef='USD'>200000</us-
gaap:DebtConversionOriginalDebtAmount1>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 decimals='INF'
contextRef='E16Q2' unitRef='UsdPerShare'>0.38</us-
gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
decimals='INF' contextRef='Y16Q2_StEqComps-CommonStock' 
unitRef='Shares'>323692</us-
gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<us-gaap:SharePrice decimals='INF' contextRef='E16Q2'
unitRef='UsdPerShare'>0.19</us-gaap:SharePrice>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals='-5'
contextRef='Y16Q2' unitRef='USD'>100000</us-
gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
decimals='INF' contextRef='Y16Q2_RelPtyTrnsByRelPty-Employees_StEqComps-
CommonStock' unitRef='Shares'>100000</us-
gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
<us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
decimals='-4' contextRef='Y16Q2_RelPtyTrnsByRelPty-Employees' 
unitRef='USD'>30000</us-
gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF'
contextRef='Y16Q2_StEqComps-CommonStock' unitRef='Shares'>50000</us-
gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices decimals='-4'
contextRef='Y16Q2' unitRef='USD'>20000</us-
gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 decimals='INF'
contextRef='Y16Q2_LegalEntity-PacificLeafVenturesLp_StEqComps-CommonStock' 
unitRef='Shares'>2000000</us-
gaap:DebtConversionConvertedInstrumentSharesIssued1>
<us-gaap:DebtConversionConvertedInstrumentAmount1 decimals='INF'
contextRef='Y16Q2_LegalEntity-PacificLeafVenturesLp' unitRef='USD'>500000</us-
gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 decimals='INF'
contextRef='E16Q2_LegalEntity-PacificLeafVenturesLp' 
unitRef='UsdPerShare'>0.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues decimals='INF'
contextRef='Y16Q2_StEqComps-CommonStock' unitRef='Shares'>7425500</us-
gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:SharePrice decimals='INF' contextRef='E16Q2_StEqComps-
CommonStock' unitRef='UsdPerShare'>0.20</us-gaap:SharePrice>
<us-gaap:StockIssuedDuringPeriodValueNewIssues decimals='-5'
contextRef='Y16Q2' unitRef='USD'>1300000</us-
gaap:StockIssuedDuringPeriodValueNewIssues>
<fil:UnitsDescription contextRef='Y16Q2'>Each unit consisted of one share 
of common stock and one common stock purchase warrant, expiring in three years, 
with an exercise price of $0.50.</fil:UnitsDescription>
<us-gaap:LossContingencyDamagesSoughtValue decimals='INF'
contextRef='Y16Q2_LitCase-InitialComplaintFiledByGrowblox' 
unitRef='USD'>75000</us-gaap:LossContingencyDamagesSoughtValue>
<us-gaap:LossContingencyDamagesSoughtValue decimals='-6'
contextRef='Y16Q2_LitCase-Counterclaim' unitRef='USD'>9000000</us-
gaap:LossContingencyDamagesSoughtValue>
<fil:SettlementAgreementTerms contextRef='Y16Q2_LitCase-
Counterclaim'>Under the settlement, the Company will deliver 1,400,000 shares of
its common stock to its adversaries. Craig Ellins, formerly CEO of the Company 
and now its chief scientific officer, will deliver 3,000,000 shares that he owns
personally. Based on our estimate of potential outcomes, we have 
accrued</fil:SettlementAgreementTerms>
<us-gaap:LossContingencyAccrualProvision decimals='-5'
contextRef='Y16Q2_LitCase-Counterclaim' unitRef='USD'>500000</us-
gaap:LossContingencyAccrualProvision>
<us-gaap:StockIssuedDuringPeriodSharesOther decimals='INF'
contextRef='Y16Q2_RelPtyTrnsByRelPty-ChiefFinancialOfficer_StEqComps-
CommonStock' unitRef='Shares'>200000</us-
gaap:StockIssuedDuringPeriodSharesOther>
<us-
gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 
decimals='INF' contextRef='Y16Q2_StEqComps-CommonStock' 
unitRef='Shares'>31359167</us-
gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-
gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 
decimals='INF' contextRef='D150401_160331_StEqComps-CommonStock' 
unitRef='Shares'>27558334</us-
gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract
contextRef='D160721_SubsequentEventType-SubsequentEvent'>P10Y</us-
gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract>
<fil:RoyaltyAgreementAmendedTerms contextRef='D160804_SubsequentEventType-
SubsequentEvent'>Principally, the Amendment eliminates Pacific Leaf&apos;s 
option to purchase up to a 20% membership interest in GB Sciences Nevada LLC 
(&amp;#147;GBSN&amp;#148;) and reduces Pacific Leaf&apos;s existing royalty rate
to 16.4%. It also caps maximum aggregate royalty payments to be made to Pacific 
Leaf at $2,420,000 with respect to any calendar year. In consideration of the 
amended terms, Pacific Leaf will receive 1,000,000 shares of the 
Company&amp;#146;s common stock and a five-year warrant to purchase 1,500,000 
shares of the Company&amp;#146;s common stock at $0.36 per 
share.</fil:RoyaltyAgreementAmendedTerms>
<us-gaap:StockIssuedDuringPeriodSharesOther decimals='INF'
contextRef='D160809_StEqComps-CommonStock_SubsequentEventType-SubsequentEvent' 
unitRef='Shares'>1400000</us-gaap:StockIssuedDuringPeriodSharesOther>
<context id='Y16Q2'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
</entity>
<period>
</period>
</context>
<context id='E16Q2'>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<instant>2016-06-30</instant>
<entity>
<identifier
</entity>
<period>
</period>
</context>
<context id='E16Q1'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
</entity>
<period>
<instant>2016-03-31</instant>
</period>
</context>
<context id='Y15Q2'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
</entity>
<period>
<startDate>2015-04-01</startDate>
<endDate>2015-06-30</endDate>
</period>
</context>
<context id='E15Q2'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<instant>2015-06-30</instant>
</context>
<context id='I160229_DebtInstr-ShortTermPromissoryNote1'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote1Member</xbrldi:explicitMemb
er></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<instant>2016-02-29</instant>
</context>
<context id='Y16Q2_DebtInstr-ShortTermPromissoryNote1'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote1Member</xbrldi:explicitMemb
er></segment>
<segment><xbrldi:explicitMember dimension='us-
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='Y16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-
CommonStock'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote1Member</xbrldi:explicitMemb
er><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='Y16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-Warrant'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote1Member</xbrldi:explicitMemb
er><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:WarrantMember</xbrldi:explicitMember></segment>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='E16Q2_DebtInstr-ShortTermPromissoryNote1_StEqComps-Warrant'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote1Member</xbrldi:explicitMemb
er><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:WarrantMember</xbrldi:explicitMember></segment>
</entity>
<period>
<instant>2016-06-30</instant>
</period>
</context>
<context id='E16Q2_DebtInstr-ShortTermPromissoryNote1'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote1Member</xbrldi:explicitMemb
er></segment>
</entity>
<period>
<instant>2016-06-30</instant>
</period>
</context>
<context id='E16Q1_DebtInstr-ShortTermPromissoryNote2'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote2Member</xbrldi:explicitMemb
er></segment>
</entity>
<period>
<instant>2016-03-31</instant>
</period>
</context>
<context id='Y16Q2_DebtInstr-ShortTermPromissoryNote2'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote2Member</xbrldi:explicitMemb
er></segment>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</period>
</context>
<context id='Y16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-
CommonStock'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote2Member</xbrldi:explicitMemb
er><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='Y16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-Warrant'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote2Member</xbrldi:explicitMemb
er><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:WarrantMember</xbrldi:explicitMember></segment>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='E16Q2_DebtInstr-ShortTermPromissoryNote2_StEqComps-Warrant'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote2Member</xbrldi:explicitMemb
er><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:WarrantMember</xbrldi:explicitMember></segment>
</entity>
<period>
</period>
</entity>
<period>
</period>
</entity>
<period>
</period>
<entity>
</entity>
<period>
<instant>2016-06-30</instant>
</context>
<context id='E16Q2_DebtInstr-ShortTermPromissoryNote2'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:DebtInstrumentAxis'>fil:ShortTermPromissoryNote2Member</xbrldi:explicitMemb
er></segment>
<segment><xbrldi:explicitMember dimension='us-
<instant>2016-06-30</instant>
</context>
<context id='I150608_LegalEntity-PacificLeafVenturesLp'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember
dimension='dei:LegalEntityAxis'>fil:PacificLeafVenturesLpMember</xbrldi:explicit
Member></segment>
<instant>2015-06-08</instant>
</context>
<context id='Y16Q2_LegalEntity-PacificLeafVenturesLp'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember
dimension='dei:LegalEntityAxis'>fil:PacificLeafVenturesLpMember</xbrldi:explicit
Member></segment>
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='I160208_LegalEntity-PacificLeafVenturesLp'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember
dimension='dei:LegalEntityAxis'>fil:PacificLeafVenturesLpMember</xbrldi:explicit
Member></segment>
</entity>
<period>
<instant>2016-02-08</instant>
</period>
</context>
<context id='Y16Q2_LegalEntity-PacificLeafVenturesLp_StEqComps-
CommonStock'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember
dimension='dei:LegalEntityAxis'>fil:PacificLeafVenturesLpMember</xbrldi:explicit
Member><xbrldi:explicitMember dimension='us-
gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
</entity>
<period>
</period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='E16Q2_LegalEntity-PacificLeafVenturesLp'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember
dimension='dei:LegalEntityAxis'>fil:PacificLeafVenturesLpMember</xbrldi:explicit
Member></segment>
</entity>
<period>
<instant>2016-06-30</instant>
</period>
</context>
<context id='D150512_160630_LegalEntity-PacificLeafVenturesLp'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember
dimension='dei:LegalEntityAxis'>fil:PacificLeafVenturesLpMember</xbrldi:explicit
Member></segment>
</entity>
<period>
<startDate>2015-05-12</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='E16Q2_PpeByType-ComputerEquipment'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:ComputerEquipmentMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
<instant>2016-06-30</instant>
</context>
<context id='E16Q1_PpeByType-ComputerEquipment'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:ComputerEquipmentMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<entity>
<instant>2016-03-31</instant>
</context>
<context id='E16Q2_PpeByType-MachineryAndEquipment'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
<instant>2016-06-30</instant>
</context>
<context id='E16Q1_PpeByType-MachineryAndEquipment'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
</context>
<instant>2016-03-31</instant>
<context id='E16Q2_PpeByType-LeaseholdsAndLeaseholdImprovements'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></segment>
<instant>2016-06-30</instant>
</context>
<context id='E16Q1_PpeByType-LeaseholdsAndLeaseholdImprovements'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
<instant>2016-03-31</instant>
</context>
<context id='E16Q2_PpeByType-CnstrInProgress'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
<instant>2016-06-30</instant>
</context>
<context id='E16Q1_PpeByType-CnstrInProgress'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:PropertyPlantAndEquipmentByTypeAxis'>us-
gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<entity>
</entity>
<period>
</period>
<instant>2016-03-31</instant>
</context>
<context id='Y16Q2_StEqComps-CommonStock'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='Y16Q2_RelPtyTrnsByRelPty-Employees'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis'>fil:EmployeesMember</xbrldi:exp
licitMember></segment>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='E16Q2_StEqComps-CommonStock'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
<entity>
<instant>2016-06-30</instant>
</context>
<context id='Y16Q2_LitCase-InitialComplaintFiledByGrowblox'>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:LitigationCaseAxis'>fil:InitialComplaintFiledByGrowbloxMember</xbrldi:expli
citMember></segment>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</period>
</context>
<context id='Y16Q2_LitCase-Counterclaim'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:LitigationCaseAxis'>fil:CounterclaimMember</xbrldi:explicitMember></segment
>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</context>
<context id='D150401_160331_StEqComps-CommonStock'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
<startDate>2015-04-01</startDate>
<endDate>2016-03-31</endDate>
</context>
<context id='Y16Q2_RelPtyTrnsByRelPty-Employees_StEqComps-CommonStock'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis'>fil:EmployeesMember</xbrldi:exp
licitMember><xbrldi:explicitMember dimension='us-
gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
</entity>
<period>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</period>
</context>
<context id='I160809'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
</entity>
<period>
<instant>2016-08-09</instant>
</period>
</context>
<context id='D160721_SubsequentEventType-SubsequentEvent'>
<entity>
<identifier
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<segment><xbrldi:explicitMember dimension='us-
gaap:SubsequentEventTypeAxis'>us-
gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
</entity>
<period>
<startDate>2016-07-21</startDate>
<endDate>2016-07-21</endDate>
</context>
<context id='D160804_SubsequentEventType-SubsequentEvent'>
</period>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
gaap:SubsequentEventTypeAxis'>us-
gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
<segment><xbrldi:explicitMember dimension='us-
</entity>
<period>
</period>
<startDate>2016-08-04</startDate>
<endDate>2016-08-04</endDate>
</context>
<context id='D160809_StEqComps-CommonStock_SubsequentEventType-
SubsequentEvent'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember 
dimension='us-gaap:SubsequentEventTypeAxis'>us-
gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
</entity>
<period>
</period>
<startDate>2016-08-09</startDate>
<endDate>2016-08-09</endDate>
</context>
<context id='Y16Q2_RelPtyTrnsByRelPty-ChiefFinancialOfficer_StEqComps-
CommonStock'>
<entity>
scheme='http://www.sec.gov/CIK'>0001165320</identifier>
<identifier
<segment><xbrldi:explicitMember dimension='us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis'>us-
gaap:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember 
dimension='us-gaap:StatementEquityComponentsAxis'>us-
gaap:CommonStockMember</xbrldi:explicitMember></segment>
<startDate>2016-04-01</startDate>
<endDate>2016-06-30</endDate>
</entity>
<period>
</period>
</context>
<unit id='Pure'>
</unit>
<unit id='USD'>
<measure>pure</measure>
<measure>iso4217:USD</measure>
</unit>
<unit id='Shares'>
<measure>shares</measure>
</unit>
<unit id='UsdPerShare'>
<divide>
<unitNumerator>
<measure>iso4217:USD</measure>
</unitNumerator>
<unitDenominator>
<measure>shares</measure>
</unitDenominator>
</divide>
</unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>gblx-20160630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., 
Copyright (C) 2008-2016 [PPXCRNPC214XVNLVLZZU]. www.edgarsuite.com -->
<schema xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' 
xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-
gaap/2015-01-31' xmlns:invest='http://xbrl.sec.gov/invest/2013-01-31' 
xmlns:fil='http://www.growbloxsciences.com/20160630' 
xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' 
xmlns:xlink='http://www.w3.org/1999/xlink' 
xmlns:xbrldt='http://xbrl.org/2005/xbrldt' 
xmlns:num='http://www.xbrl.org/dtr/type/numeric' 
targetNamespace='http://www.growbloxsciences.com/20160630' 
xmlns:link='http://www.xbrl.org/2003/linkbase' elementFormDefault='qualified' 
xmlns:xbrli='http://www.xbrl.org/2003/instance' 
attributeFormDefault='unqualified'>
<annotation>
<appinfo>
20160630_pre.xml"
<link:linkbaseRef xlink:type="simple" xlink:href="gblx-
xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="gblx-
20160630_def.xml" 
xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="gblx-
20160630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="gblx-
20160630_cal.xml" 
xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePa
yable" id="idr_DisclosureNote4NotePayable">
Payable</link:definition>
<link:definition>000090 - Disclosure - Note 4 - Note
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingC
oncern" id="idr_DisclosureNote2GoingConcern">
<link:definition>000070 - Disclosure - Note 2 - Going
Concern</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETS" id="idr_CONSOLIDATEDCONDENSEDBALANCESHEETS">
CONDENSED BALANCE SHEETS</link:definition>
<link:definition>000020 - Statement - CONSOLIDATED
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDATED
STATEMENTSOFCASHFLOWS" id="idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
<link:definition>000050 - Statement - CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subseq
uentEventsDetails" id="idr_DisclosureNote9SubsequentEventsDetails">
Subsequent Events (Details)</link:definition>
<link:definition>000240 - Disclosure - Note 9 -
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subseq
uentEvents" id="idr_DisclosureNote9SubsequentEvents">
Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:definition>000140 - Disclosure - Note 9 -
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Conver
tibleNotes" id="idr_DisclosureNote3ConvertibleNotes">
Convertible Notes</link:definition>
<link:definition>000080 - Disclosure - Note 3 -
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERATION
S" id="idr_STATEMENTSOFOPERATIONS">
<link:definition>000040 - Statement - STATEMENTS OF
OPERATIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePa
yableDetails" id="idr_DisclosureNote4NotePayableDetails">
Payable (Details)</link:definition>
<link:definition>000190 - Disclosure - Note 4 - Note
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Conver
tibleNotesDetails" id="idr_DisclosureNote3ConvertibleNotesDetails">
<link:definition>000180 - Disclosure - Note 3 -
Convertible Notes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETSParenthetical" 
id="idr_CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical">
<link:definition>000030 - Statement - CONSOLIDATED
CONDENSED BALANCE SHEETS (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Capita
lTransactionsDetails" id="idr_DisclosureNote6CapitalTransactionsDetails">
Transactions (Details)</link:definition>
<link:definition>000210 - Disclosure - Note 6 - Capital
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipment" id="idr_DisclosureNote5PropertyAndEquipment">
<link:definition>000100 - Disclosure - Note 5 - Property
and Equipment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPe
rShare" id="idr_DisclosureNote8LossPerShare">
Share</link:definition>
<link:definition>000130 - Disclosure - Note 8 - Loss Per
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DocumentDocumentAndEn
tityInformation" id="idr_DocumentDocumentAndEntityInformation">
<link:definition>000010 - Document - Document and Entity
Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisO
fPresentationAndSignificantAccountingPoliciesPolicies" 
id="idr_DisclosureNote1BasisOfPresentationAndSignificantAccountingPoliciesPolici
es">
Presentation and Significant Accounting Policies (Policies)</link:definition>
<link:definition>000150 - Disclosure - Note 1 - Basis of
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipmentScheduleOfPropertyAndEquipmentBalancesDetails" 
id="idr_DisclosureNote5PropertyAndEquipmentScheduleOfPropertyAndEquipmentBalance
sDetails">
<link:definition>000200 - Disclosure - Note 5 - Property
and Equipment: Schedule of Property and Equipment Balances 
(Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPe
rShareDetails" id="idr_DisclosureNote8LossPerShareDetails">
<link:definition>000230 - Disclosure - Note 8 - Loss Per
Share (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Capita
lTransactions" id="idr_DisclosureNote6CapitalTransactions">
Transactions</link:definition>
<link:definition>000110 - Disclosure - Note 6 - Capital
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commit
mentsAndContingencies" id="idr_DisclosureNote7CommitmentsAndContingencies">
<link:definition>000120 - Disclosure - Note 7 -
Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisO
fPresentationAndSignificantAccountingPolicies" 
id="idr_DisclosureNote1BasisOfPresentationAndSignificantAccountingPolicies">
<link:definition>000060 - Disclosure - Note 1 - Basis of
Presentation and Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipmentTables" id="idr_DisclosureNote5PropertyAndEquipmentTables">
and Equipment (Tables)</link:definition>
<link:definition>000160 - Disclosure - Note 5 - Property
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commit
mentsAndContingenciesDetails" 
id="idr_DisclosureNote7CommitmentsAndContingenciesDetails">
Commitments and Contingencies (Details)</link:definition>
<link:definition>000220 - Disclosure - Note 7 -
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingC
oncernDetails" id="idr_DisclosureNote2GoingConcernDetails">
<link:definition>000170 - Disclosure - Note 2 - Going
Concern (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
</appinfo>
</annotation>
<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-
31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-
16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-
16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd'
namespace='http://xbrl.org/2005/xbrldt'/>
<import namespace='http://fasb.org/us-gaap/2015-01-31'
schemaLocation='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-
31.xsd' />
<import namespace='http://xbrl.sec.gov/dei/2014-01-31'
schemaLocation='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd' />
<element abstract='true' nillable='true' type='xbrli:stringItemType'
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_DocumentAndEntityInformationAbstract' 
name='DocumentAndEntityInformationAbstract' />
<element nillable='true' type='nonnum:domainItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_PacificLeafVenturesLpMember' name='PacificLeafVenturesLpMember' />
<element nillable='true' type='nonnum:domainItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_EmployeesMember' name='EmployeesMember' />
<element nillable='true' type='nonnum:domainItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_InitialComplaintFiledByGrowbloxMember' 
name='InitialComplaintFiledByGrowbloxMember' />
<element nillable='true' type='nonnum:domainItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_CounterclaimMember' name='CounterclaimMember' />
<element nillable='true' type='xbrli:stringItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_RoyaltyAgreementAmendedTerms' name='RoyaltyAgreementAmendedTerms' />
<element nillable='true' type='nonnum:domainItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_ShortTermPromissoryNote1Member' name='ShortTermPromissoryNote1Member' />
<element nillable='true' type='nonnum:domainItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_ShortTermPromissoryNote2Member' name='ShortTermPromissoryNote2Member' />
<element nillable='true' type='num:percentItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='instant' 
id='fil_DebtDiscountRate' name='DebtDiscountRate' />
<element nillable='true' type='xbrli:monetaryItemType'
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
xbrli:balance='credit' id='fil_StockIssuedToSettleAdvance' 
name='StockIssuedToSettleAdvance' />
<element nillable='true' type='xbrli:stringItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_UnitsDescription' name='UnitsDescription' />
<element nillable='true' type='nonnum:textBlockItemType'
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
xmlns:fil="http://www.growbloxsciences.com/20160630"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance">
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETS" xlink:type="simple" xlink:href="gblx-
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_ConvertibleNotes0TextBlock' name='ConvertibleNotes0TextBlock' />
<element nillable='true' type='xbrli:stringItemType' 
substitutionGroup='xbrli:item' xbrli:periodType='duration' 
id='fil_SettlementAgreementTerms' name='SettlementAgreementTerms' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>gblx-20160630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., 
Copyright (C) 2008-2016 [PPXCRNPC214XVNLVLZZU]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase
20160630.xsd#idr_CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
<link:calculationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDEN
SEDBALANCESHEETS">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets' xlink:label='us-
gaap_Assets'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent' 
xlink:label='us-gaap_DepositsAssetsNoncurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_Assets' xlink:to='us-gaap_DepositsAssetsNoncurrent' use='optional' 
order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssets' xlink:label='us-
gaap_OtherAssets'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_Assets' xlink:to='us-gaap_OtherAssets' use='optional' order='2.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' 
xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_Assets' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' 
order='3.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-
gaap_AssetsCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_Assets' xlink:to='us-gaap_AssetsCurrent' use='optional' order='4.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' 
xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_AssetsCurrent' xlink:to='us-gaap_AccountsReceivableNetCurrent' 
use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-
gaap_CashAndCashEquivalentsAtCarryingValue'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_AssetsCurrent' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' 
use='optional' order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent' 
xlink:label='us-gaap_PrepaidExpenseCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_AssetsCurrent' xlink:to='us-gaap_PrepaidExpenseCurrent' use='optional' 
order='3.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' 
xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:label='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest' xlink:label='us-
gaap_MinorityInterest'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:to='us-gaap_MinorityInterest' use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity' 
xlink:label='us-gaap_StockholdersEquity'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:to='us-gaap_StockholdersEquity' use='optional' order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-
gaap_RetainedEarningsAccumulatedDeficit'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_StockholdersEquity' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' 
use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital' 
xlink:label='us-gaap_AdditionalPaidInCapital'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_StockholdersEquity' xlink:to='us-gaap_AdditionalPaidInCapital' 
use='optional' order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-
gaap_CommonStockValue'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_StockholdersEquity' xlink:to='us-gaap_CommonStockValue' use='optional' 
order='3.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity' 
xlink:label='us-gaap_DeferredCompensationEquity'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_StockholdersEquity' xlink:to='us-gaap_DeferredCompensationEquity' 
use='optional' order='4.0' weight='-1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities' xlink:label='us-
gaap_Liabilities'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_Liabilities' 
use='optional' order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermNotesPayable' 
xlink:label='us-gaap_LongTermNotesPayable'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_Liabilities' xlink:to='us-gaap_LongTermNotesPayable' use='optional' 
order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent' 
xlink:label='us-gaap_LiabilitiesCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_Liabilities' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' 
order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent' 
xlink:label='us-gaap_AccountsPayableCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableCurrent' 
use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent' 
xlink:label='us-gaap_InterestPayableCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_LiabilitiesCurrent' xlink:to='us-gaap_InterestPayableCurrent' 
use='optional' order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' 
xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccruedLiabilitiesCurrent' 
use='optional' order='3.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableCurrent' 
xlink:label='us-gaap_NotesPayableCurrent'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_LiabilitiesCurrent' xlink:to='us-gaap_NotesPayableCurrent' use='optional' 
order='4.0' weight='1.0'/>
</link:calculationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERATION
S" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_STATEMENTSOFOPERATIONS"/>
<link:calculationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERAT
IONS">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-
gaap_NetIncomeLoss'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-
gaap_ProfitLoss'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetIncomeLoss' xlink:to='us-gaap_ProfitLoss' use='optional' order='1.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss' 
xlink:label='us-gaap_OperatingIncomeLoss'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_ProfitLoss' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' 
order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues' xlink:label='us-
gaap_Revenues'/>
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
<link:calculationArc xlink:type='arc'
gaap_OperatingIncomeLoss' xlink:to='us-gaap_Revenues' use='optional' order='1.0'
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' 
xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_OperatingIncomeLoss' xlink:to='us-gaap_GeneralAndAdministrativeExpense' 
use='optional' order='2.0' weight='-1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense' 
xlink:label='us-gaap_NonoperatingIncomeExpense'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_ProfitLoss' xlink:to='us-gaap_NonoperatingIncomeExpense' use='optional' 
order='2.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense' 
xlink:label='us-gaap_OtherNonoperatingIncomeExpense'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NonoperatingIncomeExpense' xlink:to='us-
gaap_OtherNonoperatingIncomeExpense' use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-
gaap_InterestExpense'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NonoperatingIncomeExpense' xlink:to='us-gaap_InterestExpense' 
use='optional' order='2.0' weight='-1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncomeLossAttributableToNoncontrollingInterest' xlink:label='us-
gaap_IncomeLossAttributableToNoncontrollingInterest'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetIncomeLoss' xlink:to='us-
gaap_IncomeLossAttributableToNoncontrollingInterest' use='optional' order='2.0' 
weight='-1.0'/>
</link:calculationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDATED
STATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
<link:calculationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDA
TEDSTATEMENTSOFCASHFLOWS">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInFinancingActivities'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-
gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='1.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:label='us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' use='optional' order='1.0'
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock'
xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-
gaap_ProceedsFromIssuanceOfCommonStock' use='optional' order='2.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders' 
xlink:label='us-gaap_ProceedsFromMinorityShareholders'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-
gaap_ProceedsFromMinorityShareholders' use='optional' order='3.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable' 
xlink:label='us-gaap_ProceedsFromNotesPayable'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-
gaap_ProceedsFromNotesPayable' use='optional' order='4.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants' 
xlink:label='us-gaap_PaymentsForRepurchaseOfWarrants'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-
gaap_PaymentsForRepurchaseOfWarrants' use='optional' order='5.0' weight='-1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInInvestingActivities'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-
gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='2.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInDepositOtherAssets' xlink:label='us-
gaap_IncreaseDecreaseInDepositOtherAssets'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-
gaap_IncreaseDecreaseInDepositOtherAssets' use='optional' order='1.0' weight='-
1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' use='optional' order='2.0' 
weight='-1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInOperatingActivities'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-
gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='3.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable'
xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_IncreaseDecreaseInAccountsPayable' use='optional' order='1.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-
gaap_IncreaseDecreaseInAccruedLiabilities'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='2.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium'
xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_AmortizationOfDebtDiscountPremium' use='optional' order='3.0' 
weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization' 
xlink:label='us-gaap_DepreciationAndAmortization'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_DepreciationAndAmortization' use='optional' order='4.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-
gaap_ProfitLoss'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_ProfitLoss' 
use='optional' order='5.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation' 
xlink:label='us-gaap_ShareBasedCompensation'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_ShareBasedCompensation' use='optional' order='6.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' xlink:label='us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' use='optional' 
order='7.0' weight='-1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' 
order='8.0' weight='-1.0'/>
</link:calculationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipment" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipment"/>
<link:calculationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipment">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' 
xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' 
xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_PropertyPlantAndEquipmentNet' xlink:to='us-
gaap_PropertyPlantAndEquipmentGross' use='optional' order='1.0' weight='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:label='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
<link:calculationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-
gaap_PropertyPlantAndEquipmentNet' xlink:to='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
use='optional' order='2.0' weight='-1.0'/>
</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>gblx-20160630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., 
Copyright (C) 2008-2016 [PPXCRNPC214XVNLVLZZU]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
xmlns:fil="http://www.growbloxsciences.com/20160630"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all"
xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-
dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-
2005.xsd#hypercube-dimension"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-
default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-
2005.xsd#dimension-default"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-
domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-
2005.xsd#dimension-domain"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-
2005.xsd#domain-member"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DocumentDocumentAndEn
tityInformation" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DocumentDocumentAndEntityInformation"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DocumentDocumentAn
dEntityInformation"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETS" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDEN
SEDBALANCESHEETS"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETSParenthetical" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDEN
SEDBALANCESHEETSParenthetical"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERATION
S" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_STATEMENTSOFOPERATIONS"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERAT
IONS"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDATED
STATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDA
TEDSTATEMENTSOFCASHFLOWS"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisO
fPresentationAndSignificantAccountingPolicies" xlink:type="simple" 
xlink:href="gblx-
20160630.xsd#idr_DisclosureNote1BasisOfPresentationAndSignificantAccountingPolic
ies"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1Bas
isOfPresentationAndSignificantAccountingPolicies"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingC
oncern" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote2GoingConcern"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2Goi
ngConcern"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Conver
tibleNotes" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote3ConvertibleNotes"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Con
vertibleNotes"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePa
yable" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote4NotePayable"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4Not
ePayable"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipment" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipment"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipment"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Capita
lTransactions" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote6CapitalTransactions"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Cap
italTransactions"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commit
mentsAndContingencies" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote7CommitmentsAndContingencies"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Com
mitmentsAndContingencies"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPe
rShare" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote8LossPerShare"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8Los
sPerShare"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subseq
uentEvents" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote9SubsequentEvents"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Sub
sequentEvents"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisO
fPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" 
xlink:href="gblx-
20160630.xsd#idr_DisclosureNote1BasisOfPresentationAndSignificantAccountingPolic
iesPolicies"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1Bas
isOfPresentationAndSignificantAccountingPoliciesPolicies"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipmentTables" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipmentTables"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipmentTables"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingC
oncernDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote2GoingConcernDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2Goi
ngConcernDetails"/>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Conver
tibleNotesDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote3ConvertibleNotesDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Con
vertibleNotesDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis' 
xlink:label='us-gaap_DebtInstrumentAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_DebtInstrumentAxis' 
use='optional' order='1.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain' 
xlink:label='us-gaap_DebtInstrumentNameDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_DebtInstrumentAxis' xlink:to='us-gaap_DebtInstrumentNameDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain' 
xlink:label='us-gaap_DebtInstrumentNameDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='us-
gaap_DebtInstrumentNameDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ShortTermPromissoryNote1Member' 
xlink:label='fil_ShortTermPromissoryNote1Member'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_DebtInstrumentNameDomain' xlink:to='fil_ShortTermPromissoryNote1Member' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ShortTermPromissoryNote2Member' 
xlink:label='fil_ShortTermPromissoryNote2Member'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_DebtInstrumentNameDomain' xlink:to='fil_ShortTermPromissoryNote2Member' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_StatementEquityComponentsAxis' use='optional' order='2.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-
gaap_EquityComponentDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember' xlink:label='us-
gaap_WarrantMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_WarrantMember' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' 
xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' 
xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_ProceedsFromConvertibleDebt' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_DebtDiscountRate' xlink:label='fil_DebtDiscountRate'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_DebtDiscountRate' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentInterestRateEffectivePercentage' xlink:label='us-
gaap_DebtInstrumentInterestRateEffectivePercentage'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentInterestRateEffectivePercentage' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' xlink:label='us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' use='optional' 
order='5.0'/>
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' xlink:label='us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' xlink:label='us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' use='optional' 
order='7.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount'
xlink:label='us-gaap_DebtInstrumentUnamortizedDiscount'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentUnamortizedDiscount' 
use='optional' order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent' 
xlink:label='us-gaap_ConvertibleNotesPayableCurrent'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_ConvertibleNotesPayableCurrent' 
use='optional' order='9.0'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePa
yableDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote4NotePayableDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4Not
ePayableDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis'
xlink:label='dei_LegalEntityAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='dei_LegalEntityAxis' 
use='optional' order='1.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' 
xlink:from='dei_LegalEntityAxis' xlink:to='dei_EntityDomain' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain_1'/>
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default'
<link:definitionArc xlink:type='arc'
xlink:from='dei_LegalEntityAxis' xlink:to='dei_EntityDomain_1' use='optional' 
order='1.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_PacificLeafVenturesLpMember' 
xlink:label='fil_PacificLeafVenturesLpMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' 
xlink:from='dei_EntityDomain' xlink:to='fil_PacificLeafVenturesLpMember' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_StatementEquityComponentsAxis' use='optional' order='2.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-
gaap_EquityComponentDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' 
xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleConversionPrice1' xlink:label='us-
gaap_DebtInstrumentConvertibleConversionPrice1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleConversionPrice1' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentInterestRateStatedPercentage' xlink:label='us-
gaap_DebtInstrumentInterestRateStatedPercentage'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentInterestRateStatedPercentage' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate' 
xlink:label='us-gaap_DebtInstrumentMaturityDate'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentMaturityDate' 
use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount' 
xlink:label='us-gaap_DebtInstrumentCarryingAmount'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentCarryingAmount' 
use='optional' order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:label='us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms' 
xlink:label='us-gaap_DebtInstrumentPaymentTerms'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentPaymentTerms' 
use='optional' order='7.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_RoyaltyAgreementAmendedTerms' 
xlink:label='fil_RoyaltyAgreementAmendedTerms'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_RoyaltyAgreementAmendedTerms' 
use='optional' order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' use='optional' 
order='9.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentAmount1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentAmount1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentAmount1' use='optional' order='10.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' 
xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_ProceedsFromConvertibleDebt' 
use='optional' order='11.0'/>
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
<link:definitionArc xlink:type='arc'
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipmentScheduleOfPropertyAndEquipmentBalancesDetails" xlink:type="simple"
xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipmentScheduleOfPropertyAndEquipme
ntBalancesDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipmentScheduleOfPropertyAndEquipmentBalancesDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-
gaap_PropertyPlantAndEquipmentByTypeAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-
gaap_PropertyPlantAndEquipmentTypeDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_PropertyPlantAndEquipmentTypeDomain' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-
gaap_PropertyPlantAndEquipmentTypeDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_PropertyPlantAndEquipmentTypeDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MachineryAndEquipmentMember' 
xlink:label='us-gaap_MachineryAndEquipmentMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-
gaap_MachineryAndEquipmentMember' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember' 
xlink:label='us-gaap_ComputerEquipmentMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-
gaap_ComputerEquipmentMember' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:label='us-
gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressMember' 
xlink:label='us-gaap_ConstructionInProgressMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-
gaap_ConstructionInProgressMember' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' 
xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:label='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' 
xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' 
use='optional' order='3.0'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Capita
lTransactionsDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote6CapitalTransactionsDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Cap
italTransactionsDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_StatementEquityComponentsAxis' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-
gaap_EquityComponentDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' use='optional' order='2.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_RelatedPartyDomain' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_RelatedPartyDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
20160630.xsd#fil_EmployeesMember' xlink:label='fil_EmployeesMember'/>
<link:loc xlink:type='locator' xlink:href='gblx-
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_RelatedPartyDomain' xlink:to='fil_EmployeesMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefFinancialOfficerMember' 
xlink:label='us-gaap_ChiefFinancialOfficerMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_RelatedPartyDomain' xlink:to='us-gaap_ChiefFinancialOfficerMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis'
xlink:label='dei_LegalEntityAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='dei_LegalEntityAxis' 
use='optional' order='3.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' 
xlink:from='dei_LegalEntityAxis' xlink:to='dei_EntityDomain' use='optional'
order='1.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='dei_LegalEntityAxis' xlink:to='dei_EntityDomain_1' use='optional' 
order='1.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_PacificLeafVenturesLpMember' 
xlink:label='fil_PacificLeafVenturesLpMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' 
xlink:from='dei_EntityDomain' xlink:to='fil_PacificLeafVenturesLpMember' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AllocatedShareBasedCompensationExpense' xlink:label='us-
gaap_AllocatedShareBasedCompensationExpense'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_AllocatedShareBasedCompensationExpense' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
xlink:label='us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1'
xlink:label='us-gaap_DebtConversionOriginalDebtAmount1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtConversionOriginalDebtAmount1' 
use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleConversionPrice1' xlink:label='us-
gaap_DebtInstrumentConvertibleConversionPrice1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleConversionPrice1' use='optional' order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice' xlink:label='us-
gaap_SharePrice'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_SharePrice' use='optional' 
order='7.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' xlink:label='us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' use='optional' 
order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
xlink:label='us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
use='optional' order='9.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
xlink:label='us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
use='optional' order='10.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' 
use='optional' order='11.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' use='optional' 
order='12.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-
gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
<link:definitionArc xlink:type='arc'
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' use='optional' 
order='13.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentAmount1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentAmount1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentAmount1' use='optional' order='14.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesNewIssues' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesNewIssues'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesNewIssues' use='optional' order='15.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueNewIssues' xlink:label='us-
gaap_StockIssuedDuringPeriodValueNewIssues'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueNewIssues' use='optional' order='16.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_UnitsDescription' xlink:label='fil_UnitsDescription'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_UnitsDescription' use='optional' 
order='17.0'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commit
mentsAndContingenciesDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote7CommitmentsAndContingenciesDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Com
mitmentsAndContingenciesDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseAxis' 
xlink:label='us-gaap_LitigationCaseAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LitigationCaseAxis' 
use='optional' order='1.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseTypeDomain' 
xlink:label='us-gaap_LitigationCaseTypeDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_LitigationCaseAxis' xlink:to='us-gaap_LitigationCaseTypeDomain' 
use='optional' order='1.0'/>
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseTypeDomain'
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
xlink:label='us-gaap_LitigationCaseTypeDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_LitigationCaseAxis' xlink:to='us-
gaap_LitigationCaseTypeDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_InitialComplaintFiledByGrowbloxMember' 
xlink:label='fil_InitialComplaintFiledByGrowbloxMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_LitigationCaseTypeDomain' 
xlink:to='fil_InitialComplaintFiledByGrowbloxMember' use='optional' 
order='1.0'/>
20160630.xsd#fil_CounterclaimMember' xlink:label='fil_CounterclaimMember'/>
<link:loc xlink:type='locator' xlink:href='gblx-
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_LitigationCaseTypeDomain' xlink:to='fil_CounterclaimMember' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_StatementEquityComponentsAxis' use='optional' order='2.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-
gaap_EquityComponentDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' use='optional' order='3.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain'/>
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
<link:definitionArc xlink:type='arc'
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_RelatedPartyDomain' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_RelatedPartyDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefFinancialOfficerMember' 
xlink:label='us-gaap_ChiefFinancialOfficerMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_RelatedPartyDomain' xlink:to='us-gaap_ChiefFinancialOfficerMember' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue'
xlink:label='us-gaap_LossContingencyDamagesSoughtValue'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_LossContingencyDamagesSoughtValue' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_SettlementAgreementTerms' 
xlink:label='fil_SettlementAgreementTerms'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_SettlementAgreementTerms' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualProvision' 
xlink:label='us-gaap_LossContingencyAccrualProvision'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_LossContingencyAccrualProvision' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' 
use='optional' order='4.0'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPe
rShareDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote8LossPerShareDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8Los
sPerShareDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_StatementEquityComponentsAxis' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-
gaap_EquityComponentDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
xlink:label='us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
use='optional' order='1.0'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subseq
uentEventsDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote9SubsequentEventsDetails"/>
<link:definitionLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Sub
sequentEventsDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis' 
xlink:label='us-gaap_SubsequentEventTypeAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_SubsequentEventTypeAxis'
use='optional' order='1.0' xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain' 
xlink:label='us-gaap_SubsequentEventTypeDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_SubsequentEventTypeAxis' xlink:to='us-gaap_SubsequentEventTypeDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain' 
xlink:label='us-gaap_SubsequentEventTypeDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='us-
gaap_SubsequentEventTypeDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember' 
xlink:label='us-gaap_SubsequentEventMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_SubsequentEventTypeDomain' xlink:to='us-gaap_SubsequentEventMember' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' 
xlink:from='us-gaap_StatementTable' xlink:to='us-
gaap_StatementEquityComponentsAxis' use='optional' order='2.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain_1'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' 
xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-
gaap_EquityComponentDomain_1' use='optional' order='1.0' 
xbrldt:contextElement='segment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' xlink:label='us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' use='optional'
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_RoyaltyAgreementAmendedTerms' 
xlink:label='fil_RoyaltyAgreementAmendedTerms'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_RoyaltyAgreementAmendedTerms' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' 
use='optional' order='3.0'/>
<link:definitionArc xlink:type='arc'
xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' 
xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>gblx-20160630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., 
Copyright (C) 2008-2016 [PPXCRNPC214XVNLVLZZU]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
xmlns:fil="http://www.growbloxsciences.com/20160630"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance">
<roleRef xlink:type="simple"
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
<roleRef xlink:type="simple"
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedPeriodEndLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
<roleRef xlink:type="simple"
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedPeriodStartLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
<roleRef xlink:type="simple"
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedTerseLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
<roleRef xlink:type="simple"
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedTotalLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
<link:labelLink xlink:type="extended"
xlink:role="http://www.xbrl.org/2003/role/link">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefFinancialOfficerMember' 
xlink:label='us-gaap_ChiefFinancialOfficerMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ChiefFinancialOfficerMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Chief 
Financial Officer</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ChiefFinancialOfficerMember' xlink:to='lab_us-
gaap_ChiefFinancialOfficerMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MachineryAndEquipmentMember' 
xlink:label='us-gaap_MachineryAndEquipmentMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_MachineryAndEquipmentMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Machinery and 
Equipment</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_MachineryAndEquipmentMember' xlink:to='lab_us-
gaap_MachineryAndEquipmentMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember' 
xlink:label='us-gaap_ComputerEquipmentMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ComputerEquipmentMember' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Computer and Software</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ComputerEquipmentMember' xlink:to='lab_us-gaap_ComputerEquipmentMember'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ShortTermPromissoryNote1Member' 
xlink:label='fil_ShortTermPromissoryNote1Member'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_ShortTermPromissoryNote1Member' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Short-term 
Promissory Note 1</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_ShortTermPromissoryNote1Member' 
xlink:to='lab_fil_ShortTermPromissoryNote1Member'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable' 
xlink:label='us-gaap_ProceedsFromNotesPayable'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProceedsFromNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Proceeds from notes payable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ProceedsFromNotesPayable' xlink:to='lab_us-gaap_ProceedsFromNotesPayable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INVESTING 
ACTIVITIES:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid 
expenses and other assets</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Prepaid
expenses and other assets</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:to='lab_us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Changes in 
operating assets and liabilities:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='lab_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' 
xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_GeneralAndAdministrativeExpense' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>GENERAL AND 
ADMINISTRATIVE EXPENSES</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_GeneralAndAdministrativeExpense' xlink:to='lab_us-
gaap_GeneralAndAdministrativeExpense'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues' xlink:label='us-
gaap_Revenues'/>
<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues'
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NET 
REVENUE</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_Revenues' xlink:to='lab_us-gaap_Revenues'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent' 
xlink:label='us-gaap_LiabilitiesCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>TOTAL CURRENT LIABILITIES</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>TOTAL CURRENT LIABILITIES</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent' 
xlink:label='us-gaap_DepositsAssetsNoncurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DepositsAssetsNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Deposits and Prepayments</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DepositsAssetsNoncurrent' xlink:to='lab_us-gaap_DepositsAssetsNoncurrent'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract' 
xlink:label='us-gaap_AssetsCurrentAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>CURRENT ASSETS:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StatementOfFinancialPositionAbstract' xlink:label='us-
gaap_StatementOfFinancialPositionAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StatementOfFinancialPositionAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement of 
Financial Position</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='lab_us-
gaap_StatementOfFinancialPositionAbstract'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCurrentReportingStatus' 
xlink:label='dei_EntityCurrentReportingStatus'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityCurrentReportingStatus' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current
Reporting Status</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityCurrentReportingStatus' 
xlink:to='lab_dei_EntityCurrentReportingStatus'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
xlink:label='us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
xlink:to='lab_us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures'/>
20160630.xsd#fil_EmployeesMember' xlink:label='fil_EmployeesMember'/>
<link:loc xlink:type='locator' xlink:href='gblx-
<link:label xlink:type='resource'
xlink:label='lab_fil_EmployeesMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Employees</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_EmployeesMember' xlink:to='lab_fil_EmployeesMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount' 
xlink:label='us-gaap_DebtInstrumentCarryingAmount'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentCarryingAmount' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term 
Debt, Gross</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentCarryingAmount' xlink:to='lab_us-
gaap_DebtInstrumentCarryingAmount'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent' 
xlink:label='us-gaap_ConvertibleNotesPayableCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ConvertibleNotesPayableCurrent' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 
balance</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ConvertibleNotesPayableCurrent' xlink:to='lab_us-
gaap_ConvertibleNotesPayableCurrent'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Statement [Table]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-
gaap_StockholdersEquityNoteDisclosureTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockholdersEquityNoteDisclosureTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 6 - 
Capital Transactions</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-
gaap_StockholdersEquityNoteDisclosureTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:label='us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other 
financing activities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:to='lab_us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation' 
xlink:label='us-gaap_ShareBasedCompensation'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ShareBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Stock-based compensation</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ShareBasedCompensation' xlink:to='lab_us-gaap_ShareBasedCompensation'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncomeLossAttributableToNoncontrollingInterest' xlink:label='us-
gaap_IncomeLossAttributableToNoncontrollingInterest'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncomeLossAttributableToNoncontrollingInterest' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income/
(loss) attributable to non-controlling interest</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncomeLossAttributableToNoncontrollingInterest' xlink:to='lab_us-
gaap_IncomeLossAttributableToNoncontrollingInterest'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' 
xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LiabilitiesCurrentAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CURRENT 
LIABILITIES:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-
gaap_LiabilitiesCurrentAbstract'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityPublicFloat' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Public 
Float</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_DocumentAndEntityInformationAbstract' 
xlink:label='fil_DocumentAndEntityInformationAbstract'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_DocumentAndEntityInformationAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and 
Entity Information:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
xlink:label='us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Antidilutive 
Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
xlink:to='lab_us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue'
xlink:label='us-gaap_LossContingencyDamagesSoughtValue'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LossContingencyDamagesSoughtValue' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss 
Contingency, Damages Sought, Value</link:label>
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
<link:labelArc order='1.0' xlink:type='arc'
gaap_LossContingencyDamagesSoughtValue' xlink:to='lab_us-
gaap_LossContingencyDamagesSoughtValue'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentInterestRateEffectivePercentage' xlink:label='us-
gaap_DebtInstrumentInterestRateEffectivePercentage'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentInterestRateEffectivePercentage' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Nominal 
rate</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentInterestRateEffectivePercentage' xlink:to='lab_us-
gaap_DebtInstrumentInterestRateEffectivePercentage'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium'
xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AmortizationOfDebtDiscountPremium' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization 
of debt discount and beneficial conversion feature</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AmortizationOfDebtDiscountPremium' xlink:to='lab_us-
gaap_AmortizationOfDebtDiscountPremium'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-
gaap_NetIncomeLoss'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>NET LOSS ATTRIBUTABLE TO GROWBLOX SCIENCES, INC.</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>NET LOSS ATTRIBUTABLE TO GROWBLOX SCIENCES, INC.</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' 
xlink:label='dei_AmendmentFlag'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_AmendmentFlag' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment 
Flag</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualProvision' 
xlink:label='us-gaap_LossContingencyAccrualProvision'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LossContingencyAccrualProvision' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss 
Contingency Accrual, Provision</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LossContingencyAccrualProvision' xlink:to='lab_us-
gaap_LossContingencyAccrualProvision'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_SettlementAgreementTerms' 
xlink:label='fil_SettlementAgreementTerms'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_SettlementAgreementTerms' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Settlement
agreement, terms</link:label>
<link:label xlink:type='resource'
xlink:label='lab_fil_SettlementAgreementTerms' 
xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Legal 
settlement agreement terms</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_SettlementAgreementTerms' 
xlink:to='lab_fil_SettlementAgreementTerms'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
xlink:label='us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
xlink:to='lab_us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' xlink:label='us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise 
price</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' xlink:to='lab_us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' 
xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_TableTextBlockSupplementAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Tables/Schedules</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_TableTextBlockSupplementAbstract' xlink:to='lab_us-
gaap_TableTextBlockSupplementAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 7 - 
Commitments and Contingencies</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:to='lab_us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DisclosureTextBlockAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Notes</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='lab_us-
gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants' 
xlink:label='us-gaap_PaymentsForRepurchaseOfWarrants'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PaymentsForRepurchaseOfWarrants' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash used to 
purchase warrants</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PaymentsForRepurchaseOfWarrants' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Cash 
used to purchase warrants</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PaymentsForRepurchaseOfWarrants' xlink:to='lab_us-
gaap_PaymentsForRepurchaseOfWarrants'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-
gaap_IncreaseDecreaseInAccruedLiabilities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInAccruedLiabilities' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued 
expenses</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-
gaap_IncreaseDecreaseInAccruedLiabilities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableCurrent' 
xlink:label='us-gaap_NotesPayableCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NotesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Notes Payable, net of unamortized discount of $0.3 million and 
$0.4 million at June 30, 2016 and March 31, 2016, respectively</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NotesPayableCurrent' xlink:to='lab_us-gaap_NotesPayableCurrent'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets' xlink:label='us-
gaap_Assets'/>
<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets'
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL 
ASSETS</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets'
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL 
ASSETS</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityRegistrantName' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity 
Registrant Name</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' xlink:label='us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Lessee Leasing
Arrangements, Operating Leases, Term of Contract</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' xlink:to='lab_us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract'/>
20160630.xsd#fil_CounterclaimMember' xlink:label='fil_CounterclaimMember'/>
<link:loc xlink:type='locator' xlink:href='gblx-
<link:label xlink:type='resource'
xlink:label='lab_fil_CounterclaimMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Counterclaim</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_CounterclaimMember' xlink:to='lab_fil_CounterclaimMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Conversion, Converted Instrument, Shares Issued</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' xlink:to='lab_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain'/>
<link:label xlink:type='resource' xlink:label='lab_dei_EntityDomain'
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Entity</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityDomain' xlink:to='lab_dei_EntityDomain'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized' 
xlink:label='us-gaap_CommonStockSharesAuthorized'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommonStockSharesAuthorized' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, 
shares authorized</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommonStockSharesAuthorized' xlink:to='lab_us-
gaap_CommonStockSharesAuthorized'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity' 
xlink:label='us-gaap_StockholdersEquity'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>TOTAL GROWBLOX SCIENCES, INC. STOCKHOLDERS&apos; 
(DEFICIT)/EQUITY</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>TOTAL GROWBLOX SCIENCES, INC. STOCKHOLDERS&apos; 
(DEFICIT)/EQUITY</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities' xlink:label='us-
gaap_Liabilities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>TOTAL LIABILITIES</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>TOTAL LIABILITIES</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent' 
xlink:label='us-gaap_PrepaidExpenseCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PrepaidExpenseCurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Prepaid expenses</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PrepaidExpenseCurrent' xlink:to='lab_us-gaap_PrepaidExpenseCurrent'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_DocumentPeriodEndDate' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document 
Period End Date</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_DocumentPeriodEndDate' 
xlink:to='lab_dei_DocumentPeriodEndDate'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain' 
xlink:label='us-gaap_SubsequentEventTypeDomain'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SubsequentEventTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label'
xml:lang='en-US'>Subsequent Event Type</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SubsequentEventTypeDomain' xlink:to='lab_us-
gaap_SubsequentEventTypeDomain'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseTypeDomain' 
xlink:label='us-gaap_LitigationCaseTypeDomain'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LitigationCaseTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Litigation Case</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LitigationCaseTypeDomain' xlink:to='lab_us-gaap_LitigationCaseTypeDomain'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesOther' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Shares, In exchange for a full dismissal with prejudice of all 
causes</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesOther' 
xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Stock 
Issued During Period, Shares, Pursuant to settlement agreement</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
xlink:label='us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Shares, Conversion of Convertible Securities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
xlink:to='lab_us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Related Party 
[Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='lab_us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember' xlink:label='us-
gaap_WarrantMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_WarrantMember' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Warrant</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_WarrantMember' xlink:to='lab_us-gaap_WarrantMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-
gaap_UseOfEstimates'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Use of Estimates</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:label='us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 2 - Going
Concern</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:to='lab_us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net change in 
cash and cash equivalent</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net 
change in cash and cash equivalent</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='lab_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract' 
xlink:label='us-gaap_IncomeStatementAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncomeStatementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Income Statement</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='lab_us-gaap_IncomeStatementAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' 
xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LiabilitiesAndStockholdersEquity' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL 
LIABILITIES AND STOCKHOLDERS&apos; (DEFICIT)/EQUITY</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LiabilitiesAndStockholdersEquity' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL 
LIABILITIES AND STOCKHOLDERS&apos; (DEFICIT)/EQUITY</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-
gaap_LiabilitiesAndStockholdersEquity'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_CurrentFiscalYearEndDate' 
xlink:label='dei_CurrentFiscalYearEndDate'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_CurrentFiscalYearEndDate' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal
Year End Date</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_CurrentFiscalYearEndDate' 
xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseAxis' 
xlink:label='us-gaap_LitigationCaseAxis'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LitigationCaseAxis' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Litigation Case [Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LitigationCaseAxis' xlink:to='lab_us-gaap_LitigationCaseAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-
gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Value, Issued for Services</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_PacificLeafVenturesLpMember' 
xlink:label='fil_PacificLeafVenturesLpMember'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_PacificLeafVenturesLpMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pacific Leaf 
Ventures LP</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_PacificLeafVenturesLpMember' 
xlink:to='lab_fil_PacificLeafVenturesLpMember'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_DebtDiscountRate' xlink:label='fil_DebtDiscountRate'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_DebtDiscountRate' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Original 
discount rate</link:label>
<link:label xlink:type='resource'
xlink:label='lab_fil_DebtDiscountRate' 
xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-
US'>Percentage of discount upon initial issuance of debt.</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_DebtDiscountRate' xlink:to='lab_fil_DebtDiscountRate'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Reclassifications' 
xlink:label='us-gaap_Reclassifications'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_Reclassifications' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Reclassifications</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_Reclassifications' xlink:to='lab_us-gaap_Reclassifications'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:label='us-
gaap_NoncashInvestingAndFinancingItemsAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NoncashInvestingAndFinancingItemsAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Non-cash 
transactions:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:to='lab_us-
gaap_NoncashInvestingAndFinancingItemsAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInOperatingActivities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInOperatingActivities' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash used 
in operating activities</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInOperatingActivities' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash
used in operating activities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-
gaap_NetCashProvidedByUsedInOperatingActivities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted 
average common shares outstanding - basic and diluted</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:to='lab_us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense' 
xlink:label='us-gaap_NonoperatingIncomeExpense'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NonoperatingIncomeExpense' xlink:role='http://www.xbrl.org/2003/role/label'
xml:lang='en-US'>Total other expense</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NonoperatingIncomeExpense' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total 
other expense</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NonoperatingIncomeExpense' xlink:to='lab_us-
gaap_NonoperatingIncomeExpense'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense' 
xlink:label='us-gaap_OtherNonoperatingIncomeExpense'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_OtherNonoperatingIncomeExpense' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Income/
(Expense)</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_OtherNonoperatingIncomeExpense' xlink:to='lab_us-
gaap_OtherNonoperatingIncomeExpense'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract'
xlink:label='us-gaap_NonoperatingIncomeExpenseAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NonoperatingIncomeExpenseAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>OTHER INCOME 
(EXPENSE)</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NonoperatingIncomeExpenseAbstract' xlink:to='lab_us-
gaap_NonoperatingIncomeExpenseAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding' 
xlink:label='us-gaap_CommonStockSharesOutstanding'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommonStockSharesOutstanding' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, 
shares outstanding</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommonStockSharesOutstanding' xlink:to='lab_us-
gaap_CommonStockSharesOutstanding'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' xlink:label='us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Value, Settlement of Payroll Liabilities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-
gaap_PropertyPlantAndEquipmentByTypeAxis'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentByTypeAxis' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, 
Plant and Equipment, Type [Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='lab_us-
gaap_PropertyPlantAndEquipmentByTypeAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleConversionPrice1' xlink:label='us-
gaap_DebtInstrumentConvertibleConversionPrice1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentConvertibleConversionPrice1' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Conversion Price</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentConvertibleConversionPrice1' xlink:to='lab_us-
gaap_DebtInstrumentConvertibleConversionPrice1'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-
gaap_CommonStockParOrStatedValuePerShare'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommonStockParOrStatedValuePerShare' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, 
par or stated value</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-
gaap_CommonStockParOrStatedValuePerShare'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-
gaap_AssetsCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>TOTAL CURRENT ASSETS</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>TOTAL CURRENT ASSETS</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityVoluntaryFilers' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity 
Voluntary Filers</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityVoluntaryFilers' 
xlink:to='lab_dei_EntityVoluntaryFilers'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressMember' 
xlink:label='us-gaap_ConstructionInProgressMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ConstructionInProgressMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Construction 
in Progress</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ConstructionInProgressMember' xlink:to='lab_us-
gaap_ConstructionInProgressMember'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis'
xlink:label='dei_LegalEntityAxis'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_LegalEntityAxis' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Legal Entity 
[Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_LegalEntityAxis' xlink:to='lab_dei_LegalEntityAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' xlink:label='us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Instrument, Convertible, Number of Equity Instruments</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' xlink:to='lab_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Details</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss' 
xlink:label='us-gaap_OperatingIncomeLoss'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>LOSS FROM OPERATIONS</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>LOSS FROM OPERATIONS</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_OperatingIncomeLoss' xlink:to='lab_us-gaap_OperatingIncomeLoss'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued' 
xlink:label='us-gaap_CommonStockSharesIssued'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommonStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Common Stock, shares issued</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommonStockSharesIssued' xlink:to='lab_us-gaap_CommonStockSharesIssued'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' 
xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentNet' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and 
equipment, net</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentNet' 
xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-
US'>Property and Equipment, Net</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-
gaap_PropertyPlantAndEquipmentNet'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityCentralIndexKey' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central
Index Key</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityCentralIndexKey' 
xlink:to='lab_dei_EntityCentralIndexKey'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' 
xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentGross' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, 
Plant and Equipment, Gross, Total</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PropertyPlantAndEquipmentGross' xlink:to='lab_us-
gaap_PropertyPlantAndEquipmentGross'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms' 
xlink:label='us-gaap_DebtInstrumentPaymentTerms'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentPaymentTerms' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Instrument, Payment Terms</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentPaymentTerms' xlink:to='lab_us-
gaap_DebtInstrumentPaymentTerms'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_StockIssuedToSettleAdvance' 
xlink:label='fil_StockIssuedToSettleAdvance'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_StockIssuedToSettleAdvance' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock issued 
to settle advance</link:label>
<link:label xlink:type='resource'
xlink:label='lab_fil_StockIssuedToSettleAdvance' 
xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Stock
issued to settle advance</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_StockIssuedToSettleAdvance' 
xlink:to='lab_fil_StockIssuedToSettleAdvance'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1' xlink:label='us-
gaap_StockIssued1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssued1' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Stock issued to settle payables</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssued1' xlink:to='lab_us-gaap_StockIssued1'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInFinancingActivities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInFinancingActivities' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash 
provided by financing activities</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInFinancingActivities' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash 
provided by financing activities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-
gaap_NetCashProvidedByUsedInFinancingActivities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock'
xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProceedsFromIssuanceOfCommonStock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from 
issuance of common stock and warrants</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ProceedsFromIssuanceOfCommonStock' xlink:to='lab_us-
gaap_ProceedsFromIssuanceOfCommonStock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInInvestingActivities'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInInvestingActivities' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash used 
in investing activities</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInInvestingActivities' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash 
used in investing activities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-
gaap_NetCashProvidedByUsedInInvestingActivities'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies' 
xlink:label='us-gaap_CommitmentsAndContingencies'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommitmentsAndContingencies' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commitments 
and Contingencies (Note 7)</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommitmentsAndContingencies' xlink:to='lab_us-
gaap_CommitmentsAndContingencies'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' 
xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccountsReceivableNetCurrent' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts 
receivable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AccountsReceivableNetCurrent' xlink:to='lab_us-
gaap_AccountsReceivableNetCurrent'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-
gaap_CashAndCashEquivalentsAtCarryingValue'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CashAndCashEquivalentsAtCarryingValue' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash 
equivalents</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CashAndCashEquivalentsAtCarryingValue' 
xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-
US'>CASH AND CASH EQUIVALENT AT BEGINNING OF PERIOD</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CashAndCashEquivalentsAtCarryingValue' 
xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>CASH 
AND CASH EQUIVALENT AT END OF PERIOD</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-
gaap_CashAndCashEquivalentsAtCarryingValue'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalPeriodFocus' 
xlink:label='dei_DocumentFiscalPeriodFocus'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_DocumentFiscalPeriodFocus' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document 
Fiscal Period Focus</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_DocumentFiscalPeriodFocus' 
xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_UnitsDescription' xlink:label='fil_UnitsDescription'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_UnitsDescription' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Units, 
Description</link:label>
<link:label xlink:type='resource'
xlink:label='lab_fil_UnitsDescription' 
xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Units 
description</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_UnitsDescription' xlink:to='lab_fil_UnitsDescription'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueNewIssues' xlink:label='us-
gaap_StockIssuedDuringPeriodValueNewIssues'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodValueNewIssues' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Value, New Issues</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodValueNewIssues' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodValueNewIssues'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_RelatedPartyDomain' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Related Party</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_RelatedPartyDomain' xlink:to='lab_us-gaap_RelatedPartyDomain'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Statement [Line Items]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>OPERATING 
ACTIVITIES:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-
gaap_RetainedEarningsAccumulatedDeficit'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_RetainedEarningsAccumulatedDeficit' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated 
Deficit</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-
gaap_RetainedEarningsAccumulatedDeficit'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityFilerCategory' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer 
Category</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis' 
xlink:label='us-gaap_SubsequentEventTypeAxis'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SubsequentEventTypeAxis' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Subsequent Event Type [Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SubsequentEventTypeAxis' xlink:to='lab_us-gaap_SubsequentEventTypeAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Shares, Issued for Services</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Shares, Settlement of Payroll Liabilities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentAmount1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentAmount1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtConversionConvertedInstrumentAmount1' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Conversion, Converted Instrument, Amount</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtConversionConvertedInstrumentAmount1' xlink:to='lab_us-
gaap_DebtConversionConvertedInstrumentAmount1'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-
gaap_PropertyPlantAndEquipmentTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of 
Property and Equipment Balances</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PropertyPlantAndEquipmentTextBlock' xlink:to='lab_us-
gaap_PropertyPlantAndEquipmentTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-
gaap_SignificantAccountingPoliciesTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SignificantAccountingPoliciesTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Significant 
Accounting Policies</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SignificantAccountingPoliciesTextBlock' xlink:to='lab_us-
gaap_SignificantAccountingPoliciesTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccounting' 
xlink:label='us-gaap_BasisOfAccounting'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_BasisOfAccounting' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Basis of Presentation</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_BasisOfAccounting' xlink:to='lab_us-gaap_BasisOfAccounting'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 5 - 
Property and Equipment</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:to='lab_us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock' 
xlink:label='us-gaap_DebtDisclosureTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Note 4 - Note Payable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtDisclosureTextBlock' xlink:to='lab_us-gaap_DebtDisclosureTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-
gaap_InterestExpense'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Interest Expense</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_InterestExpense' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' 
xml:lang='en-US'>Interest Expense</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:label='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL 
(DEFICIT)/EQUITY</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL 
(DEFICIT)/EQUITY</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:to='lab_us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital' 
xlink:label='us-gaap_AdditionalPaidInCapital'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Additional Paid In Capital</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity' 
xlink:label='us-gaap_DeferredCompensationEquity'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DeferredCompensationEquity' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Stock
Compensation</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DeferredCompensationEquity' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-
US'>Deferred Stock Compensation</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DeferredCompensationEquity' xlink:to='lab_us-
gaap_DeferredCompensationEquity'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-
gaap_CommonStockValue'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Common Stock Common Stock, $0.0001 par value, 250,000,000 
shares authorized, 57,973,614 and 47,335,147 shares issued and outstanding at 
June 30, 2016 and March 30, 2016</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:label='us-
gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Leaseholds</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:to='lab_us-
gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' 
xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentFaceAmount' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Face value</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentFaceAmount' 
xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-US'>Initial
debt amount</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentFaceAmount' xlink:to='lab_us-gaap_DebtInstrumentFaceAmount'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_EquityComponentDomain' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Equity Component</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_EquityComponentDomain' xlink:to='lab_us-gaap_EquityComponentDomain'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain' 
xlink:label='us-gaap_DebtInstrumentNameDomain'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentNameDomain' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Debt Instrument, Name</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentNameDomain' xlink:to='lab_us-gaap_DebtInstrumentNameDomain'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' 
xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ConsolidationPolicyTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Principles of 
Consolidation</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ConsolidationPolicyTextBlock' xlink:to='lab_us-
gaap_ConsolidationPolicyTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock' 
xlink:label='us-gaap_EarningsPerShareTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_EarningsPerShareTextBlock' xlink:role='http://www.xbrl.org/2003/role/label'
xml:lang='en-US'>Note 8 - Loss Per Share</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_EarningsPerShareTextBlock' xlink:to='lab_us-
gaap_EarningsPerShareTextBlock'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ConvertibleNotes0TextBlock' 
xlink:label='fil_ConvertibleNotes0TextBlock'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_ConvertibleNotes0TextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 3 - 
Convertible Notes</link:label>
<link:label xlink:type='resource'
xlink:label='lab_fil_ConvertibleNotes0TextBlock' 
xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-
US'>Disclosure of convertible note and promissory notes.</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_ConvertibleNotes0TextBlock' 
xlink:to='lab_fil_ConvertibleNotes0TextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable'
xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInAccountsPayable' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts 
payable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncreaseDecreaseInAccountsPayable' xlink:to='lab_us-
gaap_IncreaseDecreaseInAccountsPayable'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' xlink:label='us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal'/>
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal'
<link:label xlink:type='resource' xlink:label='lab_us-
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on 
disposal</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Loss on
disposal</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' xlink:to='lab_us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount'
xlink:label='us-gaap_DebtInstrumentUnamortizedDiscount'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentUnamortizedDiscount' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unamortized 
Discount and Beneficial Feature</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentUnamortizedDiscount' 
xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-US'>Notes 
Payable, discount</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentUnamortizedDiscount' xlink:to='lab_us-
gaap_DebtInstrumentUnamortizedDiscount'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' 
xlink:label='dei_TradingSymbol'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_TradingSymbol' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading 
Symbol</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
<link:label xlink:type='resource' 
xlink:label='lab_dei_DocumentFiscalYearFocus' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document 
Fiscal Year Focus</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_DocumentFiscalYearFocus' 
xlink:to='lab_dei_DocumentFiscalYearFocus'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesNewIssues' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesNewIssues'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockIssuedDuringPeriodSharesNewIssues' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued 
During Period, Shares, New Issues</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockIssuedDuringPeriodSharesNewIssues' xlink:to='lab_us-
gaap_StockIssuedDuringPeriodSharesNewIssues'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice' xlink:label='us-
gaap_SharePrice'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SharePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Share Price</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SharePrice' xlink:to='lab_us-gaap_SharePrice'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:label='us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Instrument, Convertible, Terms of Conversion Feature</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:to='lab_us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' 
xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProceedsFromConvertibleDebt' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Aggregate 
proceeds</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProceedsFromConvertibleDebt' 
xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-US'>Total 
amount of installments received, net of conversion</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ProceedsFromConvertibleDebt' xlink:to='lab_us-
gaap_ProceedsFromConvertibleDebt'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders' 
xlink:label='us-gaap_ProceedsFromMinorityShareholders'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProceedsFromMinorityShareholders' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from 
non-controlling interest</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ProceedsFromMinorityShareholders' xlink:to='lab_us-
gaap_ProceedsFromMinorityShareholders'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInDepositOtherAssets' xlink:label='us-
gaap_IncreaseDecreaseInDepositOtherAssets'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInDepositOtherAssets' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in 
deposits</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_IncreaseDecreaseInDepositOtherAssets' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Change 
in deposits</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_IncreaseDecreaseInDepositOtherAssets' xlink:to='lab_us-
gaap_IncreaseDecreaseInDepositOtherAssets'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchase of
property and equipment</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-
US'>Purchase of property and equipment</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:to='lab_us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract' 
xlink:label='us-gaap_StockholdersEquityAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StockholdersEquityAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>STOCKHOLDERS&apos; (DEFICIT)/ EQUITY:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='lab_us-
gaap_StockholdersEquityAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent' 
xlink:label='us-gaap_AccountsPayableCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Accounts Payable {1}</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccountsPayableCurrent' 
xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accounts 
Payable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AccountsPayableCurrent' xlink:to='lab_us-gaap_AccountsPayableCurrent'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' 
xlink:label='dei_DocumentType'/>
<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType'
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document 
Type</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember' 
xlink:label='us-gaap_SubsequentEventMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SubsequentEventMember' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Subsequent Event</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SubsequentEventMember' xlink:to='lab_us-gaap_SubsequentEventMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1'
xlink:label='us-gaap_DebtConversionOriginalDebtAmount1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtConversionOriginalDebtAmount1' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Conversion, Original Debt, Amount</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtConversionOriginalDebtAmount1' xlink:to='lab_us-
gaap_DebtConversionOriginalDebtAmount1'/>
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap_AllocatedShareBasedCompensationExpense' xlink:label='us-
gaap_AllocatedShareBasedCompensationExpense'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AllocatedShareBasedCompensationExpense' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allocated 
Share-based Compensation Expense</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AllocatedShareBasedCompensationExpense' xlink:to='lab_us-
gaap_AllocatedShareBasedCompensationExpense'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_RoyaltyAgreementAmendedTerms' 
xlink:label='fil_RoyaltyAgreementAmendedTerms'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_RoyaltyAgreementAmendedTerms' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Royalty 
Agreement Amended Terms</link:label>
<link:label xlink:type='resource'
xlink:label='lab_fil_RoyaltyAgreementAmendedTerms' 
xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-
US'>Royalty Agreement Terms</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_RoyaltyAgreementAmendedTerms' 
xlink:to='lab_fil_RoyaltyAgreementAmendedTerms'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate' 
xlink:label='us-gaap_DebtInstrumentMaturityDate'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentMaturityDate' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Instrument, Maturity Date</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentMaturityDate' xlink:to='lab_us-
gaap_DebtInstrumentMaturityDate'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentInterestRateStatedPercentage' xlink:label='us-
gaap_DebtInstrumentInterestRateStatedPercentage'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentInterestRateStatedPercentage' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Instrument, Interest Rate, Stated Percentage</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentInterestRateStatedPercentage' xlink:to='lab_us-
gaap_DebtInstrumentInterestRateStatedPercentage'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' xlink:label='us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt 
Instrument, Convertible, Beneficial Conversion Feature</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' xlink:to='lab_us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_CommonStockMember' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Common Stock</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_CommonStockMember' xlink:to='lab_us-gaap_CommonStockMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1' 
xlink:label='us-gaap_ConversionOfStockAmountIssued1'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ConversionOfStockAmountIssued1' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock issued 
to upon partial conversion of long-term note payable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ConversionOfStockAmountIssued1' xlink:to='lab_us-
gaap_ConversionOfStockAmountIssued1'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FINANCING 
ACTIVITIES:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' 
xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StatementOfCashFlowsAbstract' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement of 
Cash Flows</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='lab_us-
gaap_StatementOfCashFlowsAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermNotesPayable' 
xlink:label='us-gaap_LongTermNotesPayable'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_LongTermNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Note Payable</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_LongTermNotesPayable' xlink:to='lab_us-gaap_LongTermNotesPayable'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityIncorporationDateOfIncorporation' 
xlink:label='dei_EntityIncorporationDateOfIncorporation'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityIncorporationDateOfIncorporation' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Date of 
Incorporation</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityIncorporationDateOfIncorporation' 
xlink:to='lab_dei_EntityIncorporationDateOfIncorporation'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:label='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less 
accumulated depreciation and amortization</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Less 
accumulated depreciation and amortization</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:to='lab_us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-
gaap_PropertyPlantAndEquipmentTypeDomain'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PropertyPlantAndEquipmentTypeDomain' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, 
Plant and Equipment, Type</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='lab_us-
gaap_PropertyPlantAndEquipmentTypeDomain'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ShortTermPromissoryNote2Member' 
xlink:label='fil_ShortTermPromissoryNote2Member'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_ShortTermPromissoryNote2Member' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Short-term 
Promissory Note 2</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_ShortTermPromissoryNote2Member' 
xlink:to='lab_fil_ShortTermPromissoryNote2Member'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis' 
xlink:label='us-gaap_DebtInstrumentAxis'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DebtInstrumentAxis' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Debt Instrument [Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DebtInstrumentAxis' xlink:to='lab_us-gaap_DebtInstrumentAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recent 
Accounting Pronouncements</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:to='lab_us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' 
xlink:label='us-gaap_PolicyTextBlockAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_PolicyTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Policies</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='lab_us-gaap_PolicyTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock' 
xlink:label='us-gaap_SubsequentEventsTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label'
xml:lang='en-US'>Note 9 - Subsequent Events</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_SubsequentEventsTextBlock' xlink:to='lab_us-
gaap_SubsequentEventsTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock' 
xlink:label='us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 1 - Basis
of Presentation and Significant Accounting Policies</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock' 
xlink:to='lab_us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:label='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Adjustments to reconcile net loss to net cash used in operating 
activities:</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:to='lab_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' 
xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label'
xml:lang='en-US'>Accrued Liabilities {1}</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_AccruedLiabilitiesCurrent' 
xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accrued 
Liabilities</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_AccruedLiabilitiesCurrent' xlink:to='lab_us-
gaap_AccruedLiabilitiesCurrent'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent' 
xlink:label='us-gaap_InterestPayableCurrent'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_InterestPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Accrued Interest</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_InterestPayableCurrent' xlink:to='lab_us-gaap_InterestPayableCurrent'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityWellKnownSeasonedIssuer' 
xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-
known Seasoned Issuer</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityWellKnownSeasonedIssuer' 
xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_InitialComplaintFiledByGrowbloxMember' 
xlink:label='fil_InitialComplaintFiledByGrowbloxMember'/>
<link:label xlink:type='resource'
xlink:label='lab_fil_InitialComplaintFiledByGrowbloxMember' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Initial 
Complaint Filed by Growblox</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='fil_InitialComplaintFiledByGrowbloxMember' 
xlink:to='lab_fil_InitialComplaintFiledByGrowbloxMember'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_StatementEquityComponentsAxis' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity 
Components [Axis]</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='lab_us-
gaap_StatementEquityComponentsAxis'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization' 
xlink:label='us-gaap_DepreciationAndAmortization'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_DepreciationAndAmortization' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation 
and amortization</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_DepreciationAndAmortization' xlink:to='lab_us-
gaap_DepreciationAndAmortization'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' 
xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_EarningsPerShareBasicAndDiluted' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss per 
share - basic and diluted</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_EarningsPerShareBasicAndDiluted' xlink:to='lab_us-
gaap_EarningsPerShareBasicAndDiluted'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-
gaap_ProfitLoss'/>
gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
<link:label xlink:type='resource' xlink:label='lab_us-
US'>Net income (loss)</link:label>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' 
xml:lang='en-US'>NET LOSS</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_ProfitLoss' xlink:to='lab_us-gaap_ProfitLoss'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest' xlink:label='us-
gaap_MinorityInterest'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_MinorityInterest' xlink:role='http://www.xbrl.org/2003/role/label' 
xml:lang='en-US'>Non-controlling interest</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_MinorityInterest' xlink:to='lab_us-gaap_MinorityInterest'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssets' xlink:label='us-
gaap_OtherAssets'/>
<link:label xlink:type='resource' xlink:label='lab_us-
gaap_OtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-
US'>Other Assets</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-
gaap_OtherAssets' xlink:to='lab_us-gaap_OtherAssets'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCommonStockSharesOutstanding' 
xlink:label='dei_EntityCommonStockSharesOutstanding'/>
<link:label xlink:type='resource'
xlink:label='lab_dei_EntityCommonStockSharesOutstanding' 
xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common 
Stock, Shares Outstanding</link:label>
<link:labelArc order='1.0' xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' 
xlink:from='dei_EntityCommonStockSharesOutstanding' 
xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>gblx-20160630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., 
Copyright (C) 2008-2016 [PPXCRNPC214XVNLVLZZU]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
xmlns:fil="http://www.growbloxsciences.com/20160630"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance">
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DocumentDocumentAndEn
tityInformation" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DocumentDocumentAndEntityInformation"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DocumentDocumentAn
dEntityInformation">
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_DocumentAndEntityInformationAbstract' 
xlink:label='fil_DocumentAndEntityInformationAbstract'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' 
xlink:label='dei_DocumentType'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_DocumentType' use='optional' order='2.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_DocumentPeriodEndDate' use='optional' order='3.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' 
xlink:label='dei_AmendmentFlag'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_AmendmentFlag' use='optional' order='4.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityCentralIndexKey' use='optional' order='5.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_CurrentFiscalYearEndDate' 
xlink:label='dei_CurrentFiscalYearEndDate'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='6.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCommonStockSharesOutstanding' 
xlink:label='dei_EntityCommonStockSharesOutstanding'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='7.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract'
xlink:to='dei_EntityFilerCategory' use='optional' order='8.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCurrentReportingStatus' 
xlink:label='dei_EntityCurrentReportingStatus'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='9.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityVoluntaryFilers' use='optional' order='10.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityWellKnownSeasonedIssuer' 
xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='11.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='12.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalPeriodFocus' 
xlink:label='dei_DocumentFiscalPeriodFocus'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='13.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityPublicFloat' use='optional' order='14.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityIncorporationDateOfIncorporation' 
xlink:label='dei_EntityIncorporationDateOfIncorporation'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_EntityIncorporationDateOfIncorporation' use='optional' 
order='15.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' 
xlink:label='dei_TradingSymbol'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='fil_DocumentAndEntityInformationAbstract' 
xlink:to='dei_TradingSymbol' use='optional' order='16.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETS" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDEN
SEDBALANCESHEETS">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StatementOfFinancialPositionAbstract' xlink:label='us-
gaap_StatementOfFinancialPositionAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract' 
xlink:label='us-gaap_AssetsCurrentAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_AssetsCurrentAbstract' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-
gaap_CashAndCashEquivalentsAtCarryingValue'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-
gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' 
xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AccountsReceivableNetCurrent' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent' 
xlink:label='us-gaap_PrepaidExpenseCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_PrepaidExpenseCurrent' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-
gaap_AssetsCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' 
order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' 
xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' 
use='optional' order='5.0' 
preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositsAssetsNoncurrent' 
xlink:label='us-gaap_DepositsAssetsNoncurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_DepositsAssetsNoncurrent' 
use='optional' order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssets' xlink:label='us-
gaap_OtherAssets'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_OtherAssets' use='optional' 
order='7.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets' xlink:label='us-
gaap_Assets'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_Assets' use='optional' order='8.0'
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' 
xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' 
use='optional' order='9.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent' 
xlink:label='us-gaap_AccountsPayableCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableCurrent' 
use='optional' order='1.0' 
preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent' 
xlink:label='us-gaap_InterestPayableCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_InterestPayableCurrent' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' 
xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' 
use='optional' order='3.0' 
preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableCurrent' 
xlink:label='us-gaap_NotesPayableCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_NotesPayableCurrent' 
use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent' 
xlink:label='us-gaap_LiabilitiesCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrent' 
use='optional' order='5.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermNotesPayable' 
xlink:label='us-gaap_LongTermNotesPayable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrent' xlink:to='us-gaap_LongTermNotesPayable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities' xlink:label='us-
gaap_Liabilities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_Liabilities' use='optional' 
order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies' 
xlink:label='us-gaap_CommitmentsAndContingencies'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_CommitmentsAndContingencies' 
use='optional' order='10.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract' 
xlink:label='us-gaap_StockholdersEquityAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' 
use='optional' order='11.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-
gaap_CommonStockValue'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='us-gaap_CommonStockValue' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity' 
xlink:label='us-gaap_DeferredCompensationEquity'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='us-gaap_DeferredCompensationEquity' 
use='optional' order='2.0' 
preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital' 
xlink:label='us-gaap_AdditionalPaidInCapital'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AdditionalPaidInCapital' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-
gaap_RetainedEarningsAccumulatedDeficit'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='us-
gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity' 
xlink:label='us-gaap_StockholdersEquity'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquity' 
use='optional' order='5.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest' xlink:label='us-
gaap_MinorityInterest'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StockholdersEquityAbstract' xlink:to='us-gaap_MinorityInterest'
use='optional' order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
xlink:label='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AssetsCurrentAbstract' xlink:to='us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' 
use='optional' order='12.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' 
xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_LiabilitiesAndStockholdersEquity' use='optional' order='2.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSED
BALANCESHEETSParenthetical" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDEN
SEDBALANCESHEETSParenthetical">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StatementOfFinancialPositionAbstract' xlink:label='us-
gaap_StatementOfFinancialPositionAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-
gaap_CommonStockParOrStatedValuePerShare'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_CommonStockParOrStatedValuePerShare' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized' 
xlink:label='us-gaap_CommonStockSharesAuthorized'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_CommonStockSharesAuthorized' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued' 
xlink:label='us-gaap_CommonStockSharesIssued'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_CommonStockSharesIssued' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding' 
xlink:label='us-gaap_CommonStockSharesOutstanding'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_CommonStockSharesOutstanding' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount'
xlink:label='us-gaap_DebtInstrumentUnamortizedDiscount'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfFinancialPositionAbstract' xlink:to='us-
gaap_DebtInstrumentUnamortizedDiscount' use='optional' order='5.0' 
preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERATION
S" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_STATEMENTSOFOPERATIONS"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERAT
IONS">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract' 
xlink:label='us-gaap_IncomeStatementAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues' xlink:label='us-
gaap_Revenues'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-gaap_Revenues' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' 
xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense'
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss' 
xlink:label='us-gaap_OperatingIncomeLoss'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-gaap_OperatingIncomeLoss' 
use='optional' order='3.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract'
xlink:label='us-gaap_NonoperatingIncomeExpenseAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-
gaap_NonoperatingIncomeExpenseAbstract' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-
gaap_InterestExpense'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_InterestExpense' 
use='optional' order='1.0' 
preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense' 
xlink:label='us-gaap_OtherNonoperatingIncomeExpense'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-
gaap_OtherNonoperatingIncomeExpense' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense' 
xlink:label='us-gaap_NonoperatingIncomeExpense'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-
gaap_NonoperatingIncomeExpense' use='optional' order='3.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-
gaap_ProfitLoss'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-gaap_ProfitLoss' use='optional' 
order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncomeLossAttributableToNoncontrollingInterest' xlink:label='us-
gaap_IncomeLossAttributableToNoncontrollingInterest'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-
gaap_IncomeLossAttributableToNoncontrollingInterest' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-
gaap_NetIncomeLoss'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' 
order='7.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' 
xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-gaap_EarningsPerShareBasicAndDiluted'
use='optional' order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncomeStatementAbstract' xlink:to='us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' use='optional' 
order='9.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDATED
STATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDA
TEDSTATEMENTSOFCASHFLOWS">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' 
xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-
gaap_ProfitLoss'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-
gaap_ProfitLoss' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:label='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization' 
xlink:label='us-gaap_DepreciationAndAmortization'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:to='us-gaap_DepreciationAndAmortization' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation' 
xlink:label='us-gaap_ShareBasedCompensation'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:to='us-gaap_ShareBasedCompensation' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium'
xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:to='us-gaap_AmortizationOfDebtDiscountPremium' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' xlink:label='us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract' xlink:to='us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal' use='optional' 
order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' 
order='1.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable'
xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-
gaap_IncreaseDecreaseInAccountsPayable' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-
gaap_IncreaseDecreaseInAccruedLiabilities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-
gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInOperatingActivities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='4.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment' use='optional' order='1.0' 
preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_IncreaseDecreaseInDepositOtherAssets' xlink:label='us-
gaap_IncreaseDecreaseInDepositOtherAssets'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-
gaap_IncreaseDecreaseInDepositOtherAssets' use='optional' order='2.0' 
preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInInvestingActivities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='3.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock'
xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-
gaap_ProceedsFromIssuanceOfCommonStock' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders' 
xlink:label='us-gaap_ProceedsFromMinorityShareholders'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-
gaap_ProceedsFromMinorityShareholders' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable' 
xlink:label='us-gaap_ProceedsFromNotesPayable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-
gaap_ProceedsFromNotesPayable' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants' 
xlink:label='us-gaap_PaymentsForRepurchaseOfWarrants'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-
gaap_PaymentsForRepurchaseOfWarrants' use='optional' order='4.0' 
preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:label='us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities' use='optional' 
order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInFinancingActivities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='6.0' 
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' use='optional' order='4.0'
preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-
gaap_CashAndCashEquivalentsAtCarryingValue'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='5.0' 
preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-
gaap_CashAndCashEquivalentsAtCarryingValue_1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_CashAndCashEquivalentsAtCarryingValue_1' use='optional' order='6.0' 
preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:label='us-
gaap_NoncashInvestingAndFinancingItemsAbstract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementOfCashFlowsAbstract' xlink:to='us-
gaap_NoncashInvestingAndFinancingItemsAbstract' use='optional' order='7.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1' xlink:label='us-
gaap_StockIssued1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:to='us-gaap_StockIssued1' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1' 
xlink:label='us-gaap_ConversionOfStockAmountIssued1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:to='us-
gaap_ConversionOfStockAmountIssued1' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_StockIssuedToSettleAdvance' 
xlink:label='fil_StockIssuedToSettleAdvance'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_NoncashInvestingAndFinancingItemsAbstract' 
xlink:to='fil_StockIssuedToSettleAdvance' use='optional' order='3.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisO
fPresentationAndSignificantAccountingPolicies" xlink:type="simple" 
xlink:href="gblx-
20160630.xsd#idr_DisclosureNote1BasisOfPresentationAndSignificantAccountingPolic
ies"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1Bas
isOfPresentationAndSignificantAccountingPolicies">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock'
xlink:label='us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock' 
use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingC
oncern" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote2GoingConcern"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2Goi
ngConcern">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:label='us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock' use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Conver
tibleNotes" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote3ConvertibleNotes"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Con
vertibleNotes">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ConvertibleNotes0TextBlock' 
xlink:label='fil_ConvertibleNotes0TextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='fil_ConvertibleNotes0TextBlock' 
use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePa
yable" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote4NotePayable"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4Not
ePayable">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock' 
xlink:label='us-gaap_DebtDisclosureTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_DebtDisclosureTextBlock' 
use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipment" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipment"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipment">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock' use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Capita
lTransactions" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote6CapitalTransactions"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Cap
italTransactions">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-
gaap_StockholdersEquityNoteDisclosureTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-
gaap_StockholdersEquityNoteDisclosureTextBlock' use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commit
mentsAndContingencies" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote7CommitmentsAndContingencies"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Com
mitmentsAndContingencies">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock' use='optional' 
order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPe
rShare" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote8LossPerShare"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8Los
sPerShare">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock' 
xlink:label='us-gaap_EarningsPerShareTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_EarningsPerShareTextBlock' 
use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subseq
uentEvents" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote9SubsequentEvents"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Sub
sequentEvents">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' 
xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock' 
xlink:label='us-gaap_SubsequentEventsTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SubsequentEventsTextBlock' 
use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisO
fPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" 
xlink:href="gblx-
20160630.xsd#idr_DisclosureNote1BasisOfPresentationAndSignificantAccountingPolic
iesPolicies"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1Bas
isOfPresentationAndSignificantAccountingPoliciesPolicies">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' 
xlink:label='us-gaap_PolicyTextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccounting' 
xlink:label='us-gaap_BasisOfAccounting'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_BasisOfAccounting' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' 
xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ConsolidationPolicyTextBlock' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-
gaap_UseOfEstimates'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_UseOfEstimates' use='optional' 
order='3.0'/>
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Reclassifications'
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
xlink:label='us-gaap_Reclassifications'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_Reclassifications' 
use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-
gaap_SignificantAccountingPoliciesTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='us-
gaap_SignificantAccountingPoliciesTextBlock' use='optional' order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PolicyTextBlockAbstract' xlink:to='us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' use='optional' 
order='6.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipmentTables" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipmentTables"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipmentTables">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' 
xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-
gaap_PropertyPlantAndEquipmentTextBlock'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TableTextBlockSupplementAbstract' xlink:to='us-
gaap_PropertyPlantAndEquipmentTextBlock' use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingC
oncernDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote2GoingConcernDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2Goi
ngConcernDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-
gaap_RetainedEarningsAccumulatedDeficit'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-
gaap_NetCashProvidedByUsedInOperatingActivities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-
gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='2.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Conver
tibleNotesDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote3ConvertibleNotesDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Con
vertibleNotesDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis' 
xlink:label='us-gaap_DebtInstrumentAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_DebtInstrumentAxis' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain' 
xlink:label='us-gaap_DebtInstrumentNameDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DebtInstrumentAxis' xlink:to='us-gaap_DebtInstrumentNameDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ShortTermPromissoryNote1Member' 
xlink:label='fil_ShortTermPromissoryNote1Member'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DebtInstrumentAxis' xlink:to='fil_ShortTermPromissoryNote1Member' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_ShortTermPromissoryNote2Member' 
xlink:label='fil_ShortTermPromissoryNote2Member'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_DebtInstrumentAxis' xlink:to='fil_ShortTermPromissoryNote2Member' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember' xlink:label='us-
gaap_WarrantMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_WarrantMember' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' 
xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' 
xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_ProceedsFromConvertibleDebt' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_DebtDiscountRate' xlink:label='fil_DebtDiscountRate'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_DebtDiscountRate' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentInterestRateEffectivePercentage' xlink:label='us-
gaap_DebtInstrumentInterestRateEffectivePercentage'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentInterestRateEffectivePercentage' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' xlink:label='us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments' use='optional' 
order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' xlink:label='us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1'/>
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
<link:presentationArc xlink:type='arc'
gaap_StatementLineItems' xlink:to='us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' xlink:label='us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature' use='optional' 
order='7.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount'
xlink:label='us-gaap_DebtInstrumentUnamortizedDiscount'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentUnamortizedDiscount' 
use='optional' order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent' 
xlink:label='us-gaap_ConvertibleNotesPayableCurrent'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_ConvertibleNotesPayableCurrent' 
use='optional' order='9.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePa
yableDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote4NotePayableDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4Not
ePayableDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis'
xlink:label='dei_LegalEntityAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='dei_LegalEntityAxis' use='optional' order='1.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='dei_LegalEntityAxis' xlink:to='dei_EntityDomain' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_PacificLeafVenturesLpMember' 
xlink:label='fil_PacificLeafVenturesLpMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='dei_LegalEntityAxis' xlink:to='fil_PacificLeafVenturesLpMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' 
xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' 
use='optional' order='1.0' 
preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleConversionPrice1' xlink:label='us-
gaap_DebtInstrumentConvertibleConversionPrice1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleConversionPrice1' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentInterestRateStatedPercentage' xlink:label='us-
gaap_DebtInstrumentInterestRateStatedPercentage'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentInterestRateStatedPercentage' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate' 
xlink:label='us-gaap_DebtInstrumentMaturityDate'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentMaturityDate' 
use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount' 
xlink:label='us-gaap_DebtInstrumentCarryingAmount'/>
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
<link:presentationArc xlink:type='arc'
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentCarryingAmount' 
use='optional' order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:label='us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms' 
xlink:label='us-gaap_DebtInstrumentPaymentTerms'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentPaymentTerms' 
use='optional' order='7.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_RoyaltyAgreementAmendedTerms' 
xlink:label='fil_RoyaltyAgreementAmendedTerms'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_RoyaltyAgreementAmendedTerms' 
use='optional' order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' use='optional' 
order='9.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentAmount1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentAmount1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentAmount1' use='optional' order='10.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' 
xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_ProceedsFromConvertibleDebt' 
use='optional' order='11.0' 
preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Proper
tyAndEquipmentScheduleOfPropertyAndEquipmentBalancesDetails" xlink:type="simple"
xlink:href="gblx-
20160630.xsd#idr_DisclosureNote5PropertyAndEquipmentScheduleOfPropertyAndEquipme
ntBalancesDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipmentScheduleOfPropertyAndEquipmentBalancesDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-
gaap_PropertyPlantAndEquipmentByTypeAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_PropertyPlantAndEquipmentByTypeAxis' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-
gaap_PropertyPlantAndEquipmentTypeDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_PropertyPlantAndEquipmentTypeDomain' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember' 
xlink:label='us-gaap_ComputerEquipmentMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_ComputerEquipmentMember' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MachineryAndEquipmentMember' 
xlink:label='us-gaap_MachineryAndEquipmentMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_MachineryAndEquipmentMember' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:label='us-
gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_LeaseholdsAndLeaseholdImprovementsMember' use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressMember' 
xlink:label='us-gaap_ConstructionInProgressMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-
gaap_ConstructionInProgressMember' use='optional' order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' 
xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentGross'
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
xlink:label='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' 
use='optional' order='2.0' 
preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' 
xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' 
use='optional' order='3.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Capita
lTransactionsDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote6CapitalTransactionsDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Cap
italTransactionsDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_RelatedPartyDomain' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_EmployeesMember' xlink:label='fil_EmployeesMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='fil_EmployeesMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefFinancialOfficerMember' 
xlink:label='us-gaap_ChiefFinancialOfficerMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_ChiefFinancialOfficerMember' use='optional' order='3.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis'
xlink:label='dei_LegalEntityAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='dei_LegalEntityAxis' use='optional' order='3.0'/>
<link:loc xlink:type='locator'
xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain' 
xlink:label='dei_EntityDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='dei_LegalEntityAxis' xlink:to='dei_EntityDomain' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_PacificLeafVenturesLpMember' 
xlink:label='fil_PacificLeafVenturesLpMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' 
xlink:from='dei_LegalEntityAxis' xlink:to='fil_PacificLeafVenturesLpMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentSharesIssued1' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AllocatedShareBasedCompensationExpense' xlink:label='us-
gaap_AllocatedShareBasedCompensationExpense'/>
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
<link:presentationArc xlink:type='arc'
gaap_StatementLineItems' xlink:to='us-
gaap_AllocatedShareBasedCompensationExpense' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
xlink:label='us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1'
xlink:label='us-gaap_DebtConversionOriginalDebtAmount1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_DebtConversionOriginalDebtAmount1' 
use='optional' order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtInstrumentConvertibleConversionPrice1' xlink:label='us-
gaap_DebtInstrumentConvertibleConversionPrice1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtInstrumentConvertibleConversionPrice1' use='optional' order='5.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation' use='optional' 
order='6.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice' xlink:label='us-
gaap_SharePrice'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_SharePrice' use='optional' 
order='7.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' xlink:label='us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation' use='optional' 
order='8.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
xlink:label='us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures' 
use='optional' order='9.0'/>
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
xlink:label='us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures' 
use='optional' order='10.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' 
use='optional' order='11.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices' use='optional' 
order='12.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-
gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueIssuedForServices' use='optional' 
order='13.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_DebtConversionConvertedInstrumentAmount1' xlink:label='us-
gaap_DebtConversionConvertedInstrumentAmount1'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_DebtConversionConvertedInstrumentAmount1' use='optional' order='14.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesNewIssues' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesNewIssues'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodSharesNewIssues' use='optional' order='15.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodValueNewIssues' xlink:label='us-
gaap_StockIssuedDuringPeriodValueNewIssues'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_StockIssuedDuringPeriodValueNewIssues' use='optional' order='16.0'/>
20160630.xsd#fil_UnitsDescription' xlink:label='fil_UnitsDescription'/>
<link:loc xlink:type='locator' xlink:href='gblx-
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_UnitsDescription' use='optional' 
order='17.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commit
mentsAndContingenciesDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote7CommitmentsAndContingenciesDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Com
mitmentsAndContingenciesDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseAxis' 
xlink:label='us-gaap_LitigationCaseAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_LitigationCaseAxis' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationCaseTypeDomain' 
xlink:label='us-gaap_LitigationCaseTypeDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LitigationCaseAxis' xlink:to='us-gaap_LitigationCaseTypeDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_InitialComplaintFiledByGrowbloxMember' 
xlink:label='fil_InitialComplaintFiledByGrowbloxMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LitigationCaseAxis' xlink:to='fil_InitialComplaintFiledByGrowbloxMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_CounterclaimMember' xlink:label='fil_CounterclaimMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_LitigationCaseAxis' xlink:to='fil_CounterclaimMember' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
<link:presentationArc xlink:type='arc'
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain' 
xlink:label='us-gaap_RelatedPartyDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_RelatedPartyDomain' use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefFinancialOfficerMember' 
xlink:label='us-gaap_ChiefFinancialOfficerMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-
gaap_ChiefFinancialOfficerMember' use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='4.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue'
xlink:label='us-gaap_LossContingencyDamagesSoughtValue'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_LossContingencyDamagesSoughtValue' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_SettlementAgreementTerms' 
xlink:label='fil_SettlementAgreementTerms'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_SettlementAgreementTerms' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualProvision' 
xlink:label='us-gaap_LossContingencyAccrualProvision'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_LossContingencyAccrualProvision' 
use='optional' order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' 
use='optional' order='4.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPe
rShareDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote8LossPerShareDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8Los
sPerShareDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
xlink:label='us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount' 
use='optional' order='1.0'/>
</link:presentationLink>
<link:roleRef
roleURI="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subseq
uentEventsDetails" xlink:type="simple" xlink:href="gblx-
20160630.xsd#idr_DisclosureNote9SubsequentEventsDetails"/>
<link:presentationLink xlink:type="extended"
xlink:role="http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Sub
sequentEventsDetails">
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract' 
xlink:label='us-gaap_TextBlockAbstract'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable' xlink:label='us-
gaap_StatementTable'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis' 
xlink:label='us-gaap_SubsequentEventTypeAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_SubsequentEventTypeAxis' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain' 
xlink:label='us-gaap_SubsequentEventTypeDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_SubsequentEventTypeAxis' xlink:to='us-gaap_SubsequentEventTypeDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember' 
xlink:label='us-gaap_SubsequentEventMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_SubsequentEventTypeAxis' xlink:to='us-gaap_SubsequentEventMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis' 
xlink:label='us-gaap_StatementEquityComponentsAxis'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain' 
xlink:label='us-gaap_EquityComponentDomain'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' 
use='optional' order='1.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember' 
xlink:label='us-gaap_CommonStockMember'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems' 
xlink:label='us-gaap_StatementLineItems'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' 
order='3.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' xlink:label='us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract' use='optional' 
order='1.0'/>
<link:loc xlink:type='locator' xlink:href='gblx-
20160630.xsd#fil_RoyaltyAgreementAmendedTerms' 
xlink:label='fil_RoyaltyAgreementAmendedTerms'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='fil_RoyaltyAgreementAmendedTerms' 
use='optional' order='2.0'/>
<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-
gaap/2015/elts/us-gaap-2015-01-31.xsd#us-
gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-
gaap_StockIssuedDuringPeriodSharesOther'/>
<link:presentationArc xlink:type='arc'
xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-
gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' 
use='optional' order='3.0' 
preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0X!W\# 2(  A$! Q$!_\0
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M8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\ XJN?HH Z#_A._&'_ $->N?\
M@QF_^*H_X3OQA_T->N?^#&;_ .*KGZ* .@_X3OQA_P!#7KG_ (,9O_BJ/^$[
M\8?]#7KG_@QF_P#BJY^B@#H/^$[\8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,
M9O\ XJN?HH Z#_A._&'_ $->N?\ @QF_^*H_X3OQA_T->N?^#&;_ .*KGZ*
M.@_X3OQA_P!#7KG_ (,9O_BJ/^$[\8?]#7KG_@QF_P#BJY^B@#H/^$[\8?\
M0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\ XJN?HH Z#_A._&'_ $->N?\ @QF_
M^*H_X3OQA_T->N?^#&;_ .*KGZ* .@_X3OQA_P!#7KG_ (,9O_BJ/^$[\8?]
M#7KG_@QF_P#BJY^B@#H/^$[\8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\
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M8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\ XJN?HH Z#_A._&'_ $->N?\
M@QF_^*H_X3OQA_T->N?^#&;_ .*KGZ* .@_X3OQA_P!#7KG_ (,9O_BJ/^$[
M\8?]#7KG_@QF_P#BJY^B@#H/^$[\8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,
M9O\ XJN?HH Z#_A._&'_ $->N?\ @QF_^*H_X3OQA_T->N?^#&;_ .*KGZ*
M.@_X3OQA_P!#7KG_ (,9O_BJ/^$[\8?]#7KG_@QF_P#BJY^B@#H/^$[\8?\
M0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\ XJN?HH Z#_A._&'_ $->N?\ @QF_
M^*H_X3OQA_T->N?^#&;_ .*KGZ* .@_X3OQA_P!#7KG_ (,9O_BJ/^$[\8?]
M#7KG_@QF_P#BJY^B@#H/^$[\8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\
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M8?\ 0UZY_P"#&;_XJC_A._&'_0UZY_X,9O\ XJN?HH Z#_A._&'_ $->N?\
M@QF_^*KN/A!XL\2:G\4M&L[_ ,0:K=VLGG[X9[V21&Q!(1E2<'! /X5Y/7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
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M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
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M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
MAG'P?_T$M<_[_P /_P :KV"B@#Q__AG'P?\ ]!+7/^_\/_QJC_AG'P?_ -!+
M7/\ O_#_ /&J]@HH \?_ .&<?!__ $$M<_[_ ,/_ ,:H_P"&<?!__02US_O_
M  __ !JO8** /'_^&<?!_P#T$M<_[_P__&J/^&<?!_\ T$M<_P"_\/\ \:KV
M"B@#Q_\ X9Q\'_\ 02US_O\ P_\ QJC_ (9Q\'_]!+7/^_\ #_\ &J]@HH \
M?_X9Q\'_ /02US_O_#_\:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?
M_P!!+7/^_P##_P#&J/\ AG'P?_T$M<_[_P /_P :KV"B@#Q__AG'P?\ ]!+7
M/^_\/_QJC_AG'P?_ -!+7/\ O_#_ /&J]@HH \?_ .&<?!__ $$M<_[_ ,/_
M ,:H_P"&<?!__02US_O_  __ !JO8** /'_^&<?!_P#T$M<_[_P__&J/^&<?
M!_\ T$M<_P"_\/\ \:KV"B@#Q_\ X9Q\'_\ 02US_O\ P_\ QJC_ (9Q\'_]
M!+7/^_\ #_\ &J]@HH \?_X9Q\'_ /02US_O_#_\:H_X9Q\'_P#02US_ +_P
M_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\ AG'P?_T$M<_[_P /_P :
MKV"B@#Q__AG'P?\ ]!+7/^_\/_QJC_AG'P?_ -!+7/\ O_#_ /&J]@HH \?_
M .&<?!__ $$M<_[_ ,/_ ,:H_P"&<?!__02US_O_  __ !JO8** /'_^&<?!
M_P#T$M<_[_P__&J/^&<?!_\ T$M<_P"_\/\ \:KV"B@#Q_\ X9Q\'_\ 02US
M_O\ P_\ QJC_ (9Q\'_]!+7/^_\ #_\ &J]@HH \?_X9Q\'_ /02US_O_#_\
M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
MAG'P?_T$M<_[_P /_P :KV"B@#Q__AG'P?\ ]!+7/^_\/_QJC_AG'P?_ -!+
M7/\ O_#_ /&J]@HH \?_ .&<?!__ $$M<_[_ ,/_ ,:H_P"&<?!__02US_O_
M  __ !JO8** /'_^&<?!_P#T$M<_[_P__&J/^&<?!_\ T$M<_P"_\/\ \:KV
M"B@#Q_\ X9Q\'_\ 02US_O\ P_\ QJC_ (9Q\'_]!+7/^_\ #_\ &J]@HH \
M?_X9Q\'_ /02US_O_#_\:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?
M_P!!+7/^_P##_P#&J/\ AG'P?_T$M<_[_P /_P :KV"B@#Q__AG'P?\ ]!+7
M/^_\/_QJC_AG'P?_ -!+7/\ O_#_ /&J]@HH \?_ .&<?!__ $$M<_[_ ,/_
M ,:H_P"&<?!__02US_O_  __ !JO8** /'_^&<?!_P#T$M<_[_P__&J/^&<?
M!_\ T$M<_P"_\/\ \:KV"B@#Q_\ X9Q\'_\ 02US_O\ P_\ QJC_ (9Q\'_]
M!+7/^_\ #_\ &J]@HH \?_X9Q\'_ /02US_O_#_\:H_X9Q\'_P#02US_ +_P
M_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\ AG'P?_T$M<_[_P /_P :
MKV"B@#Q__AG'P?\ ]!+7/^_\/_QJC_AG'P?_ -!+7/\ O_#_ /&J]@HH \?_
M .&<?!__ $$M<_[_ ,/_ ,:H_P"&<?!__02US_O_  __ !JO8** /'_^&<?!
M_P#T$M<_[_P__&J/^&<?!_\ T$M<_P"_\/\ \:KV"B@#Q_\ X9Q\'_\ 02US
M_O\ P_\ QJC_ (9Q\'_]!+7/^_\ #_\ &J]@HH \?_X9Q\'_ /02US_O_#_\
M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
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M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
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M:H_X9Q\'_P#02US_ +_P_P#QJO8** /'_P#AG'P?_P!!+7/^_P##_P#&J/\
MAG'P?_T$M<_[_P /_P :KV"B@#Q__AG'P?\ ]!+7/^_\/_QJMCPM\%/#?A'Q
M'::Y87NJR75KOV)/+&4.Y&0Y C!Z,>]>D44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729708432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Aug. 09, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document 
and Entity Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Growblox Sciences, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001165320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End 
Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock,
Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,495,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting 
Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known 
Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year 
Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period 
Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">gblx<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>If the value is true, then the document is an amendment to
previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>End date of current fiscal year in the format --MM-
DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>This is focus fiscal period of the document report. For a 
first quarter 2006 quarterly report, which may also provide financial 
information from prior periods, the first fiscal quarter should be given as the 
fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, 
CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>This is focus fiscal year of the document report in CCYY 
format. For a 2006 annual report, which may also provide financial information 
from prior periods, fiscal 2006 should be given as the fiscal year focus. 
Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The end date of the period reflected on the cover page if 
a periodic report. For all other reports and registration statements containing 
historical data, it is the date up through which that historical data is 
presented.  If there is no historical data in the report, use the filing date. 
The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 
485BPOS, etc). The document type is limited to the same value as the supporting 
SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities 
that have filed disclosures with the SEC. It is commonly abbreviated as 
CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate number of shares or other units outstanding of 
each of registrant's classes of capital or common stock or other ownership 
interests, if and as stated on cover of related periodic report. Where multiple 
classes or units exist define each class/interest by adding class of stock items
such as Common Class A [Member], Common Class B [Member] or Partnership Interest
[Member] onto the Instrument [Domain] of the Entity Listings, 
Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed 
all reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or for such shorter period 
that registrants were required to file such reports), and (2) have been subject 
to such filing requirements for the past 90 days. This information should be 
based on the registrant's current or most recent filing containing the related 
disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Definition</a><div><p>Indicate whether the registrant is one of the following: 
(1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, 
(4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting 
Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of 
the Exchange Act. This information should be based on the registrant's current 
or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The exact name of the entity filing the report as 
specified in its charter, which is required by forms filed with the 
SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required 
to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known 
seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form 
Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-
1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Trading symbol of an instrument as listed on an 
exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729844944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS - USD 
($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsCurrentAbstract', window );"><strong>CURRENT 
ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash 
equivalents</a></td>
<td class="nump">$ 178,325<span></span>
</td>
<td class="nump">$ 34,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">67,862<span></span>
</td>
<td class="nump">67,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">89,849<span></span>
</td>
<td class="nump">104,851<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">336,036<span></span>
</td>
<td class="nump">207,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, 
Net</a></td>
<td class="nump">2,935,172<span></span>
</td>
<td class="nump">1,953,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DepositsAssetsNoncurrent', window );">Deposits and Prepayments</a></td>
<td class="nump">269,560<span></span>
</td>
<td class="nump">271,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherAssets', window );">Other Assets</a></td>
<td class="nump">19,134<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">3,559,902<span></span>
</td>
<td class="nump">2,435,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT 
LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">762,577<span></span>
</td>
<td class="nump">902,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_InterestPayableCurrent', window );">Accrued Interest</a></td>
<td class="nump">95,145<span></span>
</td>
<td class="nump">61,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities</a></td>
<td class="nump">844,815<span></span>
</td>
<td class="nump">834,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NotesPayableCurrent', window );">Notes Payable, net of unamortized discount
of $0.3 million and $0.4 million at June 30, 2016 and March 31, 2016, 
respectively</a></td>
<td class="nump">499,847<span></span>
</td>
<td class="nump">463,532<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">2,202,384<span></span>
</td>
<td class="nump">2,261,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LongTermNotesPayable', window );">Note Payable</a></td>
<td class="nump">2,020,195<span></span>
</td>
<td class="nump">2,148,556<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">4,222,579<span></span>
</td>
<td class="nump">4,410,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies 
(Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' (DEFICIT)/ 
EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockValue', window );">Common Stock Common Stock, $0.0001 par value,
250,000,000 shares authorized, 57,973,614 and 47,335,147 shares issued and 
outstanding at June 30, 2016 and March 30, 2016</a></td>
<td class="nump">5,797<span></span>
</td>
<td class="nump">4,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredCompensationEquity', window );">Deferred Stock 
Compensation</a></td>
<td class="nump">2,318,827<span></span>
</td>
<td class="nump">2,240,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdditionalPaidInCapital', window );">Additional Paid In Capital</a></td>
<td class="nump">19,180,234<span></span>
</td>
<td class="nump">16,638,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated 
Deficit</a></td>
<td class="num">(22,120,731)<span></span>
</td>
<td class="num">(20,779,860)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">TOTAL GROWBLOX SCIENCES, INC. STOCKHOLDERS'
(DEFICIT)/EQUITY</a></td>
<td class="num">(615,873)<span></span>
</td>
<td class="num">(1,896,147)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="num">(46,804)<span></span>
</td>
<td class="num">(78,603)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', 
window );">TOTAL (DEFICIT)/EQUITY</a></td>
<td class="num">(662,677)<span></span>
</td>
<td class="num">(1,974,750)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND 
STOCKHOLDERS' (DEFICIT)/EQUITY</a></td>
<td class="nump">$ 3,559,902<span></span>
</td>
<td class="nump">$ 2,435,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of liabilities
incurred (and for which invoices have typically been received) and payable to 
vendors for goods and services received that are used in an entity's business. 
Used to reflect the current portion of the liabilities (due within one year or 
within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount due from customers or clients, within one year of 
the balance sheet date (or the normal operating cycle, whichever is longer), for
goods or services (including trade receivables) that have been delivered or sold
in the normal course of business, reduced to the estimated net realizable fair 
value by an allowance established by the entity of the amount it deems uncertain
of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1:
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3-4)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 3<br> -Subparagraph a(1)<br> -Article 5<br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> 
-Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of obligations
incurred and payable, pertaining to costs that are statutory in nature, are 
incurred on contractual obligations, or accumulate over time and for which 
invoices have not yet been received or will not be rendered. Examples include 
taxes, interest, rent and utilities. Used to reflect the current portion of the 
liabilities (due within one year or within the normal operating cycle if 
longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Excess of issue price over par or stated value of the 
entity's capital stock and amounts received from other transactions involving 
the entity's stock or stockholders. Includes adjustments to additional paid in 
capital. Some examples of such adjustments include recording the issuance of 
debt with a beneficial conversion feature and certain tax consequences of equity
instruments awarded to employees. Use this element for the aggregate amount of 
additional paid-in capital associated with common and preferred stock. For 
additional paid-in capital associated with only common stock, use the element 
additional paid in capital, common stock. For additional paid-in capital 
associated with only preferred stock, use the element additional paid in 
capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30(a)(1))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all assets that are recognized. Assets are probable future economic benefits 
obtained or controlled by an entity as a result of past transactions or 
events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.18)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br>
-Paragraph 12<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all assets that are expected to be realized in cash, sold, or consumed within
one year (or the normal operating cycle, if longer). Assets are probable future 
economic benefits obtained or controlled by an entity as a result of past 
transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-
107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of currency on hand as well as demand deposits with
banks or financial institutions. Includes other kinds of accounts that have the 
general characteristics of demand deposits. Also includes short-term, highly 
liquid investments that are both readily convertible to known amounts of cash 
and so near their maturity that they present insignificant risk of changes in 
value because of changes in interest rates. Excludes cash and cash equivalents 
within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Cash<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-
108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash 
Equivalents<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Represents the caption on the face of the balance sheet to
indicate that the entity has entered into (1) purchase or supply arrangements 
that will require expending a portion of its resources to meet the terms 
thereof, and (2) is exposed to potential losses or, less frequently, gains, 
arising from (a) possible claims against a company's resources due to future 
performance under contract terms, and (b) possible losses or likely gains from 
uncertainties that will ultimately be resolved when one or more future events 
that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-
108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-
03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-
122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Aggregate par or stated value of issued nonredeemable 
common stock (or common stock redeemable solely at the option of the issuer). 
This item includes treasury stock repurchased by the entity. Note: elements for 
number of nonredeemable common shares, par value and other disclosure concepts 
are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DeferredCompensationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);"
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Value of stock issued under share-based plans to employees
or officers which is the unearned portion, accounted for under the fair value 
method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> 
-SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value of amounts transferred to third parties for
security purposes that are expected to be returned or applied towards payment 
after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] 
interest payable on all forms of debt, including trade payables, that has been 
incurred and is unpaid. Used to reflect the current portion of the liabilities 
(due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-
107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-
107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all liabilities that are recognized. Liabilities are probable future 
sacrifices of economic benefits arising from present obligations of an entity to
transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of liabilities and equity items, including the
portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.32)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br>
-Paragraph 25<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total obligations incurred as part of normal operations 
that are expected to be paid during the following twelve months or within one 
business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of notes 
payable (with maturities initially due after one year or beyond the operating 
cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of 
receivables from officers, directors, owners, and affiliates of the entity which
is directly or indirectly attributable to that ownership interest in subsidiary 
equity which is not attributable to the parent (that is, noncontrolling 
interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 27<br> -Article 5<br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 20<br> 
-Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying values as of the balance sheet date of
the portions of long-term notes payable due within one year or the operating 
cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Definition</a><div><p>The aggregate carrying amounts, as of the balance sheet 
date, of assets not separately disclosed in the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br>
-Paragraph 10<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of asset related to consideration paid in advance 
for costs that provide economic benefits within a future period of one year or 
the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-
107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> 
-SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-
108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary 
Current Assets<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount after accumulated depreciation, depletion and 
amortization of physical assets used in the normal conduct of business to 
produce goods and services and not intended for resale. Examples include, but 
are not limited to, land, buildings, machinery and equipment, office equipment, 
and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> 
-Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cumulative amount of the reporting entity's 
undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br>
-Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of 
receivables from officers, directors, owners, and affiliates of the entity which
are attributable to the parent. The amount of the economic entity's 
stockholders' equity attributable to the parent excludes the amount of 
stockholders' equity which is allocable to that ownership interest in subsidiary
equity which is not attributable to the parent (noncontrolling interest, 
minority interest). This excludes temporary equity and is sometimes called 
permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-
122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br>
-Section E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of stockholders' equity (deficit), net of 
receivables from officers, directors, owners, and affiliates of the entity, 
attributable to both the parent and noncontrolling interests. Amount excludes 
temporary equity. Alternate caption for the concept is permanent 
equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 
55<br> -Paragraph 4I<br> -URI 
http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4590271-
111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4568740-
111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4568447-
111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6728183664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD 
($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of 
Financial Position</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par or 
stated value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesAuthorized', window );">Common Stock, shares 
authorized</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">57,973,614<span></span>
</td>
<td class="nump">47,335,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesOutstanding', window );">Common Stock, shares 
outstanding</a></td>
<td class="nump">57,973,614<span></span>
</td>
<td class="nump">47,335,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentUnamortizedDiscount', window );">Notes Payable, 
discount</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Face amount or stated value per share of common 
stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The maximum number of common shares permitted to be issued
by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total number of common shares of an entity that have been 
sold or granted to shareholders (includes common shares that were issued, 
repurchased and remain in the treasury). These shares represent capital invested
by the firm's shareholders and owners, and may be all or only a portion of the 
number of shares authorized. Shares issued include shares outstanding and shares
held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of common stock outstanding. Common stock
represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1:
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of debt discount that was originally recognized
at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 
45<br> -Paragraph 1A<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-
108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> 
-SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-
108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6898356256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeStatementAbstract', window );"><strong>Income 
Statement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Revenues', window );">NET REVENUE</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GeneralAndAdministrativeExpense', window );">GENERAL AND ADMINISTRATIVE 
EXPENSES</a></td>
<td class="nump">1,207,781<span></span>
</td>
<td class="nump">1,522,765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(1,207,781)<span></span>
</td>
<td class="num">(1,522,765)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME 
(EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(158,713)<span></span>
</td>
<td class="num">(658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherNonoperatingIncomeExpense', window );">Other Income/(Expense)</a></td>
<td class="num">(12,416)<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NonoperatingIncomeExpense', window );">Total other expense</a></td>
<td class="num">(171,129)<span></span>
</td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProfitLoss', window );">NET LOSS</a></td>
<td class="num">(1,378,910)<span></span>
</td>
<td class="num">(1,522,204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeLossAttributableToNoncontrollingInterest', window );">Net income/
(loss) attributable to non-controlling interest</a></td>
<td class="num">(38,201)<span></span>
</td>
<td class="num">(180,456)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">NET LOSS ATTRIBUTABLE TO GROWBLOX SCIENCES, 
INC.</a></td>
<td class="num">$ (1,340,709)<span></span>
</td>
<td class="num">$ (1,341,748)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and
diluted</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', 
window );">Weighted average common shares outstanding - basic and 
diluted</a></td>
<td class="nump">50,068,724<span></span>
</td>
<td class="nump">41,026,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of net income or loss for the period per each 
share in instances when basic and diluted earnings per share are the same amount
and reported as a single line item on the face of the financial statements.  
Basic earnings per share is the amount of net income or loss for the period per 
each share of common stock or unit outstanding during the reporting period.  
Diluted earnings per share includes the amount of net income or loss for the 
period available to each share of common stock or common unit outstanding during
the reporting period and to each share or unit that would have been outstanding 
assuming the issuance of common shares or units for all dilutive potential 
common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The aggregate total of expenses of managing and 
administering the affairs of an entity, including affiliates of the reporting 
entity, which are not directly or indirectly associated with the manufacture, 
sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of Income (Loss) attributable to the noncontrolling
interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of the cost of borrowed funds accounted for as 
interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-
108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-
04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-
122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The portion of profit or loss for the period, net of 
income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Net Income<br> -URI
http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-
04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-
03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-
04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other 
Comprehensive Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> 
-Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br>
-Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The aggregate amount of income or expense from ancillary
business-related activities (that is to say, excluding major activities 
considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The net result for the period of deducting operating 
expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The net amount of other income and expense amounts, the 
components of which are not separately disclosed on the income statement, 
resulting from ancillary business-related activities (that is, excluding major 
activities considered part of the normal operations of the business) also known 
as other nonoperating income (expense) recognized for the period. Such amounts 
may include: (a) dividends, (b) interest on securities, (c) net gains or losses 
on securities, (d) unusual costs, (e) gains or losses on foreign exchange 
transactions, and (f) miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The consolidated profit or loss for the period, net of 
income taxes, including the portion attributable to the noncontrolling 
interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 19<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4569616-
111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI 
http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591552-
111686<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a),(c)<br> 
-URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-
111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI 
http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591551-
111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of revenue recognized from goods sold, services 
rendered, insurance premiums, or other activities that constitute an earning 
process. Includes, but is not limited to, investment and interest income before 
deduction of interest expense when recognized as a component of revenue, and 
sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Average number of shares or units issued and outstanding 
that are used in calculating basic and diluted earnings per share 
(EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
</head>
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6730157584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD 
($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', 
window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (1,378,910)<span></span>
</td>
<td class="num">$ (1,522,204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract', window );"><strong>Adjustments to reconcile net loss to net cash 
used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DepreciationAndAmortization', window );">Depreciation and 
amortization</a></td>
<td class="nump">46,761<span></span>
</td>
<td class="nump">43,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">452,497<span></span>
</td>
<td class="nump">398,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt 
discount and beneficial conversion feature</a></td>
<td class="nump">125,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Loss 
on disposal</a></td>
<td class="nump">5,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in 
operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid
expenses and other assets</a></td>
<td class="nump">15,002<span></span>
</td>
<td class="num">(21,747)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(206,339)<span></span>
</td>
<td class="num">(12,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(17,675)<span></span>
</td>
<td class="nump">28,117<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in 
operating activities</a></td>
<td class="num">(957,918)<span></span>
</td>
<td class="num">(1,086,864)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', 
window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of 
property and equipment</a></td>
<td class="num">(877,697)<span></span>
</td>
<td class="num">(197,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInDepositOtherAssets', window );">Change in 
deposits</a></td>
<td class="num">(14,764)<span></span>
</td>
<td class="num">(4,717)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in 
investing activities</a></td>
<td class="num">(892,461)<span></span>
</td>
<td class="num">(202,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', 
window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of 
common stock and warrants</a></td>
<td class="nump">1,293,804<span></span>
</td>
<td class="nump">1,308,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromMinorityShareholders', window );">Proceeds from non-controlling
interest</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PaymentsForRepurchaseOfWarrants', window );">Cash used to purchase 
warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other 
financing activities</a></td>
<td class="nump">630,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided 
by financing activities</a></td>
<td class="nump">1,993,880<span></span>
</td>
<td class="nump">1,652,165<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net change in 
cash and cash equivalent</a></td>
<td class="nump">143,501<span></span>
</td>
<td class="nump">362,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENT
AT BEGINNING OF PERIOD</a></td>
<td class="nump">34,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENT
AT END OF PERIOD</a></td>
<td class="nump">178,325<span></span>
</td>
<td class="nump">332,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash 
transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssued1', window );">Stock issued to settle payables</a></td>
<td class="nump">255,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ConversionOfStockAmountIssued1', window );">Stock issued to upon partial 
conversion of long-term note payable</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_StockIssuedToSettleAdvance', window );">Stock issued to settle 
advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_StockIssuedToSettleAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Stock issued to settle advance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockIssuedToSettleAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of noncash expense included in interest expense to 
amortize debt discount and premium associated with the related debt instruments.
Excludes amortization of financing costs. Alternate captions include noncash 
interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> 
-SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-
108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-
03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of currency on hand as well as demand deposits with
banks or financial institutions. Includes other kinds of accounts that have the 
general characteristics of demand deposits. Also includes short-term, highly 
liquid investments that are both readily convertible to known amounts of cash 
and so near their maturity that they present insignificant risk of changes in
value because of changes in interest rates. Excludes cash and cash equivalents 
within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Cash<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-
108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash 
Equivalents<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of increase (decrease) in cash and cash 
equivalents. Cash and cash equivalents are the amount of currency on hand as 
well as demand deposits with banks or financial institutions. Includes other 
kinds of accounts that have the general characteristics of demand deposits. Also
includes short-term, highly liquid investments that are both readily convertible
to known amounts of cash and so near their maturity that they present 
insignificant risk of changes in value because of changes in interest rates. 
Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> 
-SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-
110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The value of the financial instrument issued [noncash or 
part noncash] in the conversion of stock. Noncash is defined as transactions 
during a period that do not result in cash receipts or cash payments in the 
period. "Part noncash" refers to that portion of the transaction not resulting 
in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-
108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The current period expense charged against earnings on 
long-lived, physical assets not used in production, and which are not intended 
for resale, to allocate or recognize the cost of such assets over their useful 
lives; or to record the reduction in book value of an intangible asset over the 
benefit period of such asset; or to reflect consumption during the period of an 
asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or
disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2443-
110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2941-
110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in the
aggregate amount of liabilities incurred (and for which invoices have typically 
been received) and payable to vendors for goods and services received that are 
used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in the
aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in 
moneys or securities given as security including, but not limited to, contract, 
escrow, or earnest money deposits, retainage (if applicable), deposits with 
clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in the
value of prepaid expenses and other assets not separately disclosed in the 
statement of cash flows, for example, deferred expenses, intangible assets, or 
income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from financing activities,
including discontinued operations. Financing activity cash flows include 
obtaining resources from owners and providing them with a return on, and a 
return of, their investment; borrowing money and repaying amounts borrowed, or 
settling the obligation; and obtaining and paying for other resources obtained 
from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from investing activities,
including discontinued operations. Investing activity cash flows include making 
and collecting loans and acquiring and disposing of debt or equity instruments 
and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from operating activities,
including discontinued operations. Operating activity cash flows include 
transactions, adjustments, and changes in value not defined as investing or 
financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The aggregate amount paid by the entity to reacquire the 
right to purchase equity shares at a predetermined price, usually issued 
together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash outflow associated with the acquisition of long-
lived, physical assets that are used in the normal conduct of business to 
produce goods and services and not intended for resale; includes cash outflows 
to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2:
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash inflow from the additional capital contribution 
to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. 
Includes, but is not limited to, purchase of additional shares or other increase
in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash inflow from a borrowing supported by a written 
promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary 
Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The net cash inflow or outflow from other financing 
activities. This element is used when there is not a more specific and 
appropriate element in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3095-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3098-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The consolidated profit or loss for the period, net of 
income taxes, including the portion attributable to the noncontrolling 
interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 19<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4569616-
111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI 
http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591552-
111686<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a),(c)<br> 
-URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-
111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI 
http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591551-
111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The aggregate amount of noncash, equity-based employee 
remuneration. This may include the value of stock or unit options, amortization 
of restricted stock or units, and adjustment for officers' compensation. As 
noncash, this element is an add back when calculating net cash generated by 
operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The fair value of stock issued in noncash financing 
activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-
108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6725134384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1
- Basis of Presentation and Significant Accounting 
Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', 
window );">Note 1 - Basis of Presentation and Significant Accounting 
Policies</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 1 &#150;
Basis of Presentation and Significant Accounting Policies</b></p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'><i>Basis of Presentation</i></p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>The accompanying unaudited interim condensed consolidated financial 
statements of Growblox Sciences, Inc. (the &quot;Company,&quot; &quot;We&quot; 
or &quot;Us&quot;) have been prepared in accordance with U.S. generally accepted
accounting principles (&quot;U.S. GAAP&quot;) for interim financial information 
and with the instructions to Form 10-Q and Article 8 of Regulations S-X.&nbsp; 
Accordingly, they do not include all of the information and footnotes required 
by U.S. GAAP for complete financial statements.&nbsp; In the opinion of 
management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included.&nbsp; Operating results 
for the periods presented are not necessarily indicative of the results that may
be expected for the year ending March 31, 2017. The balance sheet at March 31, 
2016 has been derived from the audited financial statements at that date but 
does not include all of the information and footnotes required by U.S. GAAP for 
complete financial statements. For further information, refer to the 
consolidated financial statements and footnotes thereto included in the 
Company's annual report on Form 10-K for the year ended March 31, 2016.</p> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Principles of
Consolidation</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The consolidated financial 
statements include all operating divisions and majority owned subsidiaries, 
reported as a single operating segment, for which we maintain controlling 
interests. Intercompany accounts and transactions have been eliminated in 
consolidation.</p> <p style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Use of 
Estimates</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The preparation of financial 
statements in conformity with accounting principles generally accepted in the 
United States of America requires management to make estimates and assumptions 
that affect the reported amounts of assets and liabilities and disclosure of 
contingent assets and liabilities at the date of the financial statements and 
the reported amounts of revenues and expenses during the reporting period.&nbsp;
Actual results could differ from those estimates.</p> <p style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Reclassifications</i></p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>Certain reclassifications have been made to the 
comparative period amounts in order to conform to the current period 
presentation.&nbsp; These reclassifications had no effect on the reported 
financial position, results of operations or cash flows of the entity.</p> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Significant 
Accounting Policies</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>A description of the Company's 
significant accounting policies is included in Note 3 of its Annual Report on 
Form 10&#150;K for the fiscal year ended March 31, 2016.</p> <p style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Recent Accounting 
Pronouncements</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>In February 2016, the Financial 
Accounting Standards Board (&quot;FASB&quot;) issued amended accounting guidance
that changes the accounting for leases and requires expanded disclosures about 
leasing activities. Under the new guidance, lessees will be required to 
recognize a right-of-use asset and a lease liability, measured on a discounted 
basis, at the commencement date for all leases with terms greater than twelve 
months. Lessor accounting will remain largely unchanged, other than certain 
targeted improvements intended to align lessor accounting with the lessee 
accounting model and with the updated revenue recognition guidance issued in 
2014. Lessees and lessors must apply a modified retrospective transition 
approach for leases existing at, or entered into after, the beginning of the 
earliest comparative period presented in the financial statements. The amended 
guidance is effective for annual reporting periods (including interim periods 
within those periods) beginning after December 15, 2018, and early application 
is permitted. The Company is currently evaluating the impact this guidance will 
have on its financial position and results of operations.</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>Management does not believe that any other recently issued but not yet
effective accounting pronouncements, if adopted, would have a material effect on
the accompanying consolidated financial statements.</p> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for the basis of presentation and 
significant accounting policies concepts. Basis of presentation describes the 
underlying basis used to prepare the financial statements (for example, US 
Generally Accepted Accounting Principles, Other Comprehensive Basis of 
Accounting, IFRS).  Accounting policies describe all significant accounting 
policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6894278368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2
- Going Concern<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Note 2 - Going
Concern</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 2 &#150;
Going Concern</b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The Company's financial 
statements have been prepared assuming the Company will continue as a going 
concern. The Company has sustained net losses since inception, which have caused
an accumulated deficit of approximately $22.1 million at June 30, 2016. In 
addition, the Company has consumed cash in its operating activities of 
approximately $1 million for the three months ended June 30, 2016 compared to 
$1.1 million for the same period last year. These factors, among others, raise 
substantial doubt about the Company's ability to continue as a going 
concern.</p> <p style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>Management has been able, thus far, to finance the
losses through a public offering, private placements and obtaining operating 
funds from stockholders. The Company is continuing to seek sources of 
financing.&nbsp; There are no assurances that the Company will be successful in 
achieving its goals.</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>In view of these conditions, the 
Company's ability to continue as a going concern is dependent upon its ability 
to obtain additional financing or capital sources, to meet its financing 
requirements, and ultimately to achieve profitable operations. Management 
believes that its current and future plans provide an opportunity to continue as
a going concern. The accompanying financial statements do not include any 
adjustments relating to the recoverability and classification of recorded 
assets, or the amounts and classification of liabilities that may be necessary 
in the event the Company is unable to continue as a going 
concern.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure when substantial doubt is raised 
about the ability to continue as a going concern. Includes, but is not limited 
to, principal conditions or events that raised substantial doubt about the 
ability to continue as a going concern, management's evaluation of the 
significance of those conditions or events in relation to the ability to meet 
its obligations, and management's plans that alleviated or are intended to 
mitigate the conditions or events that raise substantial doubt about the ability
to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -Section 
50<br> -Paragraph 13<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51888302&amp;loc=SL51888449-
203568<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> 
-SubTopic 40<br> -Section 50<br> -Paragraph 12<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51888302&amp;loc=SL51888443-
203568<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6725931376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3
- Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_ConvertibleNotes0TextBlock', window );">Note 3 - Convertible 
Notes</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 3 &#150;
Convertible Notes</b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>In February 2016, the Company 
issued a short-term Promissory Note (&quot;Note&quot;) with a face value of 
$192,500 resulting in aggregate proceeds of $175,000 reflecting a 9.1% original 
discount and a nominal rate of 10%. The Note is payable within one year of 
issuance and is convertible into 962,500 shares of the Company's common stock 
and 962,500 common stock purchase warrants at any time and from time to time 
before maturity at the option of the holder. Each warrant gives the Noteholder 
the right to purchase one share of common stock of the Company at an exercise 
price of $0.50 per share for a period of three years.&nbsp; The beneficial 
conversion feature resulting from the discounted conversion price compared to 
the market price was calculated based on the date of issuance to be $94,037 
after adjusting the effective conversion price for the relative fair value of 
the note proceeds compared to the fair value of the attached warrants and note. 
In addition to this discount related to the beneficial conversion feature, an 
additional discount of $66,912 was recorded based on the fair value of the
962,500 warrants attached to the note. This value was derived using the Black-
Scholes valuation model. At June 30, 2016, the Note had a balance of $0.09 
million net of $0.1 million unamortized discount and beneficial conversion 
feature.</p> <p style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>In March 2016, the Company issued a short-term 
Promissory Note (&quot;Note&quot;) with a face value of $300,000 resulting in 
aggregate proceeds of $250,000 reflecting a 16.67% original discount and a 
nominal rate of 20%. The Note is payable within one year of issuance and is 
convertible into 1,500,000 shares of the Company's common stock and 1,500,000 
common stock to purchase warrants at any time and from time to time before 
maturity at the option of the holder. Each warrant gives the Noteholder the 
right to purchase one share of common stock of the Company at an exercise price 
of $0.50 per share for a period of three years. The beneficial conversion 
feature resulting from the discounted conversion price compared to the market 
price was calculated based on the date of issuance to be $143,750 after 
adjusting the effective conversion price for the relative fair value of the note
proceeds compared to the fair value of the attached warrants and note. In 
addition to this discount related to the beneficial conversion feature, an 
additional discount of $93,750 was recorded based on the fair value of the 
1,500,000 warrants attached to the note. At June 30, 2016, the Note had a 
balance of $0.1 million net of $0.2 million unamortized discount and beneficial 
conversion feature.</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The Notes and Warrants were 
issued in reliance on the exemption from registration provided by 
Section&nbsp;4(2)&nbsp;of the Securities Act of 1933 (the &quot;<u>Securities 
Act</u>&quot;) and/or Rule 506 of Regulation D under the Securities Act, as 
amended.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_ConvertibleNotes0TextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of convertible note and promissory 
notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleNotes0TextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6894241248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4
- Note Payable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtDisclosureTextBlock', window );">Note 4 - Note Payable</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 4&#150; 
Note Payable</b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The Company entered into a Note 
Purchase Agreement, dated May 12, 2015 and effective as of June 8, 2015, with 
Pacific Leaf Ventures, LP (&quot;Pacific Leaf&quot;), pursuant to which Pacific 
Leaf has made installment loans (the &quot;Loans&quot;) to us in the aggregate 
amount of $1.75 million. The purpose of the financing is to provide for the 
acquisition and installation of an operating facility, equipment and other 
tangible assets by GBSN. Such facility and equipment will be dedicated to the 
cultivation of cannabis and the extraction of oils and other constituents 
present in cannabis, subject at all times to Nevada legal requirements. The note
is convertible at the option of the holder into common shares at a conversion 
price of $0.50, subject to anti-dilution adjustments.</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>To evidence the Loans, the Company issued to Pacific Leaf a 6% senior 
secured convertible promissory note (the &quot;Note&quot;), bearing interest at 
the rate of 6% per annum, payable quarterly. All outstanding principal and 
interest due under the Note were due and payable on May 12, 2020. We were 
required to prepay the outstanding principal amount of the Note on a quarterly 
basis in an amount equal to 50% of the cash flow (accrued EBITDA) of GB Sciences
Nevada, LLC (&quot;GBSN&quot;) attributable to our percentage interest in GBSN 
no later than the earlier to occur of (a) the fifth (5th) business day following
receipt of a distribution of the Company's Share of GBSN's EBITDA for the 
calendar quarter in question, or (b) thirty (30) days following the end of the 
calendar quarter in question, with the first such prepayment to be made not 
later than July 31, 2015 with respect to the quarter ending June 30, 2015. In 
order to induce the Pacific Leaf to extend the loan to the Company and to secure
the payment and performance of all of the Secured Obligations, the Company 
agreed to grant Secured Party a security interest in certain of its assets and 
enter into the lending agreement.</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>On February 8, 
2016, the Company entered into the Amended and Restated 6% Senior Convertible 
Promissory Note (&quot;Amended Note&quot;) with Pacific Leaf Ventures, LP 
(&quot;Pacific Leaf&quot;).&nbsp; The amended agreement modifies the 6% Senior
Secure Convertible Promissory Note dated May 12, 2015 and effective as of June 
8, 2015, in the principal amount of $1.75 million.</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>Per the terms of the amended agreement, Pacific Leaf may make up to 
$1.0 million in additional advances to the Company under the Amended Note 
bringing the total in the aggregate to $2.75 million. The note is convertible at
the option of the holder into common shares at a conversion price of $0.25, 
subject to anti-dilution adjustments. The Company has an option to prepay the 
Amended Note, without premium or penalty, in whole or in part, with accrued 
interest to the date of such prepayment.</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>Until the 
payment in full of the Amended Note, the Investor or its designee shall have the
option (the &quot;Option&quot;) to purchase up to a 20% membership interest in 
GBSN for a purchase price equal to $100,000 for each 2% of membership interest 
purchased (i.e., $1,000,000 if the Option is exercised in full), provided that 
the Option may not be exercised for less than a 1% membership interest in 
GBSN.</p> <p style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'> </p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>In connection with the Amended Note, the Company 
also entered into the Amended and Restated Royalty Agreement with Pacific Leaf 
dated and effective as of February 8, 2016.&nbsp; Per the terms of the Amended 
Royalty Agreement, the royalty rate at any time shall equal to the sum of (i) 
9.1%, and (ii) the percentage calculated by dividing the amount advanced in 
excess of $1.75 million by $1.0 million, multiplied by the gross revenues of 
GBSN.&nbsp; On the earlier of (i) the seventh anniversary of the royalty payment
date, or (ii) the date that all amounts outstanding under the Amended Note have 
been paid in full, the royalty rate shall be reduced by 50%.</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>On June 13, 2016 the Company received notice from 
Pacific Leaf Ventures, LP (&quot;Pacific Leaf&quot;) that it had elected to 
convert $500,000 of the Company's indebtedness to Pacific Leaf Note into common 
stock of the Company pursuant to the Amended and Restated 6% Senior Secured 
Convertible Promissory.&nbsp; Accordingly, the Company has issued 2,000,000 
shares of its common stock ($500,000 converted at a price of $0.25 per share) to
Pacific Leaf and the Company's indebtedness to Pacific Leaf pursuant to the Note
has been reduced by $500,000. As of June 30, 2016, the total amount of 
installments received, net of conversion, is $2.02 million.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for information about short-term and
long-term debt arrangements, which includes amounts of borrowings under each 
line of credit, note payable, commercial paper issue, bonds indenture, debenture
issue, own-share lending arrangements and any other contractual agreement to 
repay funds, and about the underlying arrangements, rationale for a 
classification as long-term, including repayment terms, interest rates, 
collateral provided, restrictions on use of assets and activities, whether or 
not in compliance with debt covenants, and other matters important to users of 
the financial statements, such as the effects of refinancing and noncompliance 
with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.19,20,22)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6725175776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5
- Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Note 5 - Property
and Equipment</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 5 &#150;
Property and Equipment</b></p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>Property and 
equipment balances as of June 30, 2016 and March 31, 2016:</p> <div 
align="center"> <table border="0" cellspacing="0" cellpadding="0" width="780"> 
<tr align="left"> <td width="1178" valign="bottom"
style='width:706.5pt;padding:0'> <p style='margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt'>&#160;</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;padding:0'> <p align="center" style='margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-align:center'><b>As of June 30, 
2016</b></p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:solid black 1.0pt;padding:0'> <p
align="center" style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:center'><b>As of March 31, 2016</b></p> </td> </tr> 
<tr align="left"> <td width="1178" valign="bottom" 
style='width:706.5pt;background:#CCEEFF;padding:0'> <p style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt'>Computer and 
software</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$151,748</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$151,748</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Machinery and equipment</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;background:white;padding:0'> <p 
align="right" style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right'>643,394</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;background:white;padding:0'> <p 
align="right" style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right'>641,898</p> </td> </tr> <tr align="left"> <td 
width="1178" valign="bottom" style='width:706.5pt;background:#CCEEFF;padding:0'>
<p style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Leaseholds</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>357,418</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>363,317</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Construction in progress</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>2,075,086</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>1,043,042</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:#CCEEFF;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>3,227,646</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>2,200,005</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt'>Less 
accumulated depreciation and amortization</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>(292,474)</p> </td> <td width="219" valign="bottom"
style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>(246,957)</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:#CCEEFF;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Property and equipment, net</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$2,935,172</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$1,953,048</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:white;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>&#160;</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:white;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>&#160;</p> </td> </tr> </table> </div> <p style='margin-
right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for long-lived, physical assets used
in the normal conduct of business and not intended for resale. Includes, but is 
not limited to, accounting policies and methodology, roll forwards, 
depreciation, depletion and amortization expense, including composite 
depreciation, accumulated depreciation, depletion and amortization expense, 
useful lives and method used, income statement disclosures, assets held for sale
and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51717284&amp;loc=d3e1361-
107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-
110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6894350176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6
- Capital Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Note 6 - Capital 
Transactions</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt'><b>Note 6 &#150; Capital 
Transactions</b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>During the three months ended 
June 30, 2016, the Company issued an aggregate of 835,967 shares of common stock
in settlement and release of certain obligations owed by the Company to various 
persons and recorded related expenses of $0.3 million, as follows:</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:47.25pt;text-align:justify;text-indent:-
27.0pt'>&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company
issued 512,275 shares of its common stock in connection with the conversion of 
$0.2 million in indebtedness owed by us to various persons at a conversion price
of approximately $0.38 per share.</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&nbsp;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:47.25pt;text-
align:justify;text-indent:-
27.0pt'>&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company
issued 323,692 shares of common stock in connection with settlement of payroll 
liabilities owed by us to our executives at a conversion price of $0.19 per 
share. The Company recorded approximately $0.1 million of compensation 
expense.</p> <p style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>The Company issued 100,000 shares of common stock 
to employees and recorded an expense of $0.03 million.</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>On April 8, 2016, the Company issued 200,000 of its common shares to 
its former Chief Financial Officer, in exchange for a full dismissal with 
prejudice of all causes of action pending in the complaint filed against the 
Company on August 19, 2015.</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>The Company 
issued 50,000 shares in exchange for consulting services and recorded a related 
expense of $0.02 million.</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>On June 13, 2016 the Company 
received notice from Pacific Leaf Ventures, LP (&quot;Pacific Leaf&quot;) that 
it had elected to convert $500,000 of the Company's indebtedness to Pacific Leaf
Note into common stock of the Company pursuant to the Amended and Restated 6% 
Senior Secured Convertible Promissory.&nbsp; Accordingly, the Company has issued
2,000,000 shares of its common stock ($500,000 converted at a price of $0.25 per
share) to Pacific Leaf.</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>During three months ended June 
30, 2016, the Company sold 7,425,500 units through a private placement at a 
price of $0.20 per unit resulting in net proceeds of $1.3 million.&nbsp; Each 
unit consisted of one share of common stock and one common stock purchase 
warrant, expiring in three years, with an exercise price of 
$0.50.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for shareholders' equity comprised 
of portions attributable to the parent entity and noncontrolling interest, 
including other comprehensive income. Includes, but is not limited to, balances 
of common stock, preferred stock, additional paid-in capital, other capital and 
retained earnings, accumulated balance for each classification of other 
comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(d),(e))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-
112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 
4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-
122707<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-
112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 
4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-
122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-
112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-
112656<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br>
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-
112644<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary 
Preferred Stock<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 12: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-
112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br>
-Section E<br><br>Reference 15: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff
Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section C<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6725186256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7
- Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Note 7 - 
Commitments and Contingencies</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 7 &#150;
Commitments and Contingencies</b></p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in;text-
align:justify'><b><i>Growblox Sciences, Inc.&nbsp; v. GCM Administrative 
Services, LLC</i></b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>On April 2, 2014, we commenced an
action in the United States District Court for the Southern District of New York
captioned Signature Exploration and Production Corporation v. GCM Administrative
Services, LLC, Strategic Turnaround Equity Partners, L.P. (Cayman), Seth M. 
Lukash, and Gary Herman, 14 Civ. 02280 (ER) (the &quot;Action&quot;). After the 
change of name of Signature Exploration and Production Corporation, the caption 
was amended to substitute GrowBlox Sciences, Inc. as the plaintiff. The 
complaint in the Action sought a declaratory judgment that neither Lukash nor 
Herman was entitled to receive any interest in, including any shares of stock 
of, Growblox pursuant to certain share conversion rights held under promissory 
notes in the aggregate amount of $75,000, given by a related party of ours to 
the entity defendants GCM and Strategic.</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>On May 9, 2014, 
defendants filed an answer denying the complaint's material allegations, and 
asserted a counterclaim against us, against persons identified as certain of our
officers or directors, and against GrowOpp, LLC and Tumbleweed Holdings, Inc. On
November 19, 2014, defendants filed an amended counterclaim, including a prayer 
for monetary relief or damages in the sum of $9 million. We moved to dismiss the
counterclaim and by opinion dated June 2, 2015, the Court granted the motion in 
part and dismissed counts one and two (for declaratory judgment as to an alleged
partnership or joint venture, and for breach of fiduciary duty predicated upon 
those allegations), and denied the motion in part, leaving counts three and four
of the counterclaim standing. The Court viewed the third and fourth claims as a
single claim for unjust enrichment, in which recovery would be based on quantum 
meruit, that is, upon the alleged value of any benefit conferred by defendants 
to us through alleged work and services rendered. In view of the fact that the 
pleading did not assign a particular value to that claim we are unable at 
present to advise what specific sum of money damages is sought. We did not 
challenge the fifth count of the counterclaim at this stage that seeks damages 
of $75,000 for alleged non-payment of the above-referenced promissory notes.</p>
<p style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>The Company and its adversaries entered an 
agreement in principle, subject to the execution of formal documents and dated 
as of June 20, 3016, to settle and dismiss the action. The Company's board 
approved the settlement on July 6, 2016. The parties are in the process of 
executing a formal, written settlement agreement. Under the settlement, the 
Company will deliver 1,400,000 shares of its common stock to its adversaries. 
Craig Ellins, formerly CEO of the Company and now its chief scientific officer, 
will deliver 3,000,000 shares that he owns personally. Based on our estimate of 
potential outcomes, we have accrued $0.5 million with respect to this matter as 
of June 30, 2016.</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'><b><i>Cathryn Kennedy Complaint 
Settlement</i></b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>On August 19, 2015, Cathryn 
Kennedy, our former Chief Financial Officer, filed a Complaint against us in the
District Court in Clark County, Nevada alleging that she was assigned new duties
by us which constituted a termination without cause effective July 24, 2015, and
that as a consequence thereof she is entitled to severance, vacation pay and 
stock compensation from us pursuant to her Employment Agreement dated November 
18, 2014.&nbsp; On April 8, 2016, the Company entered into a mutual agreement 
with Cathryn Kennedy per terms of which the Company issued 200,000 of its 
unrestricted common shares in exchange for a full dismissal with prejudice of 
all causes of action pending in the above-referenced Complaint.</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>From time to time, the Company also becomes 
involved in certain legal proceedings and claims which arise in the ordinary 
course of business. In our opinion, based on consultations with outside counsel,
the results of any of these ordinary course matters, individually and in the 
aggregate, are not expected to have a material effect on our results of 
operations, financial condition, or cash flows. As more information becomes 
available, if management should determine that an unfavorable outcome is 
probable on such a claim and that the amount of such probable loss that it will 
incur on that claim is reasonably estimable, we will record a reserve for the 
claim in question. If and when we record such a reserve is recorded, it could be
material and could adversely impact our results of operations, financial 
condition, and cash flows.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for commitments and 
contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-
108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-
110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-
108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-
109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6585145472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8
- Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareTextBlock', window );">Note 8 - Loss Per Share</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><b>Note 8 &#150;
Loss per Share</b></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in;text-align:justify'>The Company's 
basic loss per share has been calculated using the weighted average number of 
common shares outstanding during the period. The Company had 31,359,167 and 
27,558,334 potentially dilutive common shares at June 30, 2016 and March 31, 
2016, respectively.&nbsp; However, such common stock equivalents were not 
included in the computation of diluted net loss per share as their inclusion 
would have been anti-dilutive.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 3<br> -URI
http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-
109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-
109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> 
-SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI 
http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-
109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-
03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6725194544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9
- Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SubsequentEventsTextBlock', window );">Note 9 - Subsequent Events</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in;text-
align:justify'><b>Note 9 &#150; Subsequent Events</b></p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'><b><i>GB Sciences Nevada LLC</i></b></p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in;background:white'>On July 21, 2016, an entity associated with Pacific 
Leaf Partners, LLC completed the purchase of the building housing the Company's 
cultivation facility at 3550 W. Teco Ave., Las Vegas, NV. In connection with the
purchase, the Company entered into an amended lease agreement per the terms of 
which the initial term of the lease covering the facility was extended to ten 
years, with an optional five-year extension.</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&#160;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in;background:white'>On August 4, 2016, the <font style='background:yellow
!msorm'>Company </font><font style='background:yellow !msorm'>entered into 
</font>the Second Omnibus Amendment (&#147;Amendment&#148;) <font 
style='background:yellow !msorm'>of its existing agreements with Pacific Leaf 
</font>Ventures, LP (&#147;Pacific Leaf&#148;).&nbsp; Principally, the 
Amendment<font style='background:yellow !msorm'> eliminates Pacific Leaf's 
option to </font>purchase up to a 20% membership interest in GB Sciences Nevada 
LLC (&#147;GBSN&#148;)<font style='background:yellow !msorm'> and 
</font>reduces<font style='background:yellow !msorm'> Pacific Leaf's existing 
royalty</font> rate<font style='background:yellow !msorm'> to </font>16.4%. It 
also caps maximum aggregate <font style='background:yellow !msorm'>royalty 
</font>payments to be made <font style='background:yellow !msorm'>to Pacific 
Leaf </font>at $2,420,000 with respect to any calendar year. In consideration of
the amended<font style='background:yellow !msorm'> terms</font>, Pacific Leaf 
will receive 1,000,000 shares of the Company&#146;s common stock and a five-year
warrant to purchase 1,500,000 shares of the Company&#146;s common stock at $0.36
per share.</p> <p style='margin-right:0in;margin-left:0in;text-
align:justify'><b>Growblox Sciences, Inc. &#160;v. GCM Administrative Services, 
LLC Settlement </b></p> <p style='margin-right:0in;margin-left:0in;text-
align:justify'>On August 9, 2016, the Company finalized a settlement agreement 
in final disposition of the lawsuit filed by the Company on April 2, 2014, in 
the United States District Court for the Southern District of New York.&#160; 
The Company&#146;s obligation under the agreement is to issue 1,400,000 
shares<font style='background:yellow !msorm'> of </font>restricted common stock 
to certain non-affiliates of the Company.</p> <p style='margin-right:0in;margin-
left:0in;text-align:justify'><b>Executive Appointments</b></p> <p style='margin-
right:0in;margin-left:0in;margin:0in !msorm;background:white !msorm'>On August 
5, 2016, the Company&#146;s Board of Directors accepted the resignation of John 
Poss as Chief Financial Officer of the Company and appointed Ksenia Griswold as 
the Company&#146;s Vice President and Chief Financial Officer. Mr. Poss<font 
style='background:yellow !msorm'> will </font>continue to serve as the 
President, Chief Executive Officer, and Chief Operating Officer of the Company. 
Ms. Griswold has been serving as the controller of the Company since November, 
2015.&#160; For the five years prior to that time beginning in October, 2010, 
she worked in the Las Vegas, Nevada office of Ernst &amp; Young, LLP.&#160; At 
the time of her departure from Ernst &amp; Young, she was audit manager.&#160; 
It is expected that an amendment to Ms. Griswold&#146;s employment agreement and
compensation will be negotiated during the upcoming fiscal quarter.</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in;background:white'>&nbsp;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-
left:0in;background:white'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for significant events or 
transactions that occurred after the balance sheet date through the date the 
financial statements were issued or the date the financial statements were 
available to be issued. Examples include: the sale of a capital stock issue, 
purchase of a business, settlement of litigation, catastrophic loss, significant
foreign exchange rate changes, loans to insiders or affiliates, and transactions
not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
}</script>
e.nextSibling.style.display='block';
} else
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729798384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1
- Basis of Presentation and Significant Accounting Policies 
(Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Basis of 
Presentation</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The accompanying unaudited 
interim condensed consolidated financial statements of Growblox Sciences, Inc. 
(the &quot;Company,&quot; &quot;We&quot; or &quot;Us&quot;) have been prepared 
in accordance with U.S. generally accepted accounting principles (&quot;U.S. 
GAAP&quot;) for interim financial information and with the instructions to Form 
10-Q and Article 8 of Regulations S-X.&nbsp; Accordingly, they do not include 
all of the information and footnotes required by U.S. GAAP for complete 
financial statements.&nbsp; In the opinion of management, all adjustments 
(consisting of normal recurring accruals) considered necessary for a fair 
presentation have been included.&nbsp; Operating results for the periods 
presented are not necessarily indicative of the results that may be expected for
the year ending March 31, 2017. The balance sheet at March 31, 2016 has been 
derived from the audited financial statements at that date but does not include 
all of the information and footnotes required by U.S. GAAP for complete 
financial statements. For further information, refer to the consolidated 
financial statements and footnotes thereto included in the Company's annual 
report on Form 10-K for the year ended March 31, 2016.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ConsolidationPolicyTextBlock', window );">Principles of 
Consolidation</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Principles of
Consolidation</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The consolidated financial 
statements include all operating divisions and majority owned subsidiaries, 
reported as a single operating segment, for which we maintain controlling 
interests. Intercompany accounts and transactions have been eliminated in 
consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Use of 
Estimates</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>The preparation of financial 
statements in conformity with accounting principles generally accepted in the 
United States of America requires management to make estimates and assumptions 
that affect the reported amounts of assets and liabilities and disclosure of 
contingent assets and liabilities at the date of the financial statements and 
the reported amounts of revenues and expenses during the reporting period.&nbsp;
Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Reclassifications', window );">Reclassifications</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'><i>Reclassifications</i></p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&#160;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>Certain 
reclassifications have been made to the comparative period amounts in order to 
conform to the current period presentation.&nbsp; These reclassifications had no
effect on the reported financial position, results of operations or cash flows 
of the entity.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting 
Policies</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Significant 
Accounting Policies</i></p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>&#160;</p> <p 
style='margin-right:0in;margin-left:0in;margin-top:3.0pt;margin-
right:0in;margin-bottom:3.0pt;margin-left:0in'>A description of the Company's 
significant accounting policies is included in Note 3 of its Annual Report on 
Form 10&#150;K for the fiscal year ended March 31, 2016.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent 
Accounting Pronouncements</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'><i>Recent 
Accounting Pronouncements</i></p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>&nbsp;</p> <p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>In February 
2016, the Financial Accounting Standards Board (&quot;FASB&quot;) issued amended
accounting guidance that changes the accounting for leases and requires expanded
disclosures about leasing activities. Under the new guidance, lessees will be 
required to recognize a right-of-use asset and a lease liability, measured on a 
discounted basis, at the commencement date for all leases with terms greater
than twelve months. Lessor accounting will remain largely unchanged, other than 
certain targeted improvements intended to align lessor accounting with the 
lessee accounting model and with the updated revenue recognition guidance issued
in 2014. Lessees and lessors must apply a modified retrospective transition 
approach for leases existing at, or entered into after, the beginning of the 
earliest comparative period presented in the financial statements. The amended 
guidance is effective for annual reporting periods (including interim periods 
within those periods) beginning after December 15, 2018, and early application 
is permitted. The Company is currently evaluating the impact this guidance will 
have on its financial position and results of operations.</p> <p style='margin-
right:0in;margin-left:0in;margin-top:3.0pt;margin-right:0in;margin-
bottom:3.0pt;margin-left:0in'>&nbsp;</p> <p style='margin-right:0in;margin-
left:0in;margin-top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-
left:0in'>Management does not believe that any other recently issued but not yet
effective accounting pronouncements, if adopted, would have a material effect on
the accompanying consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for the basis of accounting, or 
basis of presentation, used to prepare the financial statements (for example, US
Generally Accepted Accounting Principles, Other Comprehensive Basis of 
Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy regarding (1) the 
principles it follows in consolidating or combining the separate financial 
statements, including the principles followed in determining the inclusion or 
exclusion of subsidiaries or other entities in the consolidated or combined 
financial statements and (2) its treatment of interests (for example, common 
stock, a partnership interest or other means of exerting influence) in other 
entities, for example consolidation or use of the equity or cost methods of 
accounting.  The accounting policy may also address the accounting treatment for
intercompany accounts and transactions, noncontrolling interest, and the income 
statement treatment in consolidation for issuances of stock by a 
subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-
107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-
111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-
02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-
122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph k<br> -Article 1<br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 02, 03<br> -Article 
3A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy pertaining to new 
accounting pronouncements that may impact the entity's financial reporting. 
Includes, but is not limited to, quantification of the expected or actual 
impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Reclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for classifying current financial 
statements, which may be different from classifications in the prior year's 
financial statements. Disclose any material changes in classification including 
an explanation of the reason for the change and the areas impacted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-
107755<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br>
-Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Reclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for all significant accounting 
policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 6<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18861-
107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-
107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-
107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18743-
107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18854-
107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy for the use of estimates 
in the preparation of financial statements in conformity with generally accepted
accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-
108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-
108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-
108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6587923152">
<tr>
}</script>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5
- Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_TableTextBlockSupplementAbstract', 
window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and 
Equipment Balances</a></td>
<td class="text"><!--egx--><p style='margin-right:0in;margin-left:0in;margin-
top:3.0pt;margin-right:0in;margin-bottom:3.0pt;margin-left:0in'>Property and 
equipment balances as of June 30, 2016 and March 31, 2016:</p> <div 
align="center"> <table border="0" cellspacing="0" cellpadding="0" width="780"> 
<tr align="left"> <td width="1178" valign="bottom" 
style='width:706.5pt;padding:0'> <p style='margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt'>&#160;</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;padding:0'> <p align="center" style='margin-right:0in;margin-
left:0in;margin:0in;margin-bottom:.0001pt;text-align:center'><b>As of June 30, 
2016</b></p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:solid black 1.0pt;padding:0'> <p
align="center" style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:center'><b>As of March 31, 2016</b></p> </td> </tr> 
<tr align="left"> <td width="1178" valign="bottom" 
style='width:706.5pt;background:#CCEEFF;padding:0'> <p style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt'>Computer and 
software</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$151,748</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$151,748</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Machinery and equipment</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;background:white;padding:0'> <p 
align="right" style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right'>643,394</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;background:white;padding:0'> <p 
align="right" style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt;text-align:right'>641,898</p> </td> </tr> <tr align="left"> <td 
width="1178" valign="bottom" style='width:706.5pt;background:#CCEEFF;padding:0'>
<p style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Leaseholds</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>357,418</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>363,317</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Construction in progress</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:solid black
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>2,075,086</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>1,043,042</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:#CCEEFF;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>3,227,646</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:#CCEEFF;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>2,200,005</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt'>Less 
accumulated depreciation and amortization</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>(292,474)</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:solid black 
1.0pt;background:white;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>(246,957)</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:#CCEEFF;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>Property and equipment, net</p> </td> <td width="219" 
valign="bottom" style='width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$2,935,172</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;border:none;border-bottom:double black 
2.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin-
right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>$1,953,048</p> </td> </tr> <tr align="left"> <td width="1178" 
valign="bottom" style='width:706.5pt;background:white;padding:0'> <p 
style='margin-right:0in;margin-left:0in;margin:0in;margin-
bottom:.0001pt'>&#160;</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:white;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>&#160;</p> </td> <td width="219" valign="bottom" 
style='width:131.25pt;background:white;padding:0'> <p align="right" 
style='margin-right:0in;margin-left:0in;margin:0in;margin-bottom:.0001pt;text-
align:right'>&#160;</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Tabular disclosure of physical assets used in the normal 
conduct of business and not intended for resale. Includes, but is not limited 
to, balances by class of assets, depreciation and depletion expense and method 
used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 13<br> -Subparagraph b<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6898309712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2
- Going Concern (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated 
Deficit</a></td>
<td class="num">$ (22,120,731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,779,860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in 
operating activities</a></td>
<td class="num">$ (957,918)<span></span>
</td>
<td class="num">$ (1,086,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from operating activities,
including discontinued operations. Operating activity cash flows include 
transactions, adjustments, and changes in value not defined as investing or 
financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cumulative amount of the reporting entity's 
undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br>
-Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6735559504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3
- Convertible Notes (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 29, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized Discount and 
Beneficial Feature</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote1Member', window );">Short-
term Promissory Note 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromConvertibleDebt', window );">Aggregate proceeds</a></td>
<td class="nump">175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_DebtDiscountRate', window );">Original discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Nominal 
rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized Discount and 
Beneficial Feature</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ConvertibleNotesPayableCurrent', window );">Note balance</a></td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote1Member', window );">Short-
term Promissory Note 1 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt 
Instrument, Convertible, Number of Equity Instruments</a></td>
<td class="nump">962,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote1Member', window );">Short-
term Promissory Note 1 | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt 
Instrument, Convertible, Number of Equity Instruments</a></td>
<td class="nump">962,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise
price | $ / shares</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt 
Instrument, Convertible, Beneficial Conversion Feature</a></td>
<td class="nump">$ 94,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized Discount and 
Beneficial Feature</a></td>
<td class="nump">66,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote2Member', window );">Short-
term Promissory Note 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromConvertibleDebt', window );">Aggregate proceeds</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_DebtDiscountRate', window );">Original discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Nominal 
rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized Discount and 
Beneficial Feature</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ConvertibleNotesPayableCurrent', window );">Note balance</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote2Member', window );">Short-
term Promissory Note 2 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt 
Instrument, Convertible, Number of Equity Instruments</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote2Member', window );">Short-
term Promissory Note 2 | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt 
Instrument, Convertible, Number of Equity Instruments</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise
price | $ / shares</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt 
Instrument, Convertible, Beneficial Conversion Feature</a></td>
<td class="nump">$ 143,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized Discount and 
Beneficial Feature</a></td>
<td class="nump">$ 93,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_DebtDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Percentage of discount upon initial issuance of 
debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DebtDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Exercise price per share or per unit of warrants or rights
outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of the portion
of long-term debt due within one year or the operating cycle if longer 
identified as Convertible Notes Payable. Convertible Notes Payable is a written 
promise to pay a note which can be exchanged for a specified amount of another, 
related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of a favorable spread to a debt holder between the 
amount of debt being converted and the value of the securities received upon 
conversion. This is an embedded conversion feature of convertible debt issued 
that is in-the-money at the commitment date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary 
Beneficial Conversion Feature<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6505963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentConvertibleBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The number of equity instruments that the holder of the 
debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-
112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-
112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Face (par) amount of debt instrument at time of 
issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 
55<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-
108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> 
-SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-
108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Effective interest rate for the funds borrowed under the 
debt agreement considering interest compounding and original issue discount or 
premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1:
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> 
-SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-
108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of debt discount that was originally recognized
at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 
45<br> -Paragraph 1A<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-
108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> 
-SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-
108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash inflow from the issuance of a long-term debt 
instrument which can be exchanged for a specified amount of another security, 
typically the entity's common stock, at the option of the issuer or the 
holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentAxis=fil_ShortTermPromissoryNote2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6898288112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4
- Note Payable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">14 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Feb. 08, 2016</div></th>
<th class="th"><div>Jun. 08, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Conversion 
Price</a></td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt 
Conversion, Converted Instrument, Shares Issued</a></td>
<td class="nump">835,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember', window );">Pacific
Leaf Ventures LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentFaceAmount', window );">Initial debt amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Conversion 
Price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, 
Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity 
Date</a></td>
<td class="text">May 12,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature', window );">Debt 
Instrument, Convertible, Terms of Conversion Feature</a></td>
<td class="text">Per the terms of the amended agreement, Pacific Leaf may make 
up to $1.0 million in additional advances to the Company under the Amended Note 
bringing the total in the aggregate to $2.75 million. The note is convertible at
the option of the holder into common shares at a conversion price of $0.25, 
subject to anti-dilution adjustments. The Company has an option to prepay the 
Amended Note, without premium or penalty, in whole or in part, with accrued 
interest to the date of such prepayment.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentPaymentTerms', window );">Debt Instrument, Payment 
Terms</a></td>
<td class="text">Until the payment in full of the Amended Note, the Investor or 
its designee shall have the option (the 'Option') to purchase up to a 20% 
membership interest in GBSN for a purchase price equal to $100,000 for each 2% 
of membership interest purchased (i.e., $1,000,000 if the Option is exercised in
full), provided that the Option may not be exercised for less than a 1% 
membership interest in GBSN.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_RoyaltyAgreementAmendedTerms', window );">Royalty Agreement Amended 
Terms</a></td>
<td class="text">In connection with the Amended Note, the Company also entered 
into the Amended and Restated Royalty Agreement with Pacific Leaf dated and 
effective as of February 8, 2016. Per the terms of the Amended Royalty 
Agreement, the royalty rate at any time shall equal to the sum of (i) 9.1%, and 
(ii) the percentage calculated by dividing the amount advanced in excess of 
$1.75 million by $1.0 million, multiplied by the gross revenues of GBSN. On the 
earlier of (i) the seventh anniversary of the royalty payment date, or (ii) the 
date that all amounts outstanding under the Amended Note have been paid in full,
the royalty rate shall be reduced by 50%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt Conversion, 
Converted Instrument, Amount</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromConvertibleDebt', window );">Total amount of installments 
received, net of conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember', window );">Pacific
Leaf Ventures LP | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt 
Conversion, Converted Instrument, Shares Issued</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_RoyaltyAgreementAmendedTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Royalty Agreement Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RoyaltyAgreementAmendedTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The value of the financial instrument(s) that the original
debt is being converted into in a noncash (or part noncash) transaction. "Part 
noncash" refers to that portion of the transaction not resulting in cash 
receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The number of shares issued in exchange for the original
debt being converted in a noncash (or part noncash) transaction. "Part noncash" 
refers to that portion of the transaction not resulting in cash receipts or 
payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of long-term debt before deduction of unamortized 
discount or premium. Includes, but is not limited to, notes payable, bonds 
payable, commercial loans, mortgage loans, convertible debt, subordinated debt 
and other types of debt, with initial maturities beyond one year or the normal 
operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 20<br> -Article 5<br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 16<br> 
-Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The price per share of the conversion feature embedded in 
the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-
161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Description of the conversion terms of a debt instrument 
which may include the conversion ratio (including all potential conversion 
ratios if contingently adjustable), type of debt or equity security into which 
the debt is convertible, the dollars of debt or the number of shares into which 
the instrument is convertible (or potentially convertible into), the conversion 
period, any contingencies associated with the conversion terms, and the 
existence and amount of a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 7<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.22(a)(5))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-
112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentConvertibleTermsOfConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Face (par) amount of debt instrument at time of 
issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 
55<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-
108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> 
-SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-
108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Contractual interest rate for funds borrowed, under the 
debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Date when the debt instrument is scheduled to be fully 
repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Description of the payment terms of the debt instrument 
(for example, whether periodic payments include principal and frequency of 
payments) and discussion about any contingencies associated with the 
payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-
112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash inflow from the issuance of a long-term debt
instrument which can be exchanged for a specified amount of another security, 
typically the entity's common stock, at the option of the issuer or the 
holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6897801152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 5
- Property and Equipment: Schedule of Property and Equipment Balances (Details) 
- USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, 
Gross, Total</a></td>
<td class="nump">$ 3,227,646<span></span>
</td>
<td class="nump">$ 2,200,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', 
window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(292,474)<span></span>
</td>
<td class="num">(246,957)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, 
net</a></td>
<td class="nump">2,935,172<span></span>
</td>
<td class="nump">1,953,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', 
window );">Computer and Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, 
Gross, Total</a></td>
<td class="nump">151,748<span></span>
</td>
<td class="nump">151,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', 
window );">Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, 
Gross, Total</a></td>
<td class="nump">643,394<span></span>
</td>
<td class="nump">641,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-
gaap_LeaseholdsAndLeaseholdImprovementsMember', window );">Leaseholds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, 
Gross, Total</a></td>
<td class="nump">357,418<span></span>
</td>
<td class="nump">363,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', 
window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, 
Gross, Total</a></td>
<td class="nump">$ 2,075,086<span></span>
</td>
<td class="nump">$ 1,043,042<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of accumulated depreciation, depletion and 
amortization for physical assets used in the normal conduct of business to 
produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</t
d>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount before accumulated depreciation, depletion and 
amortization of physical assets used in the normal conduct of business and not 
intended for resale. Examples include, but are not limited to, land, buildings, 
machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount after accumulated depreciation, depletion and 
amortization of physical assets used in the normal conduct of business to 
produce goods and services and not intended for resale. Examples include, but 
are not limited to, land, buildings, machinery and equipment, office equipment, 
and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> 
-Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-
gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-
gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-
gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-
gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-
gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729975808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6
- Capital Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 08, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionOriginalDebtAmount1', window );">Debt Conversion, Original 
Debt, Amount</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Conversion 
Price</a></td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock 
Issued During Period, Value, Settlement of Payroll Liabilities</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued 
During Period, Value, Issued for Services</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During 
Period, Value, New Issues</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_UnitsDescription', window );">Units, Description</a></td>
<td class="text">Each unit consisted of one share of common stock and one common
stock purchase warrant, expiring in three years, with an exercise price of 
$0.50.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember', window );">Pacific
Leaf Ventures LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Conversion 
Price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt Conversion, 
Converted Instrument, Amount</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_EmployeesMember', 
window );">Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', 
window );">Stock Issued During Period, Value, Restricted Stock Award, Net of 
Forfeitures</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt 
Conversion, Converted Instrument, Shares Issued</a></td>
<td class="nump">835,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based 
Compensation Expense</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', 
window );">Stock Issued During Period, Shares, Conversion of Convertible 
Securities</a></td>
<td class="nump">512,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock 
Issued During Period, Shares, Settlement of Payroll Liabilities</a></td>
<td class="nump">323,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued 
During Period, Shares, Issued for Services</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During 
Period, Shares, New Issues</a></td>
<td class="nump">7,425,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock | Pacific Leaf Ventures LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt 
Conversion, Converted Instrument, Shares Issued</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', 
window );">Stock Issued During Period, Shares, Restricted Stock Award, Net of 
Forfeitures</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period,
Shares, In exchange for a full dismissal with prejudice of all causes</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_UnitsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Units description</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_UnitsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Represents the expense recognized during the period 
arising from equity-based compensation arrangements (for example, shares of 
stock, unit, stock options or other equity instruments) with employees, 
directors and certain consultants qualifying for treatment as 
employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.F)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-
122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br>
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-
113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> 
-URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 
14<br> -Section F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The value of the financial instrument(s) that the original
debt is being converted into in a noncash (or part noncash) transaction. "Part 
noncash" refers to that portion of the transaction not resulting in cash 
receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The number of shares issued in exchange for the original 
debt being converted in a noncash (or part noncash) transaction. "Part noncash" 
refers to that portion of the transaction not resulting in cash receipts or 
payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of the original debt being converted in a 
noncash (or part noncash) transaction. "Part noncash" refers to that portion of 
the transaction not resulting in cash receipts or cash payments in the 
period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The price per share of the conversion feature embedded in 
the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-
161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Price of a single share of a number of saleable stocks of 
a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares issued during the period as a result of 
the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares issued in lieu of cash for services 
contributed to the entity. Number of shares includes, but is not limited to, 
shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of stock issued during the period that is
attributable to transactions involving issuance of stock not separately 
disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares issued during the period related to 
Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares (or other type of equity) issued during 
the period as a result of any equity-based compensation plan other than an 
employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued
could result from the issuance of restricted stock, the exercise of stock 
options, stock issued under employee stock purchase plans, and/or other employee
benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Value of stock issued in lieu of cash for services 
contributed to the entity. Value of the stock issued includes, but is not 
limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Equity impact of the value of new stock issued during the 
period. Includes shares issued in an initial public offering or a secondary 
public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Value of stock related to Restricted Stock Awards issued 
during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Value of stock (or other type of equity) issued during the
period as a result of any equity-based compensation plan other than an employee 
stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock 
issued could result from the issuance of restricted stock, the exercise of stock
options, stock issued under employee stock purchase plans, and/or other employee
benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1:
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-
113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br>
-Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">dei_LegalEntityAxis=fil_PacificLeafVenturesLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-
gaap_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-
gaap_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6733155600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7
- Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period,
Shares, In exchange for a full dismissal with prejudice of all causes | 
shares</a></td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LitigationCaseAxis=fil_InitialComplaintFiledByGrowbloxMember', 
window );">Initial Complaint Filed by Growblox</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages 
Sought, Value</a></td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LitigationCaseAxis=fil_CounterclaimMember', 
window );">Counterclaim</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages 
Sought, Value</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_SettlementAgreementTerms', window );">Settlement agreement, 
terms</a></td>
<td class="text">Under the settlement, the Company will deliver 1,400,000 shares
of its common stock to its adversaries. Craig Ellins, formerly CEO of the 
Company and now its chief scientific officer, will deliver 3,000,000 shares that
he owns personally. Based on our estimate of potential outcomes, we have 
accrued<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LossContingencyAccrualProvision', window );">Loss Contingency Accrual, 
Provision</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_SettlementAgreementTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Legal settlement agreement terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SettlementAgreementTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount charged against operating income increasing loss 
contingency liability, after adjustments to reduce previously estimated 
charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-
108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The value (monetary amount) of the award the plaintiff 
seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-
108349<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14557-
108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-
108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of stock issued during the period that is
attributable to transactions involving issuance of stock not separately 
disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-
gaap_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-
gaap_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_LitigationCaseAxis=fil_InitialComplaintFiledByGrowbloxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_LitigationCaseAxis=fil_InitialComplaintFiledByGrowbloxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_LitigationCaseAxis=fil_CounterclaimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_LitigationCaseAxis=fil_CounterclaimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6725255424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8
- Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common
Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', 
window );">Antidilutive Securities Excluded from Computation of Earnings Per
Share, Amount</a></td>
<td class="nump">31,359,167<span></span>
</td>
<td class="nump">27,558,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Securities (including those issuable pursuant to 
contingent stock agreements) that could potentially dilute basic earnings per 
share (EPS) or earnings per unit (EPU) in the future that were not included in 
the computation of diluted EPS or EPU because to do so would increase EPS or EPU
amounts or decrease loss per share or unit amounts for the period 
presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Antidilution<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> 
-URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> 
-URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6897835808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 9
- Subsequent Events (Details) - Subsequent Event -
shares<br></strong></div></th>
<th class="th"><div>Aug. 09, 2016</div></th>
<th class="th"><div>Aug. 04, 2016</div></th>
<th class="th"><div>Jul. 21, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract', window );">Lessee 
Leasing Arrangements, Operating Leases, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_fil_RoyaltyAgreementAmendedTerms', window );">Royalty Agreement Amended 
Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Principally, the Amendment eliminates Pacific Leaf's option to 
purchase up to a 20% membership interest in GB Sciences Nevada LLC 
(&#147;GBSN&#148;) and reduces Pacific Leaf's existing royalty rate to 16.4%. It
also caps maximum aggregate royalty payments to be made to Pacific Leaf at 
$2,420,000 with respect to any calendar year. In consideration of the amended 
terms, Pacific Leaf will receive 1,000,000 shares of the Company&#146;s common 
stock and a five-year warrant to purchase 1,500,000 shares of the Company&#146;s
common stock at $0.36 per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Common 
Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period,
Shares, Pursuant to settlement agreement</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_fil_RoyaltyAgreementAmendedTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Royalty Agreement Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RoyaltyAgreementAmendedTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Term of the lessee's leasing arrangement, in 
'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of
one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of stock issued during the period that is
attributable to transactions involving issuance of stock not separately 
disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-
gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-
gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>38
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "& #TG[QI0%D@$  #$1   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,U8RT[#,!#\E2I7U+@.4!YJ>Z%<H1+\@$DVC56_9+MI^_?8:4$0!=1"
M(^TECC.[.V.O/8=,7G<&W& KA7+3I/+>W!/B\@HD<ZDVH )2:BN9#U.[)(;E
M*[8$DHU&8Y)KY4'YH8\UDMGDN09K>0&#AST0:T\39HS@.?-<*U*KHE5UJ,N2
MYU#H?"U#2NH#-5P$/!DLF/5/3(829"M( ^R?-(TX.0^A,Q98X2H +T7J_$Z
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MO57!4MLP$/T5C4_T $Y,H&TF>"8D;LM,2#RU2\_"7A,-MF2T2H;P]5W+B>M
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M?[>[:?.INQZOU]UX=M+=>L_K8OU.4<<K\&9N;U[65^^HN___]_\ 4$L#!!0
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MU#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ
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M@2*&H_T%YZ1A[ZV"\:\N^0E02P,$%     @ (8 /2>%07V01 P  0 D   \
M  !X;"]W;W)K8F]O:RYX;6R5EEU3XC 40/]*ID^[#[NTY4-EQ!F$ZC*CP-B.
M^QS:(!G3I"8IJ+]^;P+H16$'GDC2WI.;FY.&2]-=*?T\4^J9O)9"FJ[N!0MK
MJVZC8?(%*ZGYK2HFX=E<Z9):Z.JGAIK/><Z&*J]+)FTC#L-.0S-!+5?2+'AE
M@@W-'$,SE6:T, O&;"G6L))R&5Q=FNZ<"_;(M $PH54UIB7K!:\B(((:FQ3<
MLJ(7M*"K5FQG0-?5=<V%Z[3#=M!PL.U2IYKDJF!K6+;@YN_F04 *-J>UL!DD
MNYVW%T1Q*XX[:X9[[9&SE<% -T!H;OF29736"\* T-JJ&RXLTT-JV:U6=<7E
M$[ ",N?:V-0MU[]9<LE+_N[RAIY9J-4?I?F[DI:*--=*"!_E'O@@F,%\C$".
MEN<[+UHZ>W [T0LZ(0"7W/ 9%]R^]0+?%LRMI/%E*;[\GRTB?7&V6TRH+$@B
M+5#(2*XW#TKC<H"71X6?6'<Y-/2HB-:EPJ#!9)Q.[D;#?I8,"72&R3B%UG7_
MKC\>) 2!8@2*3P4U$:B)0,WOH#0#Q'TRSE(RN2&3:?+0ST8 1X06(K3VIK*9
M?2>I+1B!V@C4_@X:*\M(1'Z1:VJX(6I.IIH9*+LO,BY.!X$Z!T Q@&X5R$8&
M2N9,XUTZ0_%G!^*;$ ^12V<6R$+<H$&,<\0X/\!H <,WIO2-.N,^PR]0^,6!
M\#:$3S5\*C3XYM5[J7GE1,3&A5BY\ "JXU9#*PZ'B62:2N..*7RE,&C'W3WR
M>M"9+TM9<NOR,#XM*)/E.Z< VQOMT=>CS@%UIXPA4Z9)NJ :UR?"WD9[Q/6(
M"T"D]<RPE]H=SV3I<L(4[&ZT1][_.A>U,0K;&QW2]]"611V,POY&1PM,?@R9
MI5SL+!"K')WDLL=A%#8Z.E;ICZ1^8A2V.SI5[SC$WT&L=WRJWN0'1F'!XU,%
MCV.,VOD\'R_XMEH8A46/3Q+]ZP[&V/:XM;G?/J\TN-6Y9(6[\(V?!F[,W/T+
M@)_UL6VUW=:Y_CW\,^@%[OJ&F[H68@!C$WFGJ+_DUN3MO7_U#U!+ P04
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M@93ZD6SM(X4O%7%(Z?2B,D" ]\L1!W560I+=L;2AOZ!"6PN)-U?IJ*QF 1Z
M=Z.5#LDGN\[C+ZW0%L0B5%N=)E>]3D%08%LV3IE!@'">?JY&R8=3N&?CSG0G
M(EKSXR#M$3F/SAW0$]*G^*?QE>Z,S.E^#E-7![IC/^BX:P<1O7"I>@1SE&\Y
METS!@8<\CO:J=YL?.K:5^I:H^]%V,_9!\L/4G,T=8OT/4$L#!!0    ( "&
M#TE @?+VW ,  $@1   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULC9A-
MCZ,X$(;_"N*>P2YC&[?2D1I6H]G#2J,Y[)[IQ/G0 ,X"Z<S^^S6X2'=&;L>7
M#CA/5;UEF[=CUE?3_QR.6H_)K[;IAN?T.([GIRP;MD?=UL,7<]:=_69O^K8>
M[6U_R(9SK^O='-0V&1 BLK8^=>EF/8]][S=K<QF;4Z>_]\EP:=NZ_Z_4C;D^
MIS1=!GZ<#L=Q&L@VZ^P6MSNUNAM.IDMZO7].7^A3Q6!"9N+OD[X.'ZZ32?RK
M,3^GFS]WSRF9-.A&;\<I16T_WG2EFV;*9"O_BTG?:TZ!'Z^7[%_G=JW\UWK0
ME6G^.>W&HU5+TF2G]_6E&7^8ZS>-/? IX=8TP_PWV5Z&T;1+2)JT]2_W>>KF
MSZO[1@H,\P< !L MX%;''\ P@+T'Y'.G3MG<UQ_U6&_6O;DFP[F>5IL^6;R?
MDMC,B6UFL/,TY^SGF=JLWS8%76=O4YX[!&:D=,@[D=GDW@J0^L)A#H?/"U2.
M$/)Q!79?P0V^,-<#/([/[^-S%Y^[>'8OL9L1Z9IPR(HR62A*/@>K!>0 0/+'
MBKBW(^X41<0+;T?"Q7.?4.$Z<D@NI*"?4Q52C%/U6(OT:I%.BPAH<4C.(5<R
M(,9A3!4YC=B-A5=-X=0$RI0.H<"IC%@ Y2VC7)DB4,8AG,N(?4N)=YO,P[9,
MQ-I0ZM5)W<.MO%L:A2)#.2$06!W$5F"G+>)1IN 7Y,Q !39EB<P*B&!,A20A
M2$$)$B&)^24Y?U&!YDMD5E0*&7CJ*N2@H#1FCOQ^19W)**]A+8+0B!27B@:V
M8;6 E!2B$!$;GOHMBSK/4C$9_*9%G=FHD&LALRJD%$&O6$"JI%0Q4^TW+^H\
M1X7<"YD5S>6'^?-(0BZ746OO]R_JW"G4>XG,JE"0!]U] 8%8LXM9..5?>F=E
MJGB< 8BW*W!&I@(/<XF,?99904+SO(",%%3P"$U^:P2T/1+R1H0D(2&L0HR1
M.^YS17YO!$!%H36]09&E_)X'#+.$'!^A%1=QI?QN!CF6"MD90L+.H!01I;B_
M%,=2@>U3+I"R^ZP(+BJ"@D/</O/;'@@4%?*]!;*_Q,*K[S@F0!81)@-^UP.)
MDD*VAQ#+"XBP#O#;&>"/+1+RLP62!8/0/U?D&(MLWN]FH%!2A)TQOYTQ=" 2
M\C.$@'-@$3\!F=^E&+I4Z%!2(L0C/8'Y[8>ALU#O!L3SSP)Q3ZGLPP&UU?UA
M/K@/R=9<NM&='F^CMY<#+_.[@=_&2_I4N2/^>YK-^EP?]%]U?SAU0_)J1GM\
MGD^Y>V-&;:61+SQ-CKK>W6X:O1^G2VFO>W?0=S>C.2_O+6XO3S;_ U!+ P04
M    "  A@ ])U<0?6*(!  "Q P  &    'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;(53VVZC,!#]%<L?4 .A[2HB2$VKJGU8J>K#[K,# UBU&6J;T/W[]05H
M4D7M"YX9SCESQI=B0OUF.@!+/I3LS8YVU@Y;QDS5@>+F"@?HW9\&M>+6I;IE
M9M# ZT!2DF5)<L,4%STMBU![T66!HY6BAQ=-S*@4U__V('':T90NA5?1=M87
M6%FPE5<+!;T1V!,-S8[>I=M][A$!\$? 9$YBXKT?$-]\\ESO:.(M@(3*>@7N
MEB/<@Y1>R#5^GS4_6WKB:;RH/X9IG?L#-W"/\J^H;>?,)I34T/!1VE><GF >
MX=H+5BA-^))J-!;50J%$\8^XBCZL4_QS<SO3+A.RF9"MA%]),!X;!9L/W/*R
MT#@1,W!_=NG6P;47<<K$>3-N[*"IP^!E<2S3-"O8T0N=82)Q/V-6!'/J%UMD
M]!(]"_3L9_KFG+Z)#C>SP\W/ OFY0!X%\N]&C)C]@LF_-&$G>ZI M^'J&%+A
MV-NXI6MUO9UW63B33WA9#+R%WURWHC?D@-:=;#B !M&":Y]<75/2N?>S)A(:
MZ\-;%^MXI6)B<5@>R/I*R_]02P,$%     @ (8 /24IB^*BC 0  L0,  !@
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MH7,A_.QCDZY42AR.ZP/97FG]#U!+ P04    "  A@ ])_TH,6:(!  "Q P
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M0R^*"%+3JNH^K%3U8??9@0&L^D)M$[I_O[X 3:JH?<$SPSEGSOA23MJ\V1[
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M"*'!> N?TP!5YOT:%@P.VDXS,Y?^2ON%%NWY@1I>R>(?4$L#!!0    ( "&
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MBS>Y9TQ%[WTWR&6\5^JP2!*YWK.>RB=^8(.^L^6BITI/Q2Z1!\'HQA;U78(
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M;[<M>,NY8MH(/*5QM-=G[F72L:TRPUR/A3N%W$3QPWBH7D[V^C]02P,$%
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M-JG;MDQA&Z^K<YVF>87/!G2C<85[ITD6!=;TH$4:A<I3;U'<!V2W@)7+F'E
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M]A@['$KCRH6M5?BA0L?(=K@>QCLJ_P102P,$%     @ (8 /25>U;B05)@
M;9D  !0   !X;"]S:&%R9613=')I;F=S+GAM;.U=67,;Q[5^3GY%EZY\358-
M(0+<'<=5$ G*C"F2(2 I>6Q@&L38@QEX%D),Y5?<A_R5^^Y?=L_2VVP@J<2I
MY(8/+E- 3\_ITV?YSM*-;_.\$)^7<9+__M6B*%;?O'F3SQ9J*?->NE()?#-/
MLZ4LX)_9W9M\E2D9Y@NEBF7\9K"[>_AF*:/DE2B3Z.=2G:9E4OS^U6!__]5W
MW^;1=]\6WYVELW*IDD+()!2CI(B*!W&1\)Q1FH@=D2]DIO)OWQ3???L&G^'G
M]L3[-"D6.3P3JK#^[1_*I"?V=@,QV.T?UK\<EG<]L7O2_N4C]'Q3'Z^'W*J[
M*"\R"0]>R:6JCWJ7I>MIG'X6XUFDDIG* YATUNM\^>1AU9BCO[OSQ\X';E06
MI4AP*,YDT7C6\..WO_E-*T=@CI#F.8_E7?W;N8SSQHQZW:?P4"9C6$VH/HL?
MU$-]W&F9931QE,]@W)^5S#JIW-G9W=O9ZW>]*ETN02#&13K[*1!CD@IQ719Y
M 5L5)0VR]6/G4:PR<0JONTNS!GGCI8SQ^UNU2K,"9L'7K&32&&B(T,MQX\>%
M+,J&>/ZY*;%ZAH]I#$H@,TU98]A5VO'@)Q7'.S\EZ1IXH&2>)BH4%WE>JJQ3
M*GRFG\.'C9?51VHQ:AW[Q\;&3#(9$@L>EM,TKG][-XT_-Z3A^FI\?7EQ-IR,
MS@3\XVQT-8:_W@XOAU>G(S'^?C2:C$'G/XS/Q-;K[?KC[V4&8MQOU]S3#[>W
MHZN)&([',$E#44]EOB"EGN$?ZN<RNI<Q++VQSN%LAF8J%YF:*1@TC1N">I.I
ME8Q"H3Z#"<R;6SVYG@PO196@YAQ@/S/85S(T0,X*-R(05ZIH[!((6QX!13B4
MWOVP;*/\NEB * _S7#6_8Y+:23&$7EX,WUY<7DPN1DWV6:[<R(<VEL#W68D2
MF10*%+.Q!O/]922G41P549-K5VFA[/R!2%0ATCEX#KE$5?L+/!R"E"(5^/GK
MW=Z>6$9QC%X"&0,?[+L/"@$V3UD?0"- ?&8+*S\!;'"^4K,BNE=Q0]^K6^AQ
MIHWJ+J;P)!L>1IL6%;291.$I^#30*' 1P!^Q17,?U=4 W?$W^4K.U.]?@;_-
M57:O7GTG&J9M<GWZP_?7EV>CV_'78NML='YQ>C'9?B-&?_QP,?ES4T$\^UHS
MML#:W=W=OEB!'0&M*6%W!@>[ 7R&_VD/+619+-(,-RH0!T?!R=%><-C?IW7M
M'P5[>P=!?__(#([0<H7T9>IL^,9]ZW#G9VJNP"B'CG)42O+6#2$,PP@_1TN'
M^GN1@&-8185L&"\0UW)9QN UP%6I>32+&A+-F_ON]OK3V\OK/XGQZ<4(;-@8
M//O5:4]T<9^9WQ2B9&<&>Y^E(+[ AJA#B_B=C\W6$#LQO#I[)D5/L]1;-Q+=
MX4(5$;B/[6[+C5Y2D:<!U3V/$@D2CKN =JUEHZKBAV*79B(O:#M( #<_T!#(
M)PUGD7S2T+0;=M2LF#%93>T$SKX'VS(6U^?B^F9T.YQ< ,^[6>ACVH/ZEX F
MTZ42ELT-JD83<3OZ.+KZ,&I@T]$5O/R29&1X]O[BZF(\06(^CL3H3S>X[0VS
M=7D]'HOSV^OW'N$-9S3Y?G2+NG#]?B2V]$R-11EW(4;L2MM=&J_NS98>U)AE
MDH(*BY3&JO:)D %(=N-S\#*1GCY.\WP;3%"11=.RP/T312J2)^JF>8,83B:W
M%V\_3(9O+T=B<MUE(MHH00H$P *6,Y"%J<RC&1G!,(K+HBF>GU1TMT"UD/<J
MDW=*S%A>FX+ZE-F<HE?TORJLI\/Q]^+\\OK3!F'5<G'U3@Q/093:,87CO6#>
M-^WUCV6NW2/L! "R%.P&;$MB>(7[ W\3IBMS8$.4",15DK"Y1.=.6*/Q;L!4
M,%W$029R1*.,5K]!RK\#W(,7S#;Y%V\.-'2AFA8.M.!;IBHA;P+B"FN!+<MQ
MZ%Q!#)$U9/825PA?PPP  )M.ZG0A 2ODM343_*.7Q0YK-=9?A[#LB4F#9"N
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MJB=_P$2?8K17278<]4C^IS(F$:,$/<;:U8P(+"7GE<#:X=TANPJ<V:A*JR[
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M H['2/L<-5&;DS3WV-0#KS*+80WDTIE3IP#A4<*RQC=.:I8R5$ZUERP/]\;
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M AWV0!I#=6^BITHVE.0R6+$H080D6KY4BY)BZ\X["SQ(RSN Z&)53L%( .,
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M8JZ)CI]WK6X@%UQ.7"_ 0:Z5>523;IZ/7'-[( @-:GCI8K$DU)^RT\.TMKX
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M+XZX=/6T+YA3?SFG8_#<Z?4%LV#_% UH00H1YNG.7'6F$2?^JQ\1'YF+++Z
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MV\Y*N#G?Y'GQW?\!4$L! A0#%     @ (8 /2?O&E 62 0  ,1$  !,
M         ( !     %M#;VYT96YT7U1Y<&5S72YX;6Q02P$"% ,4    "  A
M@ ])2'4%[L4    K @  "P              @ '# 0  7W)E;',O+G)E;'-0
M2P$"% ,4    "  A@ ])MJ$=<4X!  #%#P  &@              @ &Q @
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  A@ ])FR]:
M<7 "   0"   $               @ $W!   9&]C4')O<',O87!P+GAM;%!+
M 0(4 Q0    ( "& #TF:3_)U/P$  &D#   1              "  =4&  !D
M;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "& #TF97)PC$ 8  )PG   3
M              "  4,(  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ (8 /2=7GSQ)" @  X@D   T              ( !A X  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  A@ ])X5!?9!$#  ! "0  #P
M@ 'Q$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ (8 /2=99<EYV @
M)@D  !@              ( !+Q0  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( "& #TGM^2S?W ,  $81   8              "  =L6
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  A@ ])9UAG
MP_@!  #X!0  &               @ 'M&@  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ (8 /296.5YK. @  +0H  !@
M ( !&QT  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( "&
M#TE @?+VW ,  $@1   8              "  1\@  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    "  A@ ])U<0?6*(!  "Q P  &
M        @ $Q)   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ (8 /24IB^*BC 0  L0,  !@              ( !"28  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( "& #TD&IWXMHP$  +$#   8
M              "  >(G  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    "  A@ ])4C5]R:,!  "Q P  &               @ &[*0  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ (8 /2?<"[BZB 0
ML0,  !D              ( !E"L  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    "  A@ ])_TH,6:(!  "Q P  &0              @ %M
M+0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( "& #TGD
MN)"HI $  +$#   9              "  48O  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ (8 /2=M)%ZBC 0  L0,  !D
M     ( !(3$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "& #TGT^MNA*@,  .8.   9              "
M 00[  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ (8 /
M2::#F1BU @  L0H  !D              ( !93X  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    "  A@ ])%9ZBW4L"  #E!P  &0
M        @ %100  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( "& #TD![+M$# ,  %,-   9              "  =-#  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ (8 /2=0#U@#U 0  V04
M !D              ( !%D<  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    "  A@ ])%7"5?\L!  !7!   &0              @ %"20
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( "& #TDNZCA"
MQP$  *\$   9              "  41+  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ (8 /25>U;B05)@  ;9D  !0
M ( !0DT  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L%!@     A "$ V0@  (ES
$      $!
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */
var Show = {};
Show.LastAR = null,
Show.hideAR = function(){
Show.LastAR.style.display = 'none';
};
Show.showAR = function ( link, id, win ){
if( Show.LastAR ){
Show.hideAR();
}
var ref = link;
do {
ref = ref.nextSibling;
} while (ref && ref.nodeName != 'TABLE');
if (!ref || ref.nodeName != 'TABLE') {
var tmp = win ?
win.document.getElementById(id) :
document.getElementById(id);
if( tmp ){
ref = tmp.cloneNode(true);
ref.id = '';
link.parentNode.appendChild(ref);
}
}
if( ref ){
ref.style.display = 'block';
Show.LastAR = ref;
}
};
Show.toggleNext = function( link ){
var ref = link;
do{
ref = ref.nextSibling;
}while( ref.nodeName != 'DIV' );
if( ref.style &&
ref.style.display &&
ref.style.display == 'none' ){
ref.style.display = 'block';
if( link.textContent ){
link.textContent = link.textContent.replace( '+', '-' );
}else{
link.innerText = link.innerText.replace( '+', '-' );
}
}else{
ref.style.display = 'none';
if( link.textContent ){
link.textContent = link.textContent.replace( '-', '+' );
}else{
link.innerText = link.innerText.replace( '-', '+' );
}
}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
background-color: #def;
border: 2px solid #2F4497;
font-size: 1em;
position: absolute;
}
..report table.authRefData a {
display: block;
font-weight: bold;
}
..report table.authRefData p {
margin-top: 0px;
}
..report table.authRefData .hide {
background-color: #2F4497;
padding: 1px 3px 0px 0px;
text-align: right;
}
..report table.authRefData .hide a:hover {
background-color: #2F4497;
}
..report table.authRefData .body {
height: 150px;
overflow: auto;
width: 400px;
}
..report table.authRefData table{
font-size: 1em;
}
/* Report Styles */
..pl a, .pl a:visited {
color: black;
text-decoration: none;
/* table */
..report {
background-color: white;
border: 2px solid #acf;
clear: both;
color: black;
font: normal 8pt Helvetica, Arial, san-serif;
margin-bottom: 2em;
..report hr {
border: 1px solid #acf;
}
/* Top labels */
..report th {
background-color: #acf;
color: black;
font-weight: bold;
text-align: center;
}
}
}
}
..report th.void {
background-color: transparent;
color: #000000;
font: bold 10pt Helvetica, Arial, san-serif;
text-align: left;
}
..report .pl {
text-align: left;
vertical-align: top;
white-space: normal;
width: 200px;
white-space: normal; /* word-wrap: break-word; */
}
..report td.pl a.a {
cursor: pointer;
display: block;
width: 200px;
overflow: hidden;
..report td.pl div.a {
width: 200px;
}
..report td.pl a:hover {
background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
background-color: #acf;
color: black;
font-weight: bold;
}
/* Calendars... */
..report .rc {
background-color: #f0f0f0;
}
/* Even rows... */
..report .re, .report .reu {
background-color: #def;
}
..report .reu td {
border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro, .report .rou {
background-color: white;
}
..report .rou td {
border-bottom: 1px solid black;
}
..report .rou table td, .report .reu table td {
border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
white-space: nowrap;
}
/* styles for numeric types */
..report .num, .report .nump {
text-align: right;
white-space: nowrap;
}
..report .nump {
padding-left: 2em;
}
..report .nump {
padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
text-align: left;
white-space: normal;
}
..report .text .big {
margin-bottom: 1em;
width: 17em;
}
..report .text .more {
display: none;
}
..report .text .note {
font-style: italic;
font-weight: bold;
}
..report .text .small {
width: 10em;
}
..report sup {
font-style: italic;
}
..report .outerFootnotes {
font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>43</ContextCount>
  <ElementCount>129</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>14</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DocumentDocumentAndEntit
yInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - CONSOLIDATED CONDENSED BALANCE 
SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSEDBAL
ANCESHEETS</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS</ShortName>
<MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS 
(Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_CONSOLIDATEDCONDENSEDBAL
ANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS 
(Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_STATEMENTSOFOPERATIONS</
Role>
      <ShortName>STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH 
FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_CONDENSEDCONSOLIDATEDSTA
TEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000060 - Disclosure - Note 1 - Basis of Presentation and 
Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisOfPr
esentationAndSignificantAccountingPolicies</Role>
      <ShortName>Note 1 - Basis of Presentation and Significant Accounting 
Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
<LongName>000070 - Disclosure - Note 2 - Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingConc
ern</Role>
      <ShortName>Note 2 - Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000080 - Disclosure - Note 3 - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Convertib
leNotes</Role>
      <ShortName>Note 3 - Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000090 - Disclosure - Note 4 - Note Payable</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePayab
le</Role>
      <ShortName>Note 4 - Note Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000100 - Disclosure - Note 5 - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5PropertyA
ndEquipment</Role>
      <ShortName>Note 5 - Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000110 - Disclosure - Note 6 - Capital Transactions</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6CapitalTr
ansactions</Role>
      <ShortName>Note 6 - Capital Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000120 - Disclosure - Note 7 - Commitments and 
Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commitmen
tsAndContingencies</Role>
      <ShortName>Note 7 - Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000130 - Disclosure - Note 8 - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPerSh
are</Role>
      <ShortName>Note 8 - Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000140 - Disclosure - Note 9 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subsequen
tEvents</Role>
      <ShortName>Note 9 - Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000150 - Disclosure - Note 1 - Basis of Presentation and 
Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1BasisOfPr
esentationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Note 1 - Basis of Presentation and Significant Accounting 
Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote1Bas
isOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000160 - Disclosure - Note 5 - Property and Equipment 
(Tables)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5PropertyA
ndEquipmentTables</Role>
      <ShortName>Note 5 - Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5Pro
pertyAndEquipment</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000170 - Disclosure - Note 2 - Going Concern 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2GoingConc
ernDetails</Role>
      <ShortName>Note 2 - Going Concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote2Goi
ngConcern</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000180 - Disclosure - Note 3 - Convertible Notes 
(Details)</LongName>
      <ReportType>Notes</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Convertib
leNotesDetails</Role>
      <ShortName>Note 3 - Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote3Con
vertibleNotes</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000190 - Disclosure - Note 4 - Note Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4NotePayab
leDetails</Role>
      <ShortName>Note 4 - Note Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote4Not
ePayable</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000200 - Disclosure - Note 5 - Property and Equipment: Schedule 
of Property and Equipment Balances (Details)</LongName>
<ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote5PropertyA
ndEquipmentScheduleOfPropertyAndEquipmentBalancesDetails</Role>
      <ShortName>Note 5 - Property and Equipment: Schedule of Property and 
Equipment Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000210 - Disclosure - Note 6 - Capital Transactions 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6CapitalTr
ansactionsDetails</Role>
      <ShortName>Note 6 - Capital Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote6Cap
italTransactions</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000220 - Disclosure - Note 7 - Commitments and Contingencies 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Commitmen
tsAndContingenciesDetails</Role>
      <ShortName>Note 7 - Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote7Com
mitmentsAndContingencies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000230 - Disclosure - Note 8 - Loss Per Share 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8LossPerSh
areDetails</Role>
      <ShortName>Note 8 - Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote8Los
sPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="gblx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
<LongName>000240 - Disclosure - Note 9 - Subsequent Events 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Subsequen
tEventsDetails</Role>
      <ShortName>Note 9 - Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://www.growbloxsciences.com/20160630/role/idr_DisclosureNote9Sub
sequentEvents</ParentRole>
      <Position>24</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gblx-20160630.xml</File>
    <File>gblx-20160630.xsd</File>
    <File>gblx-20160630_cal.xml</File>
    <File>gblx-20160630_def.xml</File>
    <File>gblx-20160630_lab.xml</File>
    <File>gblx-20160630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>44
<FILENAME>0001445866-16-002507-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001445866-16-002507-xbrl.zip
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M93L\:== 2_,,T!>R--,A.P4.\X@I*5O,7Y!(5;+Z%+0G>6N-HZX?G;EAV<1
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MQI<[CE].(R_, [+IF6VV;/8BEN,HR"VRMIW(T)6<0M=/E"GH6C^YG3&.$JH
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MZ=?85:7!D7K;VG)W GBCC7U+70$QN?,L:\OZ3G"?VX?>6F)V_5:CV=U@8U<
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M3B O9S\;P[29#D#E<]Q-_0S;KR1SB70VTP#*\"Q?Q4=D-P#".2I8B_QP/9!
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MK9)PLH[6QB=QY[B.\>'#F6P \Y]6J_LCYB*HOWH_OI1='3"N7PU'UHFCD!(
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M^[,56)O>B0.)S2?>)@G#'4H\_/PCF_W*JKIU_TZRX/.\(T9JJM_!Z\Q7..3
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M"=>ZDSFJE8&=DSDYAG<#*1S[4L\KQ+ OW"5\X)-!R.:3^*CSVF>L#)_%K"A
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M=J-$(.S;CT-K:VUPM B2S7W,S+F\;:"T'W@WJ"H9S*861:C I8<R/BAEE+D
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M(TK9D-F7#;P<-"+0>(N6?4SPB._(>YS&"].MXX9=3$7[-/'T-QQ1:]ET32\
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M(^P#W@N@\;;@7 ,49PV$CK(3CY0&FBJYJ#3%;MNE@/:% R4!WKS6>HK[<*6
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MS2=9Z%Y!,XJ%[E6GM4T/"++II5N#Z9H*?.L%'V20%7:!>T'(Y8&MJ1E]%BA
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M*M<)MNGI!R'B.,:R]B83)-S2:(BH*Y"=JGQYY=J S%E%5*#E167%3SNS([$
M&4R2=<M+$3-7H5%#]M%KA@^TM*E+D9SW_.+*@-[BZ7W8>^*]$C,TI-A-/<>R
M_)8I+\*MU)8-3%=$29] !6A 7Z @#@$[_LN5OU?("2-J9JP-F[*!ZFH80;M1
M/*O%E\"9$:[%OY&W6D88T2JK9Q^'4NWEA+UO^.;QEU#Q\M:PRX@*2)1.)6TE
M&Z@JTEO.TSF$V^IJS6"0-0SF[KHV;Z'-6]A-W@)#[NLI>3CV$!:(OQ7_$$"_
M30'-/_IVC::.WPM"OKR61*AD)8 8PS4'HU2;9L%-))&&F-:^;@9631=889I5
M8MOY!$/'%8=FKI$S^<IEYC:47<^5P6U=:9" %JH(+134QK/;>#:LV%T;SX;%
MAP7Q[#:>"BFHT<93\Q:JY.N)?)\_)@PU^7:BTKGWXM*+O;DJ#[=Y??LXUZ(!
MS32J(VNQZMX&P<:U!NRC4H\';#/[67C4Q<YM/79O4,$^KK+Z @\!+U_6+3$-
MYJK8QT]>9V@!7*41%]GG;##9.*"G;,="+DW0@1VT'3J+Y"P^5>X&-!7LHRRK
M;WUA5KD;[Y8L'#]<=*84)?<DS.+(B@SMPN*0L2[6%5I\5/2*E\&Z',CB\/.J
MH\3WX3+]2\TE&X',8%5<]/%4@+PF\VYE1E?5]X++9RP4>_*3-LD9<I+S:1U.
M$QC7;HW<>^1%/A)7VJY_>^'XXI7R>N]XJ$$.>)=XE9._S;]H\R^@WANAO#;L
M8G''?UL3=S6I"61&4(8SC+2WAC(ALC8B:U*SX8LQS;NCV>5W*4B@\2B"G5&(
MZ+.P19%;:6DK^5*J#BU@\=GAR@>(9N9W+4^Z&E9RI84 6E#B&CD,B1?WQ!M:
MS__IS^:4/"27YFK),ZYN)9/FX$"+9XB[^?EF.GZFLQ]P]:<<=#V5VBI6TJ<'
M 5J H\V":7;F4G:R3Y2PTFOZI!(07HH</%J]H:T",_>Y<E1='&/*_^VC&-S
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M;)\5^4ZZ/8"B-!!#JYY.55I:0(=V[:\NWS E^FY5P W4U7].5.T.0%[65E;
M[P%:1T:;,@9BX]PZ,F#QT3HR8)BK0D=&DR]W,H:0>)62[ZP[E#K!-'F3<C!'
MU!%1TOC%2B;BV/'U?;K]5,7&@/"H=554Q6G;:16W9.'XX>(YWZ SBW?WJM0*
M;7'(/!3K"L^RM7'[:G'[-R7>^WN3>*1"1!EZ>>U/Z?-;?B'^&//A^MN/_P]0
M2P$"% ,4    "  A@ ])3I$Q#C]"   'Q@$ $0              @ $
M9V)L>"TR,#$V,#8S,"YX;6Q02P$"% ,4    "  A@ ])]T?1#8@'  !$/0
M$0              @ %N0@  9V)L>"TR,#$V,#8S,"YX<V102P$"% ,4
M"  A@ ])6'%&5.P'  !_80  %0              @ $E2@  9V)L>"TR,#$V
M,#8S,%]C86PN>&UL4$L! A0#%     @ (8 /26C*:<KF#0  -_(  !4
M         ( !1%(  &=B;'@M,C Q-C V,S!?9&5F+GAM;%!+ 0(4 Q0    (
M "& #TF677U7'B8  ,36 0 5              "  5U@  !G8FQX+3(P,38P
M-C,P7VQA8BYX;6Q02P$"% ,4    "  A@ ])7$P%"=D7  #^JP$ %0
M        @ &NA@  9V)L>"TR,#$V,#8S,%]P<F4N>&UL4$L%!@     &  8
*B@$  +J>      $!
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>